
<html lang="en"     class="pb-page"  data-request-id="f23b3562-2280-47ce-a45b-1c29d34e6430"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;issue:issue:10.1021/jmcmar.2021.64.issue-4;pageGroup:string:Publication Pages;article:article:10.1021/acs.jmedchem.1c00034;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts" /></meta><meta name="dc.Creator" content="Claire  Le Manach" /></meta><meta name="dc.Creator" content="Jean  Dam" /></meta><meta name="dc.Creator" content="John G.  Woodland" /></meta><meta name="dc.Creator" content="Gurminder  Kaur" /></meta><meta name="dc.Creator" content="Lutete P.  Khonde" /></meta><meta name="dc.Creator" content="Christel  Brunschwig" /></meta><meta name="dc.Creator" content="Mathew  Njoroge" /></meta><meta name="dc.Creator" content="Kathryn J.  Wicht" /></meta><meta name="dc.Creator" content="André  Horatscheck" /></meta><meta name="dc.Creator" content="Tanya  Paquet" /></meta><meta name="dc.Creator" content="Grant A.  Boyle" /></meta><meta name="dc.Creator" content="Liezl  Gibhard" /></meta><meta name="dc.Creator" content="Dale  Taylor" /></meta><meta name="dc.Creator" content="Nina  Lawrence" /></meta><meta name="dc.Creator" content="Tomas  Yeo" /></meta><meta name="dc.Creator" content="Sachel  Mok" /></meta><meta name="dc.Creator" content="Richard T.  Eastman" /></meta><meta name="dc.Creator" content="Dorjbal  Dorjsuren" /></meta><meta name="dc.Creator" content="Daniel C.  Talley" /></meta><meta name="dc.Creator" content="Hui  Guo" /></meta><meta name="dc.Creator" content="Anton  Simeonov" /></meta><meta name="dc.Creator" content="Janette  Reader" /></meta><meta name="dc.Creator" content="Mariëtte  van der Watt" /></meta><meta name="dc.Creator" content="Erica  Erlank" /></meta><meta name="dc.Creator" content="Nelius  Venter" /></meta><meta name="dc.Creator" content="Jacek W.  Zawada" /></meta><meta name="dc.Creator" content="Ayesha  Aswat" /></meta><meta name="dc.Creator" content="Luisa  Nardini" /></meta><meta name="dc.Creator" content="Theresa L.  Coetzer" /></meta><meta name="dc.Creator" content="Sonja B.  Lauterbach" /></meta><meta name="dc.Creator" content="Belinda C.  Bezuidenhout" /></meta><meta name="dc.Creator" content="Anjo  Theron" /></meta><meta name="dc.Creator" content="Dalu  Mancama" /></meta><meta name="dc.Creator" content="Lizette L.  Koekemoer" /></meta><meta name="dc.Creator" content="Lyn-Marie  Birkholtz" /></meta><meta name="dc.Creator" content="Sergio  Wittlin" /></meta><meta name="dc.Creator" content="Michael  Delves" /></meta><meta name="dc.Creator" content="Sabine  Ottilie" /></meta><meta name="dc.Creator" content="Elizabeth A.  Winzeler" /></meta><meta name="dc.Creator" content="Thomas W.  von Geldern" /></meta><meta name="dc.Creator" content="Dennis  Smith" /></meta><meta name="dc.Creator" content="David A.  Fidock" /></meta><meta name="dc.Creator" content="Leslie J.  Street" /></meta><meta name="dc.Creator" content="Gregory S.  Basarab" /></meta><meta name="dc.Creator" content="James  Duffy" /></meta><meta name="dc.Creator" content="Kelly  Chibale" /></meta><meta name="dc.Description" content="A novel diazaspiro[3.4]octane series was identified from a Plasmodium falciparum whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifec..." /></meta><meta name="Description" content="A novel diazaspiro[3.4]octane series was identified from a Plasmodium falciparum whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifec..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 12, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.1c00034" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00034" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.1c00034" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.1c00034" /></link>
        
    
    

<title>Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.1c00034" /></meta><meta property="og:title" content="Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0012.jpeg" /></meta><meta property="og:description" content="A novel diazaspiro[3.4]octane series was identified from a Plasmodium falciparum whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifecycle, which together with a novel sp3-rich scaffold provided an attractive starting point for a hit-to-lead medicinal chemistry optimization and biological profiling program. Structure–activity-relationship studies led to the identification of compounds that showed low nanomolar asexual blood-stage activity (&lt;50 nM) together with strong gametocyte sterilizing properties that translated to transmission-blocking activity in the standard membrane feeding assay. Mechanistic studies through resistance selection with one of the analogues followed by whole-genome sequencing implicated the P. falciparum cyclic amine resistance locus in the mode of resistance." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.1c00034"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00034">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.1c00034&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.1c00034&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.1c00034&amp;href=/doi/10.1021/acs.jmedchem.1c00034" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 4</span><span class="cit-fg-pageRange">, 2291-2309</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/4" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02145" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.1c00198" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite <i>Plasmodium falciparum</i> and Optimization Efforts</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Claire Le Manach</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claire Le Manach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claire++Le+Manach">Claire Le Manach</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jean Dam</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jean Dam</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jean++Dam">Jean Dam</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">John G. Woodland</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">John G. Woodland</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=John+G.++Woodland">John G. Woodland</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gurminder Kaur</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gurminder Kaur</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gurminder++Kaur">Gurminder Kaur</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lutete P. Khonde</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lutete P. Khonde</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lutete+P.++Khonde">Lutete P. Khonde</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Christel Brunschwig</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Christel Brunschwig</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Christel++Brunschwig">Christel Brunschwig</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mathew Njoroge</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mathew Njoroge</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mathew++Njoroge">Mathew Njoroge</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1276-2224" title="Orcid link">http://orcid.org/0000-0003-1276-2224</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kathryn J. Wicht</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kathryn J. Wicht</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kathryn+J.++Wicht">Kathryn J. Wicht</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">André Horatscheck</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">André Horatscheck</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Andr%C3%A9++Horatscheck">André Horatscheck</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tanya Paquet</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tanya Paquet</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tanya++Paquet">Tanya Paquet</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Grant A. Boyle</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Grant A. Boyle</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Grant+A.++Boyle">Grant A. Boyle</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Liezl Gibhard</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Liezl Gibhard</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Liezl++Gibhard">Liezl Gibhard</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dale Taylor</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dale Taylor</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dale++Taylor">Dale Taylor</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nina Lawrence</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nina Lawrence</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory 7925, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nina++Lawrence">Nina Lawrence</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tomas Yeo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tomas Yeo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tomas++Yeo">Tomas Yeo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sachel Mok</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sachel Mok</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sachel++Mok">Sachel Mok</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9605-0154" title="Orcid link">http://orcid.org/0000-0002-9605-0154</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Richard T. Eastman</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Richard T. Eastman</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Richard+T.++Eastman">Richard T. Eastman</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3580-380X" title="Orcid link">http://orcid.org/0000-0003-3580-380X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dorjbal Dorjsuren</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dorjbal Dorjsuren</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dorjbal++Dorjsuren">Dorjbal Dorjsuren</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel C. Talley</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel C. Talley</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel+C.++Talley">Daniel C. Talley</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Hui Guo</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Hui Guo</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Hui++Guo">Hui Guo</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anton Simeonov</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anton Simeonov</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anton++Simeonov">Anton Simeonov</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Janette Reader</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Janette Reader</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, Pretoria 0028, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Janette++Reader">Janette Reader</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Mariëtte van der Watt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Mariëtte van der Watt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, Pretoria 0028, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Mari%C3%ABtte++van+der+Watt">Mariëtte van der Watt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Erica Erlank</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Erica Erlank</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div><div class="loa-info-affiliations-info">Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2192, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Erica++Erlank">Erica Erlank</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Nelius Venter</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Nelius Venter</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div><div class="loa-info-affiliations-info">Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2192, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Nelius++Venter">Nelius Venter</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jacek W. Zawada</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jacek W. Zawada</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div><div class="loa-info-affiliations-info">Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2192, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jacek+W.++Zawada">Jacek W. Zawada</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ayesha Aswat</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ayesha Aswat</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div><div class="loa-info-affiliations-info">Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2192, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ayesha++Aswat">Ayesha Aswat</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Luisa Nardini</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Luisa Nardini</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div><div class="loa-info-affiliations-info">Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2192, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Luisa++Nardini">Luisa Nardini</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Theresa L. Coetzer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Theresa L. Coetzer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Theresa+L.++Coetzer">Theresa L. Coetzer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sonja B. Lauterbach</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sonja B. Lauterbach</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sonja+B.++Lauterbach">Sonja B. Lauterbach</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Belinda C. Bezuidenhout</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Belinda C. Bezuidenhout</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Department of Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Belinda+C.++Bezuidenhout">Belinda C. Bezuidenhout</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Anjo Theron</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Anjo Theron</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biosciences, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Anjo++Theron">Anjo Theron</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dalu Mancama</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dalu Mancama</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Biosciences, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dalu++Mancama">Dalu Mancama</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lizette L. Koekemoer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lizette L. Koekemoer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Wits Research Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</div><div class="loa-info-affiliations-info">Centre for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg 2192, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lizette+L.++Koekemoer">Lizette L. Koekemoer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lyn-Marie Birkholtz</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lyn-Marie Birkholtz</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Biochemistry, Genetics and Microbiology, Institute for Sustainable Malaria Control, University of Pretoria, Hatfield, Pretoria 0028, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lyn-Marie++Birkholtz">Lyn-Marie Birkholtz</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sergio Wittlin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sergio Wittlin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Swiss Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland</div><div class="loa-info-affiliations-info">University of Basel, 4003 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sergio++Wittlin">Sergio Wittlin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Delves</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Delves</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Imperial College London, South Kensington, London SW7 2AZ, U.K.</div><div class="loa-info-affiliations-info">London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Delves">Michael Delves</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sabine Ottilie</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sabine Ottilie</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Host−Microbe Systems & Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093-076, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sabine++Ottilie">Sabine Ottilie</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9797-2612" title="Orcid link">http://orcid.org/0000-0001-9797-2612</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Elizabeth A. Winzeler</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Elizabeth A. Winzeler</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Host−Microbe Systems & Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093-076, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Elizabeth+A.++Winzeler">Elizabeth A. Winzeler</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas W. von Geldern</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas W. von Geldern</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Embedded Consulting, P.O. Box 726, Richmond, Illinois 60071, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas+W.++von+Geldern">Thomas W. von Geldern</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dennis Smith</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dennis Smith</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">4 The Maltings, Walmer CT14 7AR, U.K.</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dennis++Smith">Dennis Smith</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">David A. Fidock</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">David A. Fidock</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, New York 10032, United States</div><div class="loa-info-affiliations-info">Division of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=David+A.++Fidock">David A. Fidock</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Leslie J. Street</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Leslie J. Street</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Leslie+J.++Street">Leslie J. Street</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gregory S. Basarab</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gregory S. Basarab</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gregory+S.++Basarab">Gregory S. Basarab</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5684-6046" title="Orcid link">http://orcid.org/0000-0001-5684-6046</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">James Duffy</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">James Duffy</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Medicines for Malaria Venture, ICC, Route de Pré-Bois 20, P.O. Box 1826, 1215 Geneva, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=James++Duffy">James Duffy</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Kelly Chibale</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kelly Chibale</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Drug Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</div><div class="loa-info-affiliations-info">South African Medical Research Council, Drug Discovery and Development Research Unit, Department of Chemistry and Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Rondebosch 7701, South Africa</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#0a416f66667324496263686b666f4a7f697e246b6924706b"><span class="__cf_email__" data-cfemail="f0bb959c9c89deb3989992919c95b0859384de9193de8a91">[email protected]</span></a>. Phone: +27-21-6502553. Fax: +27-21-6505195.</span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kelly++Chibale">Kelly Chibale</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1327-4727" title="Orcid link">http://orcid.org/0000-0002-1327-4727</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00034&amp;href=/doi/10.1021%2Facs.jmedchem.1c00034" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 4</span><span class="cit-pageRange">, 2291–2309</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 12, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>8 January 2021</li><li><span class="item_label"><b>Published</b> online</span>12 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 25 February 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.1c00034" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00034</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2291%26pageCount%3D19%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DClaire%2BLe%2BManach%252C%2BJean%2BDam%252C%2BJohn%2BG.%2BWoodland%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D4%26contentID%3Dacs.jmedchem.1c00034%26title%3DIdentification%2Band%2BProfiling%2Bof%2Ba%2BNovel%2BDiazaspiro%255B3.4%255Doctane%2BChemical%2BSeries%2BActive%2Bagainst%2BMultiple%2BStages%2Bof%2Bthe%2BHuman%2BMalaria%2BParasite%2BPlasmodium%2Bfalciparum%2Band%2BOptimization%2BEfforts%26numPages%3D19%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2309%26publicationDate%3DFebruary%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.1c00034"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1063</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">1</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.1c00034" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification and Profiling of a Novel Diazaspiro[3.4]octane Chemical Series Active against Multiple Stages of the Human Malaria Parasite Plasmodium falciparum and Optimization Efforts&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Claire&quot;,&quot;last_name&quot;:&quot;Le Manach&quot;},{&quot;first_name&quot;:&quot;Jean&quot;,&quot;last_name&quot;:&quot;Dam&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;G. Woodland&quot;},{&quot;first_name&quot;:&quot;Gurminder&quot;,&quot;last_name&quot;:&quot;Kaur&quot;},{&quot;first_name&quot;:&quot;Lutete&quot;,&quot;last_name&quot;:&quot;P. Khonde&quot;},{&quot;first_name&quot;:&quot;Christel&quot;,&quot;last_name&quot;:&quot;Brunschwig&quot;},{&quot;first_name&quot;:&quot;Mathew&quot;,&quot;last_name&quot;:&quot;Njoroge&quot;},{&quot;first_name&quot;:&quot;Kathryn&quot;,&quot;last_name&quot;:&quot;J. Wicht&quot;},{&quot;first_name&quot;:&quot;André&quot;,&quot;last_name&quot;:&quot;Horatscheck&quot;},{&quot;first_name&quot;:&quot;Tanya&quot;,&quot;last_name&quot;:&quot;Paquet&quot;},{&quot;first_name&quot;:&quot;Grant&quot;,&quot;last_name&quot;:&quot;A. Boyle&quot;},{&quot;first_name&quot;:&quot;Liezl&quot;,&quot;last_name&quot;:&quot;Gibhard&quot;},{&quot;first_name&quot;:&quot;Dale&quot;,&quot;last_name&quot;:&quot;Taylor&quot;},{&quot;first_name&quot;:&quot;Nina&quot;,&quot;last_name&quot;:&quot;Lawrence&quot;},{&quot;first_name&quot;:&quot;Tomas&quot;,&quot;last_name&quot;:&quot;Yeo&quot;},{&quot;first_name&quot;:&quot;Sachel&quot;,&quot;last_name&quot;:&quot;Mok&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;T. Eastman&quot;},{&quot;first_name&quot;:&quot;Dorjbal&quot;,&quot;last_name&quot;:&quot;Dorjsuren&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;C. Talley&quot;},{&quot;first_name&quot;:&quot;Hui&quot;,&quot;last_name&quot;:&quot;Guo&quot;},{&quot;first_name&quot;:&quot;Anton&quot;,&quot;last_name&quot;:&quot;Simeonov&quot;},{&quot;first_name&quot;:&quot;Janette&quot;,&quot;last_name&quot;:&quot;Reader&quot;},{&quot;first_name&quot;:&quot;Mariëtte&quot;,&quot;last_name&quot;:&quot;van der Watt&quot;},{&quot;first_name&quot;:&quot;Erica&quot;,&quot;last_name&quot;:&quot;Erlank&quot;},{&quot;first_name&quot;:&quot;Nelius&quot;,&quot;last_name&quot;:&quot;Venter&quot;},{&quot;first_name&quot;:&quot;Jacek&quot;,&quot;last_name&quot;:&quot;W. Zawada&quot;},{&quot;first_name&quot;:&quot;Ayesha&quot;,&quot;last_name&quot;:&quot;Aswat&quot;},{&quot;first_name&quot;:&quot;Luisa&quot;,&quot;last_name&quot;:&quot;Nardini&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;L. Coetzer&quot;},{&quot;first_name&quot;:&quot;Sonja&quot;,&quot;last_name&quot;:&quot;B. Lauterbach&quot;},{&quot;first_name&quot;:&quot;Belinda&quot;,&quot;last_name&quot;:&quot;C. Bezuidenhout&quot;},{&quot;first_name&quot;:&quot;Anjo&quot;,&quot;last_name&quot;:&quot;Theron&quot;},{&quot;first_name&quot;:&quot;Dalu&quot;,&quot;last_name&quot;:&quot;Mancama&quot;},{&quot;first_name&quot;:&quot;Lizette&quot;,&quot;last_name&quot;:&quot;L. Koekemoer&quot;},{&quot;first_name&quot;:&quot;Lyn-Marie&quot;,&quot;last_name&quot;:&quot;Birkholtz&quot;},{&quot;first_name&quot;:&quot;Sergio&quot;,&quot;last_name&quot;:&quot;Wittlin&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Delves&quot;},{&quot;first_name&quot;:&quot;Sabine&quot;,&quot;last_name&quot;:&quot;Ottilie&quot;},{&quot;first_name&quot;:&quot;Elizabeth&quot;,&quot;last_name&quot;:&quot;A. Winzeler&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;W. von Geldern&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;Smith&quot;},{&quot;first_name&quot;:&quot;David&quot;,&quot;last_name&quot;:&quot;A. Fidock&quot;},{&quot;first_name&quot;:&quot;Leslie&quot;,&quot;last_name&quot;:&quot;J. Street&quot;},{&quot;first_name&quot;:&quot;Gregory&quot;,&quot;last_name&quot;:&quot;S. Basarab&quot;},{&quot;first_name&quot;:&quot;James&quot;,&quot;last_name&quot;:&quot;Duffy&quot;},{&quot;first_name&quot;:&quot;Kelly&quot;,&quot;last_name&quot;:&quot;Chibale&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;4&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2291-2309&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.1c00034&quot;},&quot;abstract&quot;:&quot;A novel diazaspiro[3.4]octane series was identified from a Plasmodium falciparum whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifecycle, which together with a novel sp3-rich scaffold provided an attractive starting point for a hit-to-lead medicinal chemistry optimization and biological profiling program. Structure–activity-relationship studies led to the identification of compounds that showed low nanomolar asexual blood-stage activity (&lt;50 nM) together with strong gametocyte sterilizing properties that translated to transmission-blocking activity in the standard membrane feeding assay. Mechanistic studies through resistance selection with one of the analogues followed by whole-genome sequencing implicated the P. falciparum cyclic amine resistance locus in the mode of resistance.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00034&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00034" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00034&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00034" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.1c00034&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00034" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.1c00034&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.1c00034&amp;href=/doi/10.1021/acs.jmedchem.1c00034" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.1c00034" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.1c00034" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (3 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00034&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.1c00034%26sid%3Dliteratum%253Aachs%26pmid%3D33573376%26genre%3Darticle%26aulast%3DLe%2BManach%26date%3D2021%26atitle%3DIdentification%2Band%2BProfiling%2Bof%2Ba%2BNovel%2BDiazaspiro%255B3.4%255Doctane%2BChemical%2BSeries%2BActive%2Bagainst%2BMultiple%2BStages%2Bof%2Bthe%2BHuman%2BMalaria%2BParasite%2BPlasmodium%2Bfalciparum%2Band%2BOptimization%2BEfforts%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D4%26spage%3D2291%26epage%3D2309%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (4)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292143" title="Metabolism">Metabolism</a>,</li><li><a href="/action/doSearch?ConceptID=291528" title="Parasites">Parasites</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292529" title="Aromatic compounds">Aromatic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=291675" title="Stability">Stability</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/4" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/jmcmar.2021.64.issue-4/20210225/jmcmar.2021.64.issue-4.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">A novel diazaspiro[3.4]octane series was identified from a <i>Plasmodium falciparum</i> whole-cell high-throughput screening campaign. Hits displayed activity against multiple stages of the parasite lifecycle, which together with a novel sp<sup>3</sup>-rich scaffold provided an attractive starting point for a hit-to-lead medicinal chemistry optimization and biological profiling program. Structure–activity-relationship studies led to the identification of compounds that showed low nanomolar asexual blood-stage activity (<50 nM) together with strong gametocyte sterilizing properties that translated to transmission-blocking activity in the standard membrane feeding assay. Mechanistic studies through resistance selection with one of the analogues followed by whole-genome sequencing implicated the <i>P. falciparum</i> cyclic amine resistance locus in the mode of resistance.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_73467" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_73467" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In 2015, when the World Health Organization (WHO) defined the malaria control and elimination goals for 2030 based on trends from the previous decade, a significant decrease in malaria incidence and mortality rates was anticipated along with the elimination of the disease in several countries.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> However, the previously observed decreases in malaria incidence have worryingly started to stall since 2016, partly due to the emergence of resistance mechanisms at both the parasite and mosquito levels.<a onclick="showRef(event, 'ref2 ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4">(2−4)</a> In this context, it is critical to rapidly identify and develop new molecules that are structurally and mechanistically distinct from the current frontline therapies to treat malaria and avoid the spread of resistant parasites. To that end, these new-generation antimalarials ideally need to meet more than one target compound profiles (TCPs) as defined by Medicines for Malaria Venture (MMV)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> to kill the malaria parasite at different stages of its lifecycle and thus potentially relieve symptoms, protect, avoid relapse, and/or block transmission. To date, pan-activity, whereby the same compound targets all development stages of the malaria parasite, has been difficult to achieve as different biochemical processes are involved during the parasite lifecycle, resulting in significant differences in drug susceptibility between the major parasite stages.</div><div class="NLM_p">To identify new chemical entities with potential for further hit-to-lead and lead optimization programs, a Charles River (formerly BioFocus) proprietary library of about 12 700 compounds was screened in parallel against different parasite lifecycle stages (e.g., asexual blood stage (ABS), liver stage, and sexual stages). Hit compounds were further evaluated in a range of assays to determine their physicochemical properties and amenability to successful development.</div><div class="NLM_p">Herein, we report the identification and profiling of promising hits from a novel diazaspiro[3.4]octane chemical series, PPI28 (originally designed to target protein–protein interactions (PPI)) (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), along with the hit-to-lead efforts and mechanistic studies that followed.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0002.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PPI28 generic structure and structures of the two hit compounds <b>1</b> and <b>2</b> (racemic mixtures).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Methods</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_03484" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_03484" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> High-Throughput Screening (HTS)</h3><div class="NLM_p">The 12 700 compounds of the Charles River BioFocus proprietary library were screened in duplicate against ABS <i>Pf</i>Dd2 parasites, exoerythrocytic liver-stage parasites, and in the dual gamete formation assay (DGFA). IC<sub>50</sub> values were determined when compounds showed more than 70% inhibition in both assay duplicates. All assays were performed with <i>Plasmodium falciparum</i> parasites, except for the liver-stage assay, for which the rodent species <i>Plasmodium berghei</i> was used, based on the experimental evidence that activity against the liver stage of the murine species of the parasite generally correlates with that against the human species.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a></div><div class="NLM_p">Out of the original library, 991 preliminary hit compounds were identified, showing more than 70% inhibition of parasite growth in both duplicates of the ABS assay. These hits were further evaluated for off-target activity (e.g., cytotoxicity in HepG2 cells and cardiotoxicity in the human ether-a-go-go related gene (hERG) fluorescence polarization assay). Compounds were also tested in several absorption, distribution, metabolism, and excretion (ADME) assays to measure physicochemical properties (e.g., lipophilicity and solubility at physiologically relevant pH 7.4) and to assess metabolic liabilities (phase I and phase II metabolism using metabolic turnover assays in human liver microsomes and rat hepatocytes, and potential for CYP450 inhibition).</div><div class="NLM_p last">All HTS assay conditions are detailed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section A.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> HTS Data Analysis</h3><div class="NLM_p last">The HTS-associated data set was analyzed using StarDrop v.6.4. to v.6.6. (<a href="https://www.optibrium.com/stardrop/" class="extLink">https://www.optibrium.com/stardrop/</a>). Filtering, clustering, and scoring methods were applied to the data set to classify and rank compounds based on their biological, ADME, and structural properties. Subsequent in-depth analysis taking into account the desired profile for a hit compound as defined by MMV (<a href="https://www.mmv.org/research-development/information-scientists" class="extLink">https://www.mmv.org/research-development/information-scientists</a>) as well as other criteria including freedom to operate and synthetic feasibility led to the selection of chemical series for further investigation.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Cross-Resistance Assays on Hit Compounds</h3><div class="NLM_p last">Cross-resistance assays on hit compounds were carried out on several resistant field isolates and <i>P. falciparum</i> Dd2 lab-generated mutants using the modified [<sup>3</sup>H]-hypoxanthine incorporation assay<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section E).</div></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Resistance Selection Experiments on <b>1-A</b></h3><div class="NLM_p last">Resistance selection experiments were performed with compound <b>1-A</b>, the active enantiomer of <b>1</b>, in which ABS parasites at 2.5% parasitemia were pressured with five times the ABS Dd2-B2<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> IC<sub>50</sub> value. The cultures were monitored daily to confirm clearance of sensitive parasites. After 3 weeks of culture under drug pressure, resistant parasites were cloned, expanded, and profiled for resistance phenotypes via dose-response assays. Three clones showing varying <b>1-A</b> IC<sub>50</sub> values (17–146× Dd2-B2 IC<sub>50</sub>) were selected for whole-genome sequencing (WGS) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section F).</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Chemistry</h3><div class="NLM_p">Compounds were prepared according to three different synthetic routes A, B, and C (<a class="ref internalNav" href="#sch1" aria-label="Schemes 1">Schemes 1</a>, <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, and <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, respectively), emphasizing variations of R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> substituents (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), respectively. From the common intermediate <b>4</b>, the synthetic paths diverged depending on which side of the molecule was to be modified. All of the building blocks that were not commercially available, mainly for R<sup>1</sup> substituents, were prepared in-house, and their synthesis is detailed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 2</a>.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0007.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (A) Route A: Preparation of Compounds <b>11</b>–<b>27</b>, <b>84</b>–<b>106</b>, and <b>S1</b>–<b>S19</b> with R<sup>1</sup> Variations and Preparation of the Phenoxy Derivative <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (0) toluene, 110 °C, 3 h, 96%; (a) LiF (4 equiv), CH<sub>3</sub>CN, 60 °C, 67%; (b) trifluoroacetic acid (TFA) (30 equiv), dichloromethane (DCM), 0–25 °C, 16 h, 83–100%; (c) Ar-X (1 equiv), RuPhos (0.06 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.08 equiv), Cs<sub>2</sub>CO<sub>3</sub> (3 equiv), <i>t-</i>BuOH, 110 °C, sealed tube, 16 h, 29–99%; (d) LAH (3 equiv), tetrahydrofuran (THF), 0 °C to rt, 12 h, 64–77%; (e) MsCl (1.2 equiv), Et<sub>3</sub>N (1.5 equiv), DCM, 25 °C, 3 h, 74–78%; (f) BocNHAr (1 equiv), NaH (1.2 equiv), dimethylformamide (DMF), 0–50 °C, 12 h, 32–58%; (g) Pd(OH)<sub>2</sub> (0.2 equiv), H<sub>2</sub> (balloon), EtOH, 25 °C, 16 h, 84–98%; (h) R-COOH (1.2 equiv), 2-hydroxypyridine-<i>N</i>-oxide (HOPO) (1.2 equiv), 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (EDCI·HCl) (1.2 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) (3 equiv), DCM, 25 °C, 12 h, 29–85%; (i) HCl (4 M in dioxane) (5 equiv), DCM, 25 °C, 16 h, 40–95%; (j) PhOH (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (1.5 equiv), 90 °C, 4 h, 34%. (B) Asymmetric unit of <b>9c</b>. Displacement ellipsoids are shown at the 50% probability level. Hydrogen and salt atoms were omitted for clarity.</p></p></figure><figure id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0008.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route B: Preparation of Compounds <b>35</b>–<b>60</b> with R<sup>2</sup> Variations<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(OH)<sub>2</sub>, H<sub>2</sub> (balloon), EtOH, 25 °C, 12 h, 84–98%; (b) R-COOH (1.2 equiv), HOPO (1.2 equiv), EDCI·HCl (1.2 equiv), DIPEA (3 equiv), DCM, 25 °C, 12 h, 29–85%; (c) NaBH<sub>4</sub> (10 equiv), MeOH, 0–25 °C, 3 h, 71–93%; (d) Dess–Martin periodinane (1 equiv), wet DCM, 25 °C, 2 h, 50–67%; (e) NH<sub>2</sub>OH (1.15 equiv), NaHCO<sub>3</sub> (1.15 equiv), Na<sub>2</sub>SO<sub>4</sub> (1.15 equiv), DCM, 12 h, 25 °C, 84%; (f) POCl<sub>3</sub> (2 equiv), 1,4-diazabicyclo[2.2. 2]octane (DABCO) (2 equiv), DCM, 25 °C, 1 h, 91%; (g) tetra-<i>n</i>-butylammonium fluoride (TBAF) (1.1 equiv), AcOH (1.1 equiv), 25 °C, 48–86%; or Cs<sub>2</sub>CO<sub>3</sub> (1 equiv), DMF/H<sub>2</sub>O (10:1), 25 °C, 18 h, 56%; (h) LiOH·H<sub>2</sub>O (3 equiv), MeOH/THF/H<sub>2</sub>O (1:1:1), 0–25 °C, 2 h, 66%; (i) Mg (2.2 equiv), R-Br (2 equiv), THF, 0 °C, 1 h, 58–69%; (j) R-NH<sub>2</sub> (1.1 equiv), NaBH<sub>3</sub>CN (3 equiv), MeOH, AcOH, 25 °C, 12 h, 30–70%; (k) PPh<sub>3</sub>, diisopropyl azodicarboxylate (DIAD), NaN<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, DCM, 0–25 °C; (l) ethynyltrimethylsilane (1 equiv), Cu(I)I (0.02 equiv), DIPEA (0.02 equiv), AcOH (0.02 equiv), DMF/H<sub>2</sub>O (1:1), 80 °C, 16, 52%; (m) PPh<sub>3</sub> (1.4 equiv), THF, H<sub>2</sub>O (5:1), 0 °C, 15 min, 80 °C, 2 h, 72%; (n) R-COOH (1.5 equiv), hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU) (1.3 equiv), DIPEA (2 equiv), DMF, 25 °C, 16 h, 61–65%.</p></p></figure><figure id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0009.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Route C: Preparation of Compounds <b>68</b>–<b>83</b> with R<sup>3</sup> Variations<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(OH)<sub>2</sub> (0.2 equiv), H<sub>2</sub> (balloon), EtOH, 16 h, 25 °C, 84–98%; (b) acid (1.2 equiv), HOPO (1.2 equiv), EDCI·HCl (1.2 equiv), DIPEA (3 equiv), DCM, 25 °C, 16 h, 29–85%; (c) (c1) TFA (30 equiv), DCM, 0–25 °C, 16 h, 88%, (c2) Cbz-Cl (2 equiv), Et<sub>3</sub>N (2 equiv), DCM, 0 °C, 1 h, 65%; (d) NaBH<sub>4</sub> (10 equiv), MeOH, 0 °C and then 25 °C, 3 h, 71–93%; (e) Dess–Martin periodinane (1 equiv), wet DCM, 0–25 °C, 2 h; (f) (f1) Ph-NH<sub>2</sub> (1.1 equiv), AcOH (trace), NaBH<sub>3</sub>CN (3 equiv), MeOH, 25 °C, 12 h, 30–70%, (f2) Boc<sub>2</sub>O (2.5 equiv), 1,2-dichloroethane (DCE), 80 °C, sealed tube, 18 h, 49%; (g) 10% Pd/C (20 mass %), EtOH, 25 °C, 16 h, 86%; (h) (h1) Ar-X (1.2 equiv), RuPhos (0.04 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.06 equiv), K<sub>2</sub>CO<sub>3</sub> (3 equiv), <i>t-</i>BuOH, 110 °C, sealed tube, 16 h; (h2) HCl (4 M in dioxane) (15 equiv), MeOH, 0–25 °C, 16 h, 26–50% over two steps; or (i) (i1) R-CHO (1.1 equiv), NaBH<sub>3</sub>CN (3 equiv), MeOH, 25 °C, 16 h, followed by TBAF (1.1 equiv), THF, 2 h, 25 °C, 35–44%; (i2) TFA (35 equiv), DCM, 25 °C, 16 h, 61–64%.</p></p></figure><div class="NLM_p">The <i>tert</i>-butyl 3-(2-ethoxy-2-oxoethylidene) azetidine-1-carboxylate intermediate <b>3</b> was prepared from a Wittig reaction with commercially available <i>tert</i>-butyl 3-oxoazetidine-1-carboxylate and ethyl 2-(triphenylphosphanylidene)acetate as reported in the literature (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> A [3 + 2] cycloaddition with <b>3</b> and <i>N</i>-(methoxymethyl)-<i>N</i>-(trimethylsilylmethyl) benzylamine in the presence of lithium fluoride afforded intermediate <b>4</b>.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><div class="NLM_p">Compounds <b>11</b>–<b>27</b>, <b>84</b>–<b>106</b>, and <b>S1</b>–<b>S19</b> were prepared according to route A (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>), whereby intermediate <b>4</b> was subjected to an <i>N</i>-Boc-deprotection followed by a Buchwald–Hartwig coupling to give intermediates <b>5a</b>–<b>c</b>. Reduction of the ethyl ester functionality with lithium aluminum hydride led to the corresponding alcohol intermediates <b>6a</b>–<b>c</b>. Subsequent mesylation and nucleophilic substitution with various <i>N</i>-Boc-anilines afforded the corresponding aniline intermediates <b>8a</b>–<b>c</b>. After debenzylation followed by HOPO/EDCI-mediated amide coupling with the desired carboxylic acid, intermediates <b>10a</b>–<b>c</b> were obtained, which were subjected to acidic <i>N</i>-Boc-deprotection to yield the final compounds <b>11</b>–<b>27</b>, <b>78</b>–<b>100</b>, and <b>S1</b>–<b>S19</b>.</div><div class="NLM_p">The phenoxy derivative <b>29</b> was obtained by reacting the mesylate intermediate <b>7a</b> with phenol and K<sub>2</sub>CO<sub>3</sub> as a base to give intermediate <b>28</b>, followed by debenzylation and amide coupling as described above.</div><div class="NLM_p">Compounds <b>35</b>–<b>60</b> were prepared according to route B (<a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>). Intermediate <b>5a</b> obtained from a Buchwald–Hartwig coupling as described in route A was debenzylated in the presence of palladium hydroxide to afford the free amine <b>30</b>, which was then coupled to <i>tert</i>-butyldimethylsilyl (TBDMS)-protected hydroxyphenylacetic acid using EDCI and HOPO to give the amide intermediate <b>31</b>. Subsequent reduction with sodium borohydride gave the alcohol intermediate <b>32</b>, which was oxidized to the key aldehyde intermediate <b>33</b> using Dess–Martin periodinane, allowing access to compounds with a variety of R<sup>2</sup> substituents. All following intermediates were deprotected in an ultimate step to yield the final compounds. The aldoxime derivative <b>35</b> was obtained by reacting the aldehyde <b>33</b> with hydroxylamine followed by removal of the silyl protecting group. The carboxylic acid <b>36</b> was obtained from basic hydrolysis of intermediate <b>31</b>. From the aldehyde intermediate <b>33</b>, Grignard additions followed by deprotections afforded hydroxylated analogues <b>38</b> and <b>39</b>, while reductive aminations led to the formation of additional amine derivatives <b>40</b>–<b>53</b>, in particular aliphatic targets that could not be accessed through the mesylate intermediate. The nitrile <b>55</b> was obtained from dehydration of the aldoxime intermediate <b>34</b> using phosphonyltrichloride and DABCO.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> The Mitsunobu reaction was performed to convert alcohol <b>32</b> to the azide intermediate <b>54</b>, from which the triazole <b>56</b> and the amine <b>58</b> were prepared via copper-catalyzed azide–alkyne cycloaddition and Staudinger reduction, respectively. Amine <b>58</b> was further subjected to amide couplings with a couple of carboxylic acids to give analogues <b>59</b> and <b>60</b>.</div><div class="NLM_p">Finally compounds <b>68</b>–<b>81</b> were prepared following route C (<a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>), in which intermediate <b>4</b> was debenzylated in the presence of palladium hydroxide. The resulting intermediate <b>61</b> was coupled to TBDMS-protected hydroxyphenylacetic acid using the same EDCI/HOPO coupling conditions as described in routes A and B. <i>N</i>-Boc-deprotection, followed by Cbz protection of the azetidine, gave intermediate <b>63</b>. Subsequent reduction of the R<sup>2</sup> ethyl ester followed by Dess–Martin oxidation resulted in intermediate <b>65</b>. The latter was subjected to a reductive amination followed by Boc protection to give the <i>N-</i>Boc-aniline intermediate <b>66</b>, which was, in turn, hydrogenated to yield the key azetidine intermediate <b>67</b>. Various coupling methods were used to <i>N</i>-arylate or <i>N</i>-alkylate the azetidine, which, after simultaneous deprotection of the TBDMS and <i>N</i>-Boc protecting groups under acidic conditions, led to the final compounds <b>68</b>–<b>83</b>.</div><div class="NLM_p last">The synthesis and analytical data of all compounds are detailed in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 2</a>.</div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Asexual Blood-Stage Activity</h3><div class="NLM_p last">Selected hits and all compounds synthesized during the hit-to-lead campaign were evaluated for in vitro ABS activity against the <i>Pf</i>NF54 drug-sensitive strain of <i>P. falciparum</i>. Selected compounds with <i>Pf</i>NF54 IC<sub>50</sub> < 500 nM were tested against the K1 multidrug-resistant strain of <i>P. falciparum</i> to assess the potential for cross-resistance. A compound was considered to have potential for cross-resistance when (<i>Pf</i>K1 IC<sub>50</sub>)/(<i>Pf</i>NF54 IC<sub>50</sub>) ≥ 4. No cross-resistance was observed with PPI28 compounds. Chloroquine and artesunate were used as reference drugs in all experiments.</div></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Assessment of Transmission-Blocking Potential</h3><div class="NLM_p">Compounds with ABS <i>Pf</i>NF54 IC<sub>50</sub> < 500 nM were assessed for transmission-blocking potential using a panel of assays, including stage IV/V gametocyte assays, a male gamete exflagellation assay, and the standard membrane feeding assay (SMFA).</div><div id="sec2_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Gametocytocidal Activity<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a></h4><div class="NLM_p last">Compounds were assessed for gametocytocidal activity against <i>P. falciparum</i><i>Pf</i>NF54 stage IV/V gametocytes on three different assay platforms, namely, PrestoBlue fluorescence assay, ATP bioluminescence assay, and a luciferase reporter assay. Compounds are considered active against gametocytes if they show an IC<sub>50</sub> < 1 μM on at least two assay platforms.</div></div><div id="sec2_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Exflagellation Inhibition Assay (EIA)</h4><div class="NLM_p last">Compounds with ABS <i>Pf</i>NF54 IC<sub>50</sub> < 500 nM were also tested in the EIA on >95% stage V gametocytes as described in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section H.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></div></div><div id="sec2_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> SMFA</h4><div class="NLM_p last">Compounds with IC<sub>50</sub> < 500 nM in the EIA were assessed in the SMFA to confirm transmission-blocking potential, using the two different species <i>Anopheles gambiae</i> s.s. and <i>Anopheles arabiensis</i>. Transmission-blocking potential was quantified by two different parameters: transmission-blocking activity ( <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_m001.gif" alt="" id="_i17" /></img></span>, where <i>p</i> is prevalence of infected mosquitoes, <i>C</i> is control, and <i>T</i> is treated) and transmission-reducing activity (%TRA: <span class="NLM_inline-formula"><img class="imgWithoutFigViewer inline-formula-styles" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_m002.gif" alt="" id="_i18" /></img></span>, where <i>i</i> is oocyst intensity in the mosquito midgut, <i>C</i> is control, and <i>T</i> is treated).<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> Data were managed in Microsoft Excel and analyzed using GraphPad Prism version 9.0.0. All data were evaluated for normality using the Shapiro–Wilk test. Data were not normally distributed, and the Mann–Whitney <i>U</i> test was performed to determine statistical significance between treatment and control cohorts. Unpaired <i>t</i>-tests were used to compare the TBA and TRA between the two species. A <i>P</i>-value <0.05 was considered statistically significant.</div></div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> ADME Profiling</h3><div class="NLM_p">To assess metabolic stability, selected compounds were incubated with human (h), rat (r), and mouse (m) liver microsomal preparations. The intrinsic clearance CL<sub>int</sub> and subsequently the hepatic extraction ratio <i>E</i><sub>H</sub> were derived from the percentage of compound remaining after 30 min.</div><div class="NLM_p">Selected compounds were also assessed for hepatocyte stability. The apparent intrinsic clearance CL<sub>int,app</sub> and subsequently <i>E</i><sub>H</sub> were calculated from the hepatocyte CL<sub>int</sub> derived from the <i>t</i><sub>1/2</sub>.</div><div class="NLM_p last">Aqueous solubility was measured at pH 6.5 for compounds displaying <i>Pf</i>NF54 IC<sub>50</sub> < 500 nM.</div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> hERG Inhibition and Cytotoxicity</h3><div class="NLM_p">Selected compounds were assessed for potential cardiotoxicity risks by measuring their activity against the hERG potassium channel using in vitro IonWorks patch-clamp electrophysiology.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a></div><div class="NLM_p last">Compounds with <i>Pf</i>NF54 IC<sub>50</sub> < 500 nM were also tested for cytotoxicity against Chinese hamster ovary (CHO) cells.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Mutant <i>Pfcarl</i> Profiling and Drug Combination Studies</h3><div class="NLM_p">Selected compounds were evaluated in a matrix study to better understand possible mechanisms of action (MoA) and/or resistance (MoR) of the diazaspiro[3.4]octane chemical series and potential interactions with other antimalarial compounds. The matrix assay considers compound–compound interactions against a panel of sensitive and drug-resistant parasite strains. In this case, a set of parasite lines harboring various cyclic amine resistance locus (<i>Pfcarl</i>) mutations was included to observe any potential cross-resistance with other known drugs that select for <i>Pfcarl</i>-associated drug-resistance mutations. The methodology of the assay is described in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section N.</div><div class="NLM_p last">All studies were performed on racemic mixtures unless mentioned otherwise.</div></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i22">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> High-Throughput Screening Data Analysis and Chemical Series Prioritization</h3><div class="NLM_p">The HTS data set was analyzed using filtering and structure-similarity-based clustering methods to identify chemical series of interest for drug discovery programs (<a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>). Among the series that were prioritized, the diazaspiro[3.4]octane, PPI28, was particularly attractive due to the biological profile of its two most promising hits <b>1</b> and <b>2</b> and an average lipophilic ligand efficiency (LLE), defined as pIC<sub>50</sub> – log <i>P</i>,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> around 3.5. Hit compounds displayed good activity against ABS parasites (<i>Pf</i>Dd2 IC<sub>50</sub> = 143 and 164 nM for <b>1</b> and <b>2</b>, respectively) along with activity against liver stages and male gamete formation (96 and 99% inhibition at 2 μM, respectively). Evaluation of killing kinetics of <b>2</b> in a speed assay<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> indicated a fast-killing profile for the series, which is a desirable feature for molecules that clear ABS parasitemia (TCP-1).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> Moreover, the diazaspiro[3.4]octane scaffold (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) contained a high number of sp<sup>3</sup> carbons and, as such, notably differed from most antimalarials in clinical trials or use.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18,19)</a> Structures with higher sp<sup>3</sup> character are usually considered a beneficial attribute in drug discovery as they often have physicochemical properties (e.g., solubility, lipophilicity) associated with improved drug metabolism and pharmacokinetics (DMPK) and/or toxicological profiles, thus allowing medicinal chemists to navigate a more desirable chemical space.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> PPI28 hits certainly belonged to a favorable space in terms of physicochemical properties as shown by the log <i>D</i> values in the [1–4] range and the topological polar surface area (TPSA) <90 Å<sup>2</sup>, permitting modulation of lipophilicity and polarity during the optimization process while remaining in a druggable space. In addition, within the malaria research context, three-dimensional structures offer new opportunities for identifying distinct mechanisms of action from the current antimalarials, many of which possess rather flat core structures.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Finally, in terms of the potential for analog optimization, the three attachment points of the PPI28 structure allowed us to envisage a wide range of modifications for structure–activity relationship (SAR) exploration and optimization of properties identified as weaknesses within the series (i.e., metabolic stability and solubility).</div><figure id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0003.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical space and clusters of the hit compounds. (A) Chemical space of the compounds with >70% inhibition of ABS Dd2 parasite growth. Hits with ABS Dd2 IC<sub>50</sub> < 2 μM are represented by a bigger circle and colored according to their activity (green to red, 0.1–2 μM). (B) Chemical clusters of hits with ABS Dd2 IC<sub>50</sub> < 2 μM. Compounds are colored according to their activity and sized according to their LLE (logIC<sub>50</sub> – log <i>P</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec3_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> Hit Validation and Profiling</h3><div class="NLM_p">The two most promising hits from the selected diazaspiro[3.4]octane series, PPI28, were resynthesized and tested in the <i>Pf</i>NF54 ABS assay to confirm activity. The enantiomers of <b>1</b> and <b>2</b> were subsequently separated (<b>1-A</b>/<b>1-B and 2-A</b>/<b>2-B</b>, respectively) and further characterized for killing kinetics, potential for cross-resistance against field isolates and laboratory-generated mutant panels, ability to target other parasite lifecycle stages, and toxicity (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Biological Profiles of the Active Enantiomer of the Two Hit Compounds</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center"><b>1-A</b></th><th class="colsep0 rowsep0" align="center"><b>2-A</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pf</i>NF54/K1/Dd2 IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">44/36/37</td><td class="colsep0 rowsep0" align="left">57/66/61</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pf</i>Dd2KAF156 IC<sub>50</sub> (nM) (ratio with Dd2)</td><td class="colsep0 rowsep0" align="left">4502 (122×)</td><td class="colsep0 rowsep0" align="left">774 (13×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cytotoxicity CHO/HepG2 cells (μM) (SI over <i>Pf</i>NF54 IC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">43 (977×)/20 (454×)</td><td class="colsep0 rowsep0" align="left">41 (621×)/20 (303×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pb</i> liver IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">201</td><td class="colsep0 rowsep0" align="left">600</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pf</i> male/female gamete formation IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="left">246/614</td><td class="colsep0 rowsep0" align="left">405/2800</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">hERG IC<sub>50</sub> (μM) (SI over <i>Pf</i>NF54 IC<sub>50</sub>)</td><td class="colsep0 rowsep0" align="left">>30 (682×)</td><td class="colsep0 rowsep0" align="left">2.2 (33×)</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">killing kinetics</td><td class="colsep0 rowsep0" align="left">fast-killing (chloroquine-like)</td><td class="colsep0 rowsep0" align="left">fast-killing (chloroquine-like)</td></tr></tbody></table></div></div><div class="NLM_p">For each pair of enantiomers, one entity was highly potent (<i>Pf</i>NF54 IC<sub>50</sub><b>1-A</b> = 44 nM, <b>2-A</b> = 66 nM), whereas the other enantiomer was moderately to significantly less potent [<i>Pf</i>NF54 IC<sub>50</sub><b>1-B</b> = 4.4 μM (100× less potent than <b>1-A</b>), <b>2-B</b> = 230 nM (4× less potent than <b>2-A</b>)].</div><div class="NLM_p">Fast-killing kinetics observed in the speed assay for the racemic hit <b>2</b> were confirmed in the two-point parasite reduction ratio (PRR) assay with the active enantiomers <b>1-A</b> and <b>2-A</b> (Supporting Information File 1, Section G, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Figures S1 and S2</a>), thus establishing the TCP-1 potential for the series.</div><div class="NLM_p">More in-depth parasite lifecycle activity characterization highlighted the transmission-blocking potential (TCP-5)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> of PPI28 compounds. While potency against late gametocytes (stage IV/V) was weak, their ability to inhibit exflagellation was significant (98–100% inhibition at 2 μM, IC<sub>50</sub> ≤ 500 nM) (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S11</a>). Compounds <b>1-A</b> and <b>2-A</b> also exhibited activity against hepatic schizonts, as indicated by their <i>Pb</i> liver IC<sub>50</sub> values of 200 and 600 nM, respectively, thus demonstrating the chemoprotection potential (TCP-4).<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a></div><div class="NLM_p">The potential for cross-resistance with other drug-resistant parasite lines was also investigated. The active enantiomers were shown to be equipotent against all tested field strains; however, cross-resistance was observed against the laboratory-selected KAF156 Dd2 mutant bearing a single-nucleotide polymorphism (SNP) in <i>Pfcarl</i> and giving rise to the I1139K mutation (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Tables S6 and S7</a>). Although the imidazolopiperazine KAF156 was in clinical trials at the time of our work,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> the PPI28 series remained of interest for further exploration due to its attractive biological profile and the opportunities to be developed either as a potential back-up to KAF156 if the MoA appeared to be the same or as a new asset if the MoA was determined to be different. The fact that the structures of PPI28 compounds and KAF156 differed significantly also weighed in favor of investigating the PPI28 series further.</div><div class="NLM_p">Resistance selection experiments with <b>1-A</b> confirmed the MoR to be associated with <i>P. falciparum</i> cyclic amine resistance locus (PfCARL protein; Pf3D7_0321900). Parasites cultured under drug pressure at 5× the IC<sub>50</sub> recrudesced within 2 weeks, with resistant clones showing IC<sub>50</sub> shifts of 17× or 120–150× the IC<sub>50</sub> of the parental strain. These clones were subjected to whole-genome sequencing, revealing either the mutation L1073Q (120–150-fold shift for two clones) or A1122E (17-fold shift) in PfCARL. No additional SNPs were observed. However, a number of distinct copy number variations (CNVs) were observed between the clones (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section F). Mutations in PfCARL typically represent an MoR rather than the MoA or drug target.<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> Transposon mutagenesis studies recently provided strong evidence that PfCARL is essential.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> This protein resides in the parasite endoplasmic reticulum where it is suspected to be involved in protein folding, processing, and sorting.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a></div><div class="NLM_p last">The amide derivative <b>1-A</b> displayed superior antiplasmodial activity along with superior margins over cytotoxicity and hERG inhibition relative to the other hit <b>2-A</b>. As a result, SAR studies that followed were based on <b>1-A</b>, and the carbonyl group at R<sup>1</sup> was maintained in all of the compounds that were subsequently prepared to mitigate the cardiotoxicity risk.</div></div><div id="sec3_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> Initial Structure–Activity-Relationship (SAR) Studies</h3><div class="NLM_p">SAR studies primarily focused on investigating diverse changes at each of the three attachment points R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> to determine the minimal pharmacophore and explore the scope of tolerated functionalities to maintain or improve potency. The results of the initial SAR exploration are summarized in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>.</div><figure id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0004.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of the main findings from the initial SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">A variety of functional groups to replace the phenol hydroxy group (e.g., amine, or polar groups such as nitrile, sulfone, carboxylic acid, acetamide groups) or the whole phenol moiety (e.g., pyrazole, pyridine, hydroxypiperidine, indazole moieties) were investigated, along with modification of the position of hydroxy substitution (from para to meta) or modulations of the methylene linker (e.g., length, position of the carbonyl, urea). All changes led to a significant loss of potency (<i>Pf</i>NF54 IC<sub>50</sub> > 6 μM), highlighting the importance of the <i>para</i>-hydroxy phenol moiety for the interaction with the target (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S1</a>).</div><div class="NLM_p">In a similar approach, a range of functionalities was probed to explore the R<sup>2</sup> position and evaluate the impact on potency and other properties such as solubility and metabolic stability. Alkylation of the aniline or replacing the aniline with a phenol was not tolerated for activity, showing the importance of the free NH for target binding. Polar substituents (e.g., oxime <b>35</b>, carboxylic acid <b>36</b>, primary and secondary alcohols <b>37</b>–<b>39</b>, nitrile <b>55</b>, triazole <b>56</b>, amides <b>59</b>–<b>60</b>) resulted in a significant loss in activity, as did the replacement of the benzene ring with pyridine heterocycles (<b>52</b>–<b>53</b>). Likewise, substituting the aniline by a linear or cyclic aliphatic group (e.g., methylcyclopropyl amine or cyclopropyl amide, difluorocyclohexyl amine, tetrahydropyranyl amine, piperazine) led to less potent compounds. Since these results suggested that the phenyl moiety was necessary to retain potency, three-dimensional phenyl replacements such as adamantane and bicyclo[1,1,1]-pentane, known for mimicking phenyl hydrophobic interactions and improving physicochemical properties,<a onclick="showRef(event, 'ref26 ref27 ref28 ref29'); return false;" href="javascript:void(0);" class="ref ref26 ref27 ref28 ref29">(26−29)</a> were investigated as in <b>47</b> and <b>48</b> but afforded less potent compounds. Only minimal modifications where small electron-withdrawing groups (EWGs) such as fluorine were added on the aniline were tolerated, as exemplified by <b>49</b> (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S2</a>).</div><div class="NLM_p">The SAR scope at the R<sup>3</sup> position also appeared to be very limited, with only minor changes being allowed (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S3</a>). Substitution of the phenyl by heterocycles (e.g., pyridine and pyrimidine analogues <b>74</b>–<b>77</b>) or saturated rings (i.e., difluorocyclohexane <b>78</b>), as well as introduction of a linker [e.g., methylene (<b>79</b>) or amide (<b>81</b>)] led to inactive compounds at the highest concentration tested (6 μM). Again, fluorinating any position of the aryl ring was tolerated, with the 3,5-difluorophenyl substituent giving the best activity (<b>71</b>: <i>Pf</i>NF54 IC<sub>50</sub> = 30 vs 140 nM for the racemic hit <b>1</b>). This encouraged us to explore the 5- and 6-positions of the 3-fluorophenyl group to introduce water-solubilizing groups such as morpholine to enhance aqueous solubility. However, these changes were not tolerated, as shown by analogues <b>82</b> and <b>83</b>.</div><div class="NLM_p">Several analogues combining different R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> phenyl and/or phenol fluoro substitutions were subsequently prepared to assess if multiple fluorinations could impact positively both antiplasmodial activity and metabolic stability.</div><div class="NLM_p">Numerous biotransformations were likely to affect the compounds of this series; notably, phase I oxidations at R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup> and/or phase II glucuronidation of the phenol at R<sup>1</sup>. Initial (and higher throughput) metabolic stability studies in liver microsomes focused on identifying phase I liabilities. The poor microsomal stability exhibited by compound <b>84</b>, bearing a fluoro-substituted phenyl at R<sup>1</sup>, R<sup>2</sup>, and R<sup>3</sup>, compared to the piperidinol analog <b>85</b> (<i>E</i><sub>H</sub> (h,r,m) = 0.86/0.75/0.85 vs <0.42/0.3/0.33) suggested that the phenol at the R<sup>1</sup> position was likely a major site of metabolism and that fluorine groups at the R<sup>2</sup> and R<sup>3</sup> positions were able to block phase I metabolism on the two phenyl rings. This hypothesis was supported by metabolite identification (Met ID) experiments in microsomes with <b>1-A</b>, <b>49</b>, and <b>68</b>, wherein oxidative metabolism was not seen at R<sup>2</sup> and R<sup>3</sup> when fluoro-substituted (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>, and <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section L).</div><figure id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0005.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Biotransformations of <b>1-A</b>, <b>49</b>, and <b>68</b> in mouse liver microsomes. Sites of oxidation assigned from fragmentation patterns are indicated in red. +, minor; ++, moderate; +++, major.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Based on these initial results, we fixed R<sup>2</sup> and R<sup>3</sup> as 4-fluorophenyl and 4-fluoro phenyl or 3,5-difluorophenyl groups, respectively, to maintain potency while optimizing metabolic stability in the following studies. As the phenol at R<sup>1</sup> was determined to be essential for activity, we focused on exploring additional options to replace or stabilize the phenol moiety and on determining if a compound meeting the early lead criteria could be achieved for this series (<a href="https://www.mmv.org/research-development/information-scientists" class="extLink">https://www.mmv.org/research-development/information-scientists</a>).</div></div><div id="sec3_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> Investigation of Phenol Surrogates to Address Metabolism</h3><div class="NLM_p">Prior to establishing our strategy to mitigate metabolism at the R<sup>1</sup> position, a mouse pharmacokinetics (PK) study was performed on the active enantiomer of the R<sup>3</sup>-fluorinated analogue <b>68</b>, <b>68-A</b>, to understand the major routes of phase I and phase II metabolism and address metabolic liabilities in future targets. The PK study was also a key experiment to determine if liver microsomes (phase I metabolism) were a predictive system for in vivo clearance or if another in vitro system such as hepatocytes (phase I and phase II) was preferable. The PK studies indicated that clearance was high, and subsequent Met ID studies on mouse blood and excreta determined that phenol glucuronide was the main metabolite. Products from oxidative metabolism were also identified, albeit in a lower proportion than what was foreseen from in vitro microsomal stability experiments (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section M). This highlighted that, in this case, phase II metabolism occurred faster than phase I oxidations and that hepatocytes would likely be more predictive than microsomes.</div><div class="NLM_p">In light of the Met ID results and the indication from the initial SAR studies that typical phenol bioisosteres did not maintain potency, we focused on several R<sup>1</sup> alterations aimed at decreasing electron density and/or hindering the sites of phase I and phase II metabolism (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>). Active compounds (<i>Pf</i>NF54 IC<sub>50</sub> < 500 nM) were assessed for metabolic stability in liver microsomes first, and for those showing improved microsomal stability (<i>E</i><sub>H</sub> < 0.5), hepatocyte stability was subsequently evaluated.</div><div class="NLM_table-wrap" id="tbl2">Table 2<img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0010.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0011.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">Mean from <i>n</i> values of ≥2 independent experiments with sensitive (NF54) strains of <i>P. falciparum</i>. The majority of the individual values varied less than 2× (maximum 3×).</p></div><div class="footnote" id="t2fn2"><sup><sup>b</sup></sup><p class="last">Chloroquine and artesunate were used as reference drugs in all experiments. Against <i>Pf</i>NF54, our laboratory standard IC<sub>50</sub> values for chloroquine and artesunate are 16 and 4.0 nM, respectively (mean from ≥10 independent assays). IC<sub>50</sub> values that differed more than 3× from laboratory standard values were not included in the analysis. h, human; r, rat; m, mouse.</p></div></div><div></div></div><div class="NLM_p">To decrease the electron density of the phenol and/or block the sites of phase I metabolism, EWG substituents were introduced at the ortho- and meta-positions to the hydroxy group of the phenol. In addition, several ortho substituents, including bulkier groups such as chlorine,<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> trifluoromethyl or <i>tert</i>-butyl moieties, as well as polar functionalities (e.g., nitrile<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> or carboxamide) were investigated to hinder the hydroxy group of the phenol or reduce its reactivity through intramolecular hydrogen bonding. Based on literature examples, the difluoromethyl phenyl group was also explored as a phenol surrogate.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> Notably, the <i>ortho-</i>trifluoromethyl group resulted in the most potent compound of all of the substituents surveyed (<b>87</b><i>Pf</i>NF54 IC<sub>50</sub> = 44 nM). However, the addition of an ortho substituent to the phenol did not improve metabolic stability to a desirable <i>E</i><sub>H</sub> value (<0.5), as exemplified by the chloro, trifluoromethyl, and nitrile analogues, <b>86</b>, <b>87</b>, and <b>88</b>, respectively (microsomal <i>E</i><sub>H</sub> (h,r,m) = 0.82/0.6/0.82; 0.87/0.7/0.76; and 0.76/0.54/0.52). Met ID experiments showed that phase I metabolism still occurred on the phenol ring (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section L).</div><div class="NLM_p">In general, disubstitution was beneficial to metabolic stability but detrimental to activity compared to monosubstitution, as illustrated by the fluorinated matched pair <b>89</b>/<b>84</b> (<i>Pf</i>NF54 IC<sub>50</sub> = 2.7 μM; <i>E</i><sub>H</sub> (h,r,m) = 0.69/0.48/0.64 mL/(min kg) vs <i>Pf</i>NF54 IC<sub>50</sub> = 0.362 μM; <i>E</i><sub>H</sub> (h,r,m) = 0.86/0.73/0.85).</div><div class="NLM_p">The addition of polar substituents led to a greater than 10-fold decline in activity compared to the original hit <b>1-A</b> as illustrated by the nitrile and carboxamide analogues <b>88</b> and <b>90</b>, respectively (<i>Pf</i>NF54 IC<sub>50</sub> = 3.1 and 4.6 μM, respectively). Replacement of the phenol by the difluoromethyl phenyl as in <b>91</b> came with a substantial potency cost and did not improve metabolic stability (<i>Pf</i>NF54 IC<sub>50</sub> > 6 μM; <i>E</i><sub>H</sub> (h,r,m) = 0.93/0.83/0.92).</div><div class="NLM_p">Modifications aimed at decreasing log <i>D</i> and/or modulating the p<i>K</i><sub>a</sub> of the phenol were also carried out to investigate the impact of these parameters on potency and metabolism. These included replacement of the phenol by more polar heterocycles such as the hydroxy-pyridines (<b>92</b>–<b>94</b>), pyridine-<i>N-</i>oxide <b>95</b>, and the hydroxy-pyrimidine <b>96</b>. Although the <i>N</i>-oxide and pyrimidine analogues showed improved microsomal stability, they did not retain potency (<i>Pf</i>NF54 IC<sub>50</sub> = 5 μM, <i>E</i><sub>H</sub> (h,r,m) = 0.69/0.5/0.75; <i>Pf</i>NF54 IC<sub>50</sub> = 0.86 μM, <i>E</i><sub>H</sub> (h,r,m) = 0.61/0.35/0.53). Conversely, the hydroxy-pyridine <b>94</b> exhibited high potency but low microsomal metabolic stability (<i>Pf</i>NF54 IC<sub>50</sub> = 0.036 μM, <i>E</i><sub>H</sub> (h,r,m) = 0.89/0.75/0.87). The remaining hydroxy-pyridines <b>92</b> and <b>93</b> and hydroxy-pyrimidine <b>96</b> did not lead to any notable improvement.</div><div class="NLM_p">To lower log <i>D</i>, substituents on the methylene linker such as a pendant amine were added, resulting in the amino acid <b>97</b>, which displayed an attractive biological profile [<i>Pf</i>NF54 IC<sub>50</sub> = 16 nM; CHO CC<sub>50</sub> = 18 μM (1125× selectivity); hERG IC<sub>50</sub> = 1.6 μM (100× selectivity)] and improved ADME properties, i.e., aqueous solubility at pH 6.5 (40 μM) and metabolic stability, although the latter remained high (<i>E</i><sub>H</sub> (h,r,m) = 0.81/0.45/0.61). Interestingly, when the amino acid stereocenter was inverted (compared to <b>97</b>) as in <b>98</b>, a significant improvement in microsomal stability (<i>E</i><sub>H</sub> (h,r,m) < 0.42/0.3/0.33) was observed, albeit at the cost of a 4–5-fold loss in potency. Following up on methylene linker substitutions, several analogues were prepared that bore a phenol or CF<sub>3</sub>-substituted phenol and various substitution patterns on the CH<sub>2</sub>, including hydroxy, methyl, dimethyl, and difluoro groups, all of which were well-tolerated for activity (<i>Pf</i>NF54 IC<sub>50</sub><b>100</b>, <b>102</b>, <b>103</b> <50 nM) except for the electron-withdrawing difluoro substitution as in <b>99</b>. The latter confirmed previous observations that the phenol p<i>K</i><sub>a</sub> must be above 8.5 to maintain activity. Remarkably, in all cases where a stereocenter was involved at R<sup>1</sup>, the (<i>R</i>) enantiomer was consistently more active than the (<i>S</i>) enantiomer (<b>100</b>/<b>101</b>: 16/105 nM; <b>102</b>/<b>103</b>: 15/45 nM). In terms of metabolism however, the hydroxy, methyl, and dimethyl substitutions on the methylene bridge did not show any benefits (<i>E</i><sub>H</sub> (h,r,m) > 0.8 in all species).</div><div class="NLM_p">When we combined the CF<sub>3</sub>-phenol with a disubstituted methylene linker (e.g., difluoro, dimethyl, gem-substitution with a methyl and a hydroxy group), activity dropped dramatically, as exemplified by the difluorinated analogue <b>104</b> (<i>Pf</i>NF54 IC<sub>50</sub> = 4.2 μM), and compounds remained highly susceptible to metabolism [compounds <b>104</b>, <b>S12</b>, and <b>S13</b> (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S4</a>), <i>E</i><sub>H</sub> (h,r,m) > 0.8 in all species].</div><div class="NLM_p">Encouraged by the results with the amino derivatives <b>97</b> and <b>98</b>, it was considered worthwhile to investigate other amino acids at R<sup>1</sup> (e.g., tyrosine and phenylalanine). Remarkably, the tyrosine analogue <b>105</b> displayed a similar profile to that of <b>97</b>, which opened new opportunities to explore other interactions with the presumed target, where an additional carbon in the linker was tolerated.</div><div class="NLM_p last">Further analogues of <b>105</b> were prepared where the phenol hydroxy group was replaced by an amine, a methanol, a nitrile, or a trifluoromethyl group to probe the new space and assess whether it allowed for phenol modifications. The aniline derivative <b>106</b> stood out with an attractive in vitro profile (<i>Pf</i>NF54 IC<sub>50</sub> = 33 nM; <i>E</i><sub>H</sub> (h,r,m) < 0.42/0.3/0.33; sol. pH 6.5 = 55 μM), while the other analogues were found to be considerably less active (compounds <b>S17</b>–<b>S19</b>, Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S4</a>).</div></div><div id="sec3_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> Hepatocyte Clearance and Pharmacokinetics Studies</h3><div class="NLM_p">Selected compounds, mostly with microsomal stability in a desirable range (<i>E</i><sub>H</sub> < 0.5), were tested in hepatocytes, typically in rat cells and, for specific compounds, in human cells (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section J). The observed mouse in vivo clearance for compounds <b>68-A</b>, <b>98</b>, and <b>106</b> was significantly higher than that predicted from hepatocytes, suggesting additional clearance mechanisms to hepatic clearance. Bioavailability was low for all compounds, likely due to poor solubility and/or permeability (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>).</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Predicted and Observed In Vivo Clearance in Mice</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">predicted mouse in vivo CL<sub>s</sub> from hepatocytes<a class="ref internalNav" href="#t3fn1" aria-label="a">a</a> (mL min kg)</th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">mouse PK iv dose (3 mg/kg)</th><th class="rowsep1 colsep0" align="center" char=".">mouse PK po dose (10 mg/kg)</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="left">compound</th><th class="colsep0 rowsep0" align="center" char=".">human</th><th class="colsep0 rowsep0" align="center" char=".">rat</th><th class="colsep0 rowsep0" align="center" char="."><i>t</i><sub>1/2</sub> (h)</th><th class="colsep0 rowsep0" align="center" char=".">Blood Cl (mL/(min kg))</th><th class="colsep0 rowsep0" align="center" char="."><i>V</i><sub>d</sub> (L/kg)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<sub>0–∞</sub> (min μM)</th><th class="colsep0 rowsep0" align="center" char=".">bioavailability BA (%)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68-A</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char=".">4</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="char" char=".">109</td><td class="colsep0 rowsep0" align="char" char=".">10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">8.0</td><td class="colsep0 rowsep0" align="char" char=".">33.7</td><td class="colsep0 rowsep0" align="char" char=".">23.5</td><td class="colsep0 rowsep0" align="char" char=".">180</td><td class="colsep0 rowsep0" align="char" char="."><1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>106</b></td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">3.4</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">40.6</td><td class="colsep0 rowsep0" align="char" char=".">20.7</td><td class="colsep0 rowsep0" align="char" char=".">149</td><td class="colsep0 rowsep0" align="char" char=".">8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">CL<sub>s</sub> was predicted from hepatocytes CL<sub>int</sub>, using the well-stirred model (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Supporting Information File 1</a>, Section J).</p></div></div></div><div class="NLM_p">To prioritize compounds for further profiling and estimate the potential for in vivo efficacy, we used a pharmacokinetics/pharmacodynamics (PK/PD) criterion defined as <i>C</i><sub>av</sub>/IC<sub>50</sub>, where <i>C</i><sub>av</sub> was projected from the oral unbound in vivo AUC<sub>u,o</sub>. Calculated values were then compared to those of reference compounds currently in clinical trials, e.g., MMV048 and KAF156 (<a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a>), to assess the extent of improvement needed to achieve the next stages of development. Based on this simple model, it clearly appeared that to achieve values that would translate to in vivo efficacy comparable to the reference compounds, <i>C</i><sub>av</sub>/IC<sub>50</sub> values would need to be improved by 100- to 1000-fold. In light of the extensive efforts that had already been conducted to optimize potency and reduce metabolic liabilities, it seemed unlikely that such improvements would be achievable with this series.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Comparison of PK/PD Criteria between PPI28 Compounds <b>68-A</b>, <b>98</b>, and <b>106</b> and Phase II Clinical Candidates KAF156 and MMV048</div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center" char="."><b>68-A</b></th><th class="colsep0 rowsep0" align="center"><b>98</b></th><th class="colsep0 rowsep0" align="center" char="."><b>106</b></th><th class="colsep0 rowsep0" align="center" char=".">KAF156</th><th class="colsep0 rowsep0" align="center" char=".">MMV048<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>Pf</i>NF54 IC<sub>50</sub> (nM)</td><td class="colsep0 rowsep0" align="char" char=".">103</td><td class="colsep0 rowsep0" align="left">75</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">16<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a></td><td class="colsep0 rowsep0" align="char" char=".">28</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo mouse CL<sub>b</sub> (mL/(min kg))</td><td class="colsep0 rowsep0" align="char" char=".">62.7</td><td class="colsep0 rowsep0" align="left">33.7</td><td class="colsep0 rowsep0" align="char" char=".">40.6</td><td class="colsep0 rowsep0" align="char" char=".">37.8<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" align="char" char=".">3.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">in vivo mouse CL<sub>int</sub> (mL/(min kg))</td><td class="colsep0 rowsep0" align="char" char=".">5042</td><td class="colsep0 rowsep0" align="left">2155</td><td class="colsep0 rowsep0" align="char" char=".">2959</td><td class="colsep0 rowsep0" align="char" char=".">548<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Oral bioavailability</td><td class="colsep0 rowsep0" align="char" char=".">10</td><td class="colsep0 rowsep0" align="left"><1</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">74<a onclick="showRef(event, 'ref34'); return false;" href="javascript:void(0);" class="ref ref34">(34)</a></td><td class="colsep0 rowsep0" align="char" char=".">>100</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">AUC<sub>u</sub> at 20 mpk, po (min μmol/L)</td><td class="colsep0 rowsep0" align="char" char=".">3</td><td class="colsep0 rowsep0" align="left">3 (assuming BA = 10%)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="char" char=".">65.4</td><td class="colsep0 rowsep0" align="char" char=".">4452</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>av<sub>u,24h</sub></sub> at 20 mpk, po (nM)</td><td class="colsep0 rowsep0" align="char" char=".">2</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">1</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="char" char=".">3092</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>C</i><sub>av<sub>u,24h</sub></sub>/<i>Pf</i>NF54 IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">0.02</td><td class="colsep0 rowsep0" align="left">0.03</td><td class="colsep0 rowsep0" align="char" char=".">0.04</td><td class="colsep0 rowsep0" align="char" char=".">2.77</td><td class="colsep0 rowsep0" align="char" char=".">110</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">human PPB (%)</td><td class="colsep0 rowsep0" align="char" char=".">95.9</td><td class="colsep0 rowsep0" align="left">97.5<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">97.5<a class="ref internalNav" href="#t4fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="char" char=".">93.1<a onclick="showRef(event, 'ref35'); return false;" href="javascript:void(0);" class="ref ref35">(35)</a></td><td class="colsep0 rowsep0" align="char" char=".">84.0</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">PPB was assumed to be similar to that of compound <b>97</b>.</p></div></div></div></div><div id="sec3_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> Transmission-Blocking Potential</h3><div class="NLM_p">Compounds showing ABS activity <500 nM were tested against late-stage gametocytes and gametes. Selected active compounds on one or more sexual stages were further evaluated in the SMFA on two main African malaria vector species, <i>A. gambiae</i> s.s. and <i>A. arabiensis</i>, to evaluate their potential for transmission blocking. Results from these assays are shown in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. Transmission-Blocking Potential of PPI28 Series<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" colspan="3" align="center"> </th><th class="colsep0 rowsep0" colspan="2" align="center" char="."> </th><th class="rowsep1 colsep0" colspan="4" align="center" char=".">SMFA at 2μM</th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="rowsep1 colsep0" colspan="3" align="center">stage IV/V gametocytes % inhibition at 1 μM</th><th class="rowsep1 colsep0" colspan="2" align="center" char=".">EIA</th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>A. gambiae</i></th><th class="rowsep1 colsep0" colspan="2" align="center" char="."><i>A. arabiensis</i></th></tr><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compound</th><th class="colsep0 rowsep0" align="center">PB</th><th class="colsep0 rowsep0" align="center">Luc</th><th class="colsep0 rowsep0" align="center">ATP</th><th class="colsep0 rowsep0" align="center" char=".">% inhibition at 2 μM</th><th class="colsep0 rowsep0" align="center" char=".">IC<sub>50</sub> (nM)</th><th class="colsep0 rowsep0" align="center" char=".">%TRA</th><th class="colsep0 rowsep0" align="center" char=".">%TBA</th><th class="colsep0 rowsep0" align="center" char=".">%TRA</th><th class="colsep0 rowsep0" align="center" char=".">%TBA</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1-A</b></td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">54</td><td class="colsep0 rowsep0" align="left">8</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">244</td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">46</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>68</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">38</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>87</b></td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="left">2</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">51</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">36</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>97</b></td><td class="colsep0 rowsep0" align="left">29</td><td class="colsep0 rowsep0" align="left">31</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="char" char=".">87</td><td class="colsep0 rowsep0" align="char" char=".">82</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">32</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="char" char=".">37</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>98</b></td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">471</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">42</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>106</b></td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="left">ND</td><td class="colsep0 rowsep0" align="char" char=".">81</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td><td class="colsep0 rowsep0" align="char" char=".">ND</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S3</b></td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">28</td><td class="colsep0 rowsep0" align="left">21</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">176</td><td class="colsep0 rowsep0" align="char" char=".">79</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">33</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S14</b></td><td class="colsep0 rowsep0" align="left">33</td><td class="colsep0 rowsep0" align="left">50</td><td class="colsep0 rowsep0" align="left">0</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">77</td><td class="colsep0 rowsep0" align="char" char=".">34</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">42</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>S15</b></td><td class="colsep0 rowsep0" align="left">20</td><td class="colsep0 rowsep0" align="left">39</td><td class="colsep0 rowsep0" align="left">3</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">143</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">72</td><td class="colsep0 rowsep0" align="char" char=".">62</td><td class="colsep0 rowsep0" align="char" char=".">43</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">PB, PrestoBlue assay; Luc, luciferase assay; ATP, ATP assay; transmission-blocking activity (%TRA), reduction in oocyst intensity; transmission-reducing activity (%TBA), reduction in prevalence of infected mosquitoes; ND, not determined.</p></div></div></div><div class="NLM_p">Typically, PPI28 compounds did not exhibit gametocytocidal activity (<30% inhibition at 1 μM). However, several compounds showed strong inhibition in the EIA (80–100% inhibition at 2 μM). IC<sub>50</sub> values were determined on a selection of compounds and confirmed the series potential for gametocyte sterilization and thereby male gamete targeting with activities ranging from 27 to 470 nM. The targeting of male gametes translated into transmission-reduction as evident in a decrease in oocyst formation in the mosquito gut (TRA) at >70% in <i>A. gambiae</i> s.s. and >58% in <i>A. arabiensis</i> for all compounds at 2 μM. Furthermore, >90% TRA was reported for the phenylalanine analogue <b>S15</b> in <i>A. gambiae</i> s.s. There was no significant statistical difference observed in the TRA between the two species evaluated (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_003.xlsx" class="ext-link">Supporting Information File 3</a>). The reduction in the number of mosquitoes that were infected (TBA) (regardless of how many oocysts were found in the gut) was generally lower, albeit still significant. Essentially, for compounds <b>87</b>, <b>98</b>, <b>S3</b>, and <b>S15</b>, 42–72% of the <i>A. gambiae</i> s.s. that fed on a 2 μM drug-treated gametocyte-infected blood meal did not become infected and, as a result, reduced the transmission chain. There was no significant statistical difference between the two species for TBA recorded for six of the compounds; however, this was not true for compounds <b>68</b> and <b>S15</b>. The differences observed for the latter might be due to the higher control prevalence/intensity, lower sample size in the <i>A. gambiae</i> s.s. experiments, or other unknown variables. It is worth noting that these results were obtained from female mosquitoes that had only one blood meal, whereas in a mass drug administration (MDA) program, the female mosquitoes would feed every 2–3 days, potentially increasing the blocking activity.</div><div class="NLM_p last">Interestingly, the two compounds <b>97</b> and <b>S14</b> that displayed a sub-100 nM activity in the male gamete exflagellation assay showed the least reduction in the prevalence of infection but showed significant reduction in the number of oocysts in the midgut of infected mosquitoes (72 and 77%).</div></div><div id="sec3_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> Mutant <i>Pfcarl</i> Profiling and Drug Combination Studies</h3><div class="NLM_p">As discussed earlier, drug selection experiments demonstrated that resistance to <b>1-A</b> was associated with mutations in <i>Pfcarl</i>. To better understand the implications that this drug locus plays in modulating cross-resistance and drug–drug interactions,<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> we profiled a set of PPI28 analogues against these selected mutant parasites along with a panel of existing <i>Pfcarl</i> mutant parasites. As shown in <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a></a>, all diazaspiro[3.4]octane chemical series analogues tested, along with the antimalarial clinical candidate KAF156 and related imidazolopiperazine GNF179, demonstrated altered activities against tested <i>Pfcarl</i> mutant parasites (complete data set shown in Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S21</a>), which suggests a specific chemical–protein interaction. For example, compound <b>1-A</b> exhibited reduced activity against all mutant lines, ranging from a 3.5-fold to 95.5-fold shift, except against the E1104K mutant parasite (MMV692834<sup>R</sup> clone Fl2-A7) that showed increased susceptibility to this compound (15.5 ± 1.7 nM mean IC<sub>50</sub> ± standard deviation (SD), compared to the Dd2 value of 78.7 ± 48.0 nM). Interestingly, the E1104K clone was also more susceptible to <b>S3</b> and <b>S14</b> relative to Dd2 wild-type parasites, whereas all other compounds were significantly less active against the <i>Pfcarl</i> mutant parasites. It is worth noting that imidazolopiperazine compounds KAF156 and GNF179 only showed significant shifts in IC<sub>50</sub> relative to the parental Dd2 line when tested against the E1104K and I1139K clones (>10-fold shift in IC<sub>50</sub> compared to <2.2-fold shift against all other <i>Pfcarl</i> mutants). These differences between mutant parasites’ drug susceptibility to the imidazolpiperazine and the diazaspiro[3.4]octane chemical series could potentially be exploited for further drug optimization that minimizes the effects of PfCARL-mediated drug resistance.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Profiling of Diazaspiro[3.4]octane Chemical Series Analogues, GNF179, and Clinical Candidate Antimalarial KAF156 against PfCARL Mutant Parasite Clones [IC<sub>50</sub> (nM)]<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">PfCARL mutant parasite clone (mutation)</th><th class="colsep0 rowsep0" align="left"> </th><th class="colsep0 rowsep0" align="center" char=".">GNF179</th><th class="colsep0 rowsep0" align="center" char=".">KAF156</th><th class="colsep0 rowsep0" align="center" char="."><b>1-A</b></th><th class="colsep0 rowsep0" align="center" char="."><b>2-A</b></th><th class="colsep0 rowsep0" align="center" char="."><b>98</b></th><th class="colsep0 rowsep0" align="center" char="."><b>106</b></th><th class="colsep0 rowsep0" align="center" char="."><b>S3</b></th><th class="colsep0 rowsep0" align="center" char="."><b>S14</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">Dd2 (wild type)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">8.8</td><td class="colsep0 rowsep0" align="char" char=".">78.7</td><td class="colsep0 rowsep0" align="char" char=".">155.4</td><td class="colsep0 rowsep0" align="char" char=".">151.9</td><td class="colsep0 rowsep0" align="char" char=".">90.8</td><td class="colsep0 rowsep0" align="char" char=".">58.4</td><td class="colsep0 rowsep0" align="char" char=".">26.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">3.2</td><td class="colsep0 rowsep0" align="char" char=".">48.0</td><td class="colsep0 rowsep0" align="char" char=".">77.3</td><td class="colsep0 rowsep0" align="char" char=".">13.0</td><td class="colsep0 rowsep0" align="char" char=".">8.6</td><td class="colsep0 rowsep0" align="char" char=".">5.0</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">1-A<sup>R</sup> E6 (L1073Q)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">12.8</td><td class="colsep0 rowsep0" align="char" char=".">12.6</td><td class="colsep0 rowsep0" align="char" char="."><b>7518.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1698.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>3935.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>563.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>901.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>98.0</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">2604.2</td><td class="colsep0 rowsep0" align="char" char=".">906.6</td><td class="colsep0 rowsep0" align="char" char=".">334.6</td><td class="colsep0 rowsep0" align="char" char=".">53.6</td><td class="colsep0 rowsep0" align="char" char=".">110.8</td><td class="colsep0 rowsep0" align="char" char=".">16.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char="."><b>95.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>10.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>25.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>6.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>15.4</b></td><td class="colsep0 rowsep0" align="char" char="."><b>3.7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">1-A<sup>R</sup> H10 (A1122E)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">13.9</td><td class="colsep0 rowsep0" align="char" char=".">14.8</td><td class="colsep0 rowsep0" align="char" char="."><b>1223.3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1813.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>2610.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>326.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>522.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>63.7</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">3.6</td><td class="colsep0 rowsep0" align="char" char=".">3.8</td><td class="colsep0 rowsep0" align="char" char=".">336.0</td><td class="colsep0 rowsep0" align="char" char=".">847.6</td><td class="colsep0 rowsep0" align="char" char=".">1539.5</td><td class="colsep0 rowsep0" align="char" char=".">39.0</td><td class="colsep0 rowsep0" align="char" char=".">82.3</td><td class="colsep0 rowsep0" align="char" char=".">6.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char="."><b>15.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>11.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>17.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>3.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>8.9</b></td><td class="colsep0 rowsep0" align="char" char=".">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMV692834<sup>R</sup> Fl1-D11 (I1072V)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">14.5</td><td class="colsep0 rowsep0" align="char" char=".">15.2</td><td class="colsep0 rowsep0" align="char" char="."><b>279.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>426.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>351.3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>131.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>320.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>39.5</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">66.9</td><td class="colsep0 rowsep0" align="char" char=".">74.0</td><td class="colsep0 rowsep0" align="char" char=".">27.8</td><td class="colsep0 rowsep0" align="char" char=".">21.5</td><td class="colsep0 rowsep0" align="char" char=".">214.6</td><td class="colsep0 rowsep0" align="char" char=".">9.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">3.5</td><td class="colsep0 rowsep0" align="char" char=".">2.7</td><td class="colsep0 rowsep0" align="char" char=".">2.3</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">5.5</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMV692834<sup>R</sup> Fl2-A7 (E1104K)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char="."><b>130.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>108.4</b></td><td class="colsep0 rowsep0" align="char" char="."><b>15.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1309.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>967.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1253.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>26.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>8.9</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">99.5</td><td class="colsep0 rowsep0" align="char" char=".">15.7</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">527.2</td><td class="colsep0 rowsep0" align="char" char=".">259.3</td><td class="colsep0 rowsep0" align="char" char=".">236.9</td><td class="colsep0 rowsep0" align="char" char=".">7.5</td><td class="colsep0 rowsep0" align="char" char=".">1.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char="."><b>14.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>12.3</b></td><td class="colsep0 rowsep0" align="char" char=".">0.2</td><td class="colsep0 rowsep0" align="char" char="."><b>8.4</b></td><td class="colsep0 rowsep0" align="char" char="."><b>6.4</b></td><td class="colsep0 rowsep0" align="char" char="."><b>13.8</b></td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMV692834<sup>R</sup> Fl3-A8 (L1108W)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">20.4</td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="char" char="."><b>735.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1983.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1820.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>340.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>302.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1450.3</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">9.6</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">110.1</td><td class="colsep0 rowsep0" align="char" char=".">753.8</td><td class="colsep0 rowsep0" align="char" char=".">310.6</td><td class="colsep0 rowsep0" align="char" char=".">15.7</td><td class="colsep0 rowsep0" align="char" char=".">29.9</td><td class="colsep0 rowsep0" align="char" char=".">120.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char="."><b>9.3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>12.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>12.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>3.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>5.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>55.1</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMV910804<sup>R</sup> 3F3 (V1053G)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">11.5</td><td class="colsep0 rowsep0" align="char" char=".">11.1</td><td class="colsep0 rowsep0" align="char" char="."><b>1105.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1843.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>914.4</b></td><td class="colsep0 rowsep0" align="char" char="."><b>205.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>333.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>90.5</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">1205.7</td><td class="colsep0 rowsep0" align="char" char=".">994.0</td><td class="colsep0 rowsep0" align="char" char=".">131.6</td><td class="colsep0 rowsep0" align="char" char=".">15.5</td><td class="colsep0 rowsep0" align="char" char=".">24.9</td><td class="colsep0 rowsep0" align="char" char=".">25.6</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char="."><b>14.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>11.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>6.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>2.3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>5.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>3.4</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">MMV910804<sup>R</sup> 3G3 (M1050I)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char=".">16.4</td><td class="colsep0 rowsep0" align="char" char=".">14.8</td><td class="colsep0 rowsep0" align="char" char="."><b>376.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>332.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1692.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>180.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>131.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1373.5</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">9.3</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">85.3</td><td class="colsep0 rowsep0" align="char" char=".">79.9</td><td class="colsep0 rowsep0" align="char" char=".">242.2</td><td class="colsep0 rowsep0" align="char" char=".">15.2</td><td class="colsep0 rowsep0" align="char" char=".">9.2</td><td class="colsep0 rowsep0" align="char" char=".">149.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char="."><b>4.8</b></td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char="."><b>11.1</b></td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char="."><b>52.2</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" rowspan="2" align="left">KAF156<sup>R</sup> 8iG3 (I1139K)</td><td class="colsep0 rowsep0" align="left">mean IC<sub>50</sub></td><td class="colsep0 rowsep0" align="char" char="."><b>4831.3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>4103.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>13342.2</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1936.6</b></td><td class="colsep0 rowsep0" align="char" char="."><b>5126.7</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1168.0</b></td><td class="colsep0 rowsep0" align="char" char="."><b>2366.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>1101.8</b></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">SD</td><td class="colsep0 rowsep0" align="char" char=".">1015.7</td><td class="colsep0 rowsep0" align="char" char=".">984.2</td><td class="colsep0 rowsep0" align="char" char=".">1389.0</td><td class="colsep0 rowsep0" align="char" char=".">412.4</td><td class="colsep0 rowsep0" align="char" char=".">1102.1</td><td class="colsep0 rowsep0" align="char" char=".">125.6</td><td class="colsep0 rowsep0" align="char" char=".">837.8</td><td class="colsep0 rowsep0" align="char" char=".">253.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">fold shift</td><td class="colsep0 rowsep0" align="char" char="."><b>525.1</b></td><td class="colsep0 rowsep0" align="char" char="."><b>466.3</b></td><td class="colsep0 rowsep0" align="char" char="."><b>169.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>12.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>33.8</b></td><td class="colsep0 rowsep0" align="char" char="."><b>12.9</b></td><td class="colsep0 rowsep0" align="char" char="."><b>40.5</b></td><td class="colsep0 rowsep0" align="char" char="."><b>41.9</b></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup><sup>a</sup></sup><p class="last">Shown is the mean IC<sub>50</sub> value (nM), SD, and fold IC<sub>50</sub> shift relative to Dd2 (parental line from which resistant lines were selected) of at least four replicates against the diazaspiro[3.4]octane chemical series analogues or the clinical antimalarial candidate KAF156 and the related compound GNF179. The PfCARL mutation of drug-selected clones is shown. IC<sub>50</sub> values in bold are significantly different compared to Dd2 as determined by Student’s <i>t</i>-test. Fold shift values in bold are >3 relative to Dd2. Complete data set and values are shown in Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Table S21</a>.</p></div></div></div><div class="NLM_p">As mutations in drug-resistance determinants have previously shown to modulate drug–drug interactions, we also explored the implications of <i>Pfcarl</i> mutations on drug–drug interactions between PPI28 analogues and other compounds with antimalarial activity to understand interactions with PfCARL and potentially further elucidate the MoA.<a onclick="showRef(event, 'ref36 ref37'); return false;" href="javascript:void(0);" class="ref ref36 ref37">(36,37)</a> From the validation set combinations (assayed in three independent experiments), we observed specific antagonistic interactions with pyronaridine and piperaquine, two clinically used antimalarial drugs (Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Figure S5</a>). Compound <b>1-A</b> antagonized the antimalarial activity of pyronaridine only in mutant parasites, with the <i>Pfcarl</i> mutations encoding A1122E and I1072V. Similarly, overt antagonism with piperaquine was only noted for compound <b>2-A</b> in the parasite with PfCARL A1122E mutation and for GNF179 in the parasite with I1072V mutation. More dramatically, compound <b>S14</b> antagonized with all tested compounds that associate with PfCARL-mediated resistance in the PfCARL L1108W and M1050I mutant parasites (MMV692834-resistant clone Fl3-A8 and MMV910804-resistant clone 3G3, respectively) and to a lesser degree V1053G mutant parasites (MMV010804-resistant clone 3F3), compared to the parental line Dd2 and all other <i>Pfcarl</i> mutant parasites (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> and Supporting Information File 1, <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">Figure S6</a>).</div><figure id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0006.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. High degree of antagonism observed in L1108W and M1050I PfCARL mutant parasites (MMV692834-resistant clone Fl3-A8 and MMV910804-resistant clone 3G3, respectively) and to a lesser degree in V1053G mutant parasite (MMV010804-resistant clone 3F3), compared to the parental line Dd2 for combinations that include <b>S14</b>. Shown are representative matrix blocks (of three independent experiments), normalized proliferation responses over 72 h assays, as determined by SYBR Green I fluorescence intensity. Black represents uninhibited parasite proliferation; red represents inhibited parasite growth.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Complete pairwise drug–drug interaction results are available at (<a href="https://tripod.nih.gov/matrix-client/" class="extLink">https://tripod.nih.gov/matrix-client/</a> in the PfCARL project file).</div></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i35">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02517" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02517" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Following screening efforts of a Charles River proprietary library of 12 700 compounds against different lifecycle stages of the malaria parasite, a novel diazaspiro[3.4]octane chemical series, PPI28, was selected for a hit-to-lead program. In addition to the attractive biological profile of the hit compounds that showed high potency against ABS, liver stage, and male gametes, the sp<sup>3</sup>-rich scaffold opened up a wide range of possibilities for optimization at three positions. However, although potency was improved, metabolic liabilities could not be solved.</div><div class="NLM_p">Nevertheless, from a biological and mechanistic perspective, the PPI28 series remains very attractive. In addition to very potent activity against ABS parasites, the series shows potential for transmission blocking in the SMFA, by sterilizing male gametes. Mutant <i>Pfcarl</i> profiling experiments also highlighted differentiated responses between the imidazolopiperazine and the diazaspiro[3.4]octane chemical series that can be leveraged for further drug optimization and insight into the mechanism by which PfCARL mediates drug resistance.</div><div class="NLM_p last">These PPI28 analogues, though not themselves amenable to further studies due to several liabilities, could serve as reference compounds in ligand-based virtual screening efforts to identify pan-active hits with a novel mechanism of action and initiate new malaria drug discovery programs.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i36">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47731" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47731" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">All commercially available chemicals were purchased from either Sigma-Aldrich or Combi-Blocks. Unless otherwise stated, all solvents used were anhydrous. <sup>1</sup>H NMR spectra were recorded on a Bruker spectrometer at 300 or 400 MHz. <sup>13</sup>C NMR spectra were recorded at 75 or 100 MHz on a Bruker spectrometer. Analytical thin-layer chromatography (TLC) was performed on aluminum-backed silica gel 60 F<sub>254</sub> (70–230 mesh) plates. Column chromatography was performed with a Teledyne ISCO CombiFlash RF system using Siliasep universal flash cartridges from SiliCycle (FLHR10030B). Chemical shifts (δ) are given in ppm downfield. Coupling constants, <i>J</i>, are recorded in hertz (Hz). Purity was determined by liquid chromatography-mass spectrometry (LCMS), and all final compounds were confirmed to have >95% purity. The protocols and data not shown below are supplied in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf" class="ext-link">Supporting Information File 2</a>.</div><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> Preparation of <i>tert</i>-Butyl 3-(2-Ethoxy-2-oxoethylidene) Azetidine-1-carboxylate Intermediate <b>3</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></h3><div class="NLM_p">To a solution of <i>tert</i>-butyl 3-oxoazetidine-1-carboxylate (70.0 g, 234 mmol, 1 equiv) in toluene (400 mL) was added ethyl 2-(triphenylphosphanylidene) acetate (86.0 g, 239 mmol, 1.02 equiv). The reaction was stirred at 110 °C for 3 h, cooled, and then stirred at 25 °C for an additional 12 h. The resulting precipitate was removed by filtration and washed with Et<sub>2</sub>O. The filtrates were combined and evaporated under reduced pressure, and the residue was purified on a Teledyne ISCO CombiFlash system eluting a gradient of EtOAc in hexane (0–20%) on a silica column to yield <i>tert</i>-butyl 3-(2-ethoxy-2-oxoethylidene)azetidine-1-carboxylate <b>3</b> (54 g, 96%) as a colorless oil.</div><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 5.79–5.76 (m, 1H), 4.84–4.81 (m, 2H), 4.62–4.58 (m, 2H), 4.19 (q, <i>J</i> = 7.1 Hz, 2H), 1.47 (s, 9H), 1.29 (t, <i>J</i> = 7.2 Hz, 3H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>12</sub>H<sub>19</sub>NO<sub>4</sub>: 241.13, found: <i>m</i>/<i>z</i> 186.1 [M – C<sub>4</sub>H<sub>8</sub> + H]<sup>+</sup>. (Note: the loss of <i>t</i>-Bu fragment (56) is often seen for compounds with Boc groups.)</div><div class="NLM_p last">Note: Initially, methyl 2-(triphenylphosphanylidene)acetate was used to form tert-butyl 3-(2-methoxy-2-oxoethylidene)azetidine-1-carboxylate. The same procedures were used.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> Preparation of 2-<i>O</i>-<i>tert</i>-Butyl 5-<i>O</i>-Ethyl 7-Benzyl-2,7-diazaspiro[3.4]octane-2,5-dicarboxylate Intermediate (<b>4</b>)<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></h3><div class="NLM_p">To a solution of <i>tert</i>-butyl 3-(2-ethoxy-2-oxo-ethylidene)azetidine-1-carboxylate <b>3</b> (10.0 g, 41.5 mmol, 1 equiv) in CH<sub>3</sub>CN (80 mL) were added LiF (4.3 g, 166 mmol, 4 equiv) and <i>N</i>-(methoxymethyl)-1-phenyl-<i>N</i>-(trimethylsilylmethyl)methanamine (12.5 g, 50 mmol, 1.2 equiv) at 25 °C. The reaction mixture was stirred at 60 °C for 24 h. The reaction was monitored by LCMS. After completion of the reaction, the solvents were removed under reduced pressure. The residue was purified by silica gel chromatography on a Teledyne ISCO CombiFlash system using a gradient of EtOAc in hexane (0–50%). The desired compound 2-<i>O</i>-<i>tert</i>-butyl 5-<i>O</i>-ethyl 7-benzyl-2,7-diazaspiro[3.4]octane-2,5-dicarboxylate <b>4</b> (10.4 g, 67% yield) was obtained as a colorless oil that was taken up to the next step without further purification.</div><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.40–7.21 (m, 5H), 4.28–4.12 (m, 2H), 3.97 (d, <i>J</i> = 8.5 Hz, 1H), 3.90–3.80 (m, 2H), 3.73 (d, <i>J</i> = 9.3 Hz, 1H), 3.65 (d, <i>J</i> = 2.3 Hz, 2H), 3.10–2.99 (m, 2H), 2.95 (d, <i>J</i> = 9.1 Hz, 1H), 2.85–2.69 (m, 2H), 1.44 (s, 9H), 1.30 (t, <i>J</i> = 7.1 Hz, 3H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>21</sub>H<sub>30</sub>N<sub>2</sub>O<sub>4</sub>: 374.22, found: <i>m</i>/<i>z</i> 375.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> General Procedure for Azetidine Boc-Deprotection</h3><div class="NLM_p">TFA (30 equiv) was slowly added to a solution of <i>N</i>-Boc azetidine intermediate (1 equiv) in DCM (100 mL, <i>C</i> = 0.36 M) at 0 °C. The resulting reaction mixture was allowed to warm and stirred at 25 °C for 16 h. After LCMS confirmed completion of the reaction, the mixture was evaporated in vacuo. The residue was subsequently dissolved in MeOH and evaporated under reduced pressure. The obtained solid was dissolved in DCM/MeOH (9:1, 20 mL) and stirred with Amberlyst A21 ion-exchange resin for 1 h. The resin was filtered off and the filtrate was evaporated under reduced pressure to afford ethyl 6-benzyl-2,6-diazaspiro[3.4]octane-8-carboxylate (83% to quantitative yield). The product was dissolved in H<sub>2</sub>O and dried on a freeze-drier for 24 h, and the resulting thick yellow syrup was used as is in the next step.</div><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.64–7.43 (m, 5H), 4.48 (s, 2H), 4.40–4.14 (m, 6H), 3.97–3.65 (m, 5H), 1.36 (t, <i>J</i> = 7.2 Hz, 3H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>16</sub>H<sub>22</sub>N<sub>2</sub>O<sub>2</sub>: 274.17, found: <i>m/z</i> 275.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> General Procedure for the Buchwald–Hartwig Coupling (Route A)</h3><div class="NLM_p">Methyl or ethyl 6-benzyl-2,6-diazaspiro[3.4]octane-8-carboxylate (1 equiv) was dissolved in <i>tert</i>-BuOH (<i>C</i> = 0.36 M) with the corresponding aryl halide (1 equiv) in a vessel that can be sealed. RuPhos (1.01 g, 2.2 mmol, 0.06 equiv) and Cs<sub>2</sub>CO<sub>3</sub> (11.4 g, 108.3 mmol, 3 equiv) were added, followed by Pd<sub>2</sub>(dba)<sub>3</sub> (2.6 g, 2.9 mmol, 0.08 equiv). The resulting solution was flushed with nitrogen for 15 min, and the reaction vessel was sealed and stirred at 110 °C for 12 h. At this time, LCMS indicated that the starting material had disappeared and that the desired compound had been formed. H<sub>2</sub>O was added to the reaction mixture, and extraction was performed with EtOAc. The organic layers were combined and dried over Na<sub>2</sub>SO<sub>4</sub> before being evaporated under reduced pressure. When further purification was needed, the residue was purified by silica gel chromatography on a Teledyne ISCO CombiFlash system using a gradient of EtOAc in hexane. Compounds were obtained in 29–99% yield (40% with iodobenzene, 29% with 1-bromo-4-fluorobenzene, quantitative with 1-bromo-3,5-difluorobenzene).</div><div id="sec5_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> R<sup>3</sup> = Ph: Methyl 6-Benzyl-2-phenyl-2,6-diazaspiro[3.4]octane-8-carboxylate (<b>5a</b>)</h4><div class="NLM_p">40% yield, yellow oil, purification: silica column chromatography with a 0–30% gradient of EtOAc in hexane.</div><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.29–7.32 (m, 4H), 7.23–7.24 (m, 1H), 7.19 (t, 2H, <i>J</i> = 7.5 Hz), 6.73 (t, 1H, <i>J</i> = 7.3 Hz), 6.42 (d, 2H, <i>J</i> = 8.0 Hz), 3.85 (d, 1H, <i>J</i> = 6.8 Hz), 3.75 (d, 2H, <i>J</i> = 8.0 Hz), 3.62–3.70 (m, 6H), 3.05–3.14 (m, 3H), 2.75–2.77 (m, 1H), 2.69–2.77 (m, 1H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>21</sub>H<sub>24</sub>N<sub>2</sub>O<sub>2</sub>: 336.18, found: <i>m</i>/<i>z</i> 337.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> R<sup>3</sup> = 4-Ph: Methyl 6-Benzyl-2-(4-fluorophenyl)-2,6-diazaspiro[3.4]octane-8-carboxylate (<b>5b</b>)</h4><div class="NLM_p">29% yield, yellow oil, purification: silica gel chromatography on a Teledyne ISCO CombiFlash system with a 0–50% gradient of EtOAc in hexane.</div><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.47–7.26 (m, 3H), 7.01–6.89 (m, 1H), 6.45–6.35 (m, 1H), 3.86 (d, <i>J</i> = 6.8 Hz, 1H), 3.80–3.67 (m, 4H), 3.13 (qd, <i>J</i> = 8.7, 8.3, 2.9 Hz, 2H), 2.85–2.71 (m, 1H). LCMS (ESI)<sup>+</sup>: exact mass calcd for C<sub>21</sub>H<sub>23</sub>FN<sub>2</sub>O<sub>2</sub>: 354.17, found: <i>m</i>/<i>z</i> 355.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> R<sup>3</sup> = 3,5-Ph: Ethyl 7-Benzyl-2-(3,5-difluorophenyl)-2,7-diazaspiro[3.4]octane-5-carboxylate (<b>5c</b>)</h4><div class="NLM_p">99% yield, orange thick syrup, no purification needed.</div><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.24–7.10 (m, 5H), 6.08 (tt, <i>J</i> = 9.3, 2.3 Hz, 1H), 5.89–5.75 (m, 2H), 4.09 (qd, <i>J</i> = 7.2, 2.1 Hz, 2H), 3.76 (d, <i>J</i> = 1.5 Hz, 2H), 3.69–3.57 (m, 4H), 3.03–2.95 (m, 3H), 2.80–2.69 (m, 2H), 1.14 (t, <i>J</i> = 7.1 Hz, 3H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>22</sub>H<sub>24</sub>F<sub>2</sub>N<sub>2</sub>O<sub>2</sub>: 386.18, found: <i>m</i>/<i>z</i> 387.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> General Procedure for R<sup>2</sup> Ester Reduction</h3><div id="sec5_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> R<sup>1</sup> = Benzyl (Route A)</h4><div class="NLM_p">Methyl or ethyl 7-benzyl-2-(3,5-difluorophenyl)-2,7-diazaspiro[3.4]octane-5-carboxylate (1 equiv) was dissolved in dry THF (<i>C</i> = 0.36 M) under N<sub>2</sub>. The solution was cooled down to 0 °C, and LAH (3 equiv) was added portionwise. The resulting mixture was allowed to warm from 0 to 25 °C and was stirred for 12 h, at which time LCMS indicated completion of the reaction. H<sub>2</sub>O was added at 0 °C, and the solution was filtered to remove the lithium salts. The filtrate was extracted with EtOAc, and the combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>. The solvents were removed under reduced pressure. The desired compounds were obtained in 64–77% yield and used without any further purification in the next step.</div><div id="sec5_5_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Representative Intermediate</h5></div><div id="sec5_5_1_2" class="NLM_sec NLM_sec_level_4"><div class="NLM_p first last"><b>R<sup>1</sup> = Bn, R<sup>2</sup> = CH<sub>2</sub>-OH, R<sup>3</sup> = 3,5-diF-Ph: (6-Benzyl-2-(3,5-difluorophenyl)-2,6-diazaspiro[3.4]octan-8-yl)methanol (6c)</b>: <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 7.42–7.31 (m, 5H), 6.18 (tt, <i>J</i> = 9.3, 2.2 Hz, 1H), 6.00–5.82 (m, 2H), 4.07 (d, <i>J</i> = 7.8 Hz, 1H), 3.93–3.53 (m, 8H), 3.03 (d, <i>J</i> = 9.9 Hz, 1H), 2.81–2.64 (m, 3H), 2.41–2.29 (m, 1H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>20</sub>H<sub>22</sub>F<sub>2</sub>N<sub>2</sub>O: 344.17, found: <i>m</i>/<i>z</i> 345.2 [M + H]<sup>+</sup>.</div></div></div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> General Procedure for Mesylation, Followed by Amination</h3><div id="sec5_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> Step 1: Mesylation</h4><div class="NLM_p">To a solution of the appropriate alcohol intermediate (1 equiv) and Et<sub>3</sub>N (1.5 equiv) in DCM (<i>C</i> = 1.4 M) at 0 °C was slowly added MsCl (1.2 equiv). The reaction was stirred at 25 °C for 3 h, allowing the bath to warm up. When LCMS confirmed completion of the reaction, H<sub>2</sub>O was added to the reaction mixture and the solution was extracted with EtOAc. The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure to obtain the crude product, which was used without further purification in the next step (74–78%).</div><div id="sec5_6_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i49" class="anchor-spacer"></div><h5 class="article-section__title" id="_i49"> Representative Intermediates</h5></div><div id="sec5_6_1_2" class="NLM_sec NLM_sec_level_4"><div class="NLM_p first last"><b>R<sup>1</sup> = Bn, R<sup>2</sup> = CH<sub>2</sub>-OMs, R<sup>3</sup> = Ph: {6-Benzyl-2-phenyl-2,6-diazaspiro[3.4]octan-8-yl}methyl Methanesulfonate (7a) (74%, Brown Oil)</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.33–7.18 (m, 6H), 6.74 (t, 1H, <i>J</i> = 7.2 Hz), 6.44 (d, 2H, <i>J</i> = 8.1 Hz), 7.40–7.37 (m, 1H), 4.28–4.23 (m, 1H), 3.88–3.83 (m, 2H), 3.72 (d, 1H, <i>J</i> = 6.9 Hz), 3.66–3.58 (m, 3H), 3.00 (d, 1H, <i>J</i> = 9.4 Hz), 2.96–2.88 (m, 4H), 2.73 (d, 1H, <i>J</i> = 9.4 Hz), 2.57–2.51 (m, 1H), 2.40–2.36 (m, 1H). LCMS (ESI)<sup>+</sup>: exact mass calcd for C<sub>21</sub>H<sub>26</sub>N<sub>2</sub>O<sub>3</sub>S: 386.17, found: <i>m</i>/<i>z</i> 387.2 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_6_2" class="NLM_sec NLM_sec_level_3"><div class="NLM_p first last"><b>R<sup>1</sup> = Bn, R<sup>2</sup> = CH<sub>2</sub>-OMs, R<sup>3</sup> = 3,5-diF-Ph: [7-Benzyl-2-(3,5-difluorophenyl)-2,7-diazaspiro[3.4]octan-5-yl]methyl Methanesulfonate (7c) (78%, Brown Oil)</b>: LCMS ESI<sup>+</sup>: <i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>24</sub>F<sub>2</sub>N<sub>2</sub>O<sub>3</sub>S: 422.15, found 423.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> Step 2: Amination from Mesylate Intermediate 7 (Route A)</h4><div class="NLM_p">To a solution of appropriate amine (1 equiv) in DMF (<i>C</i> = 0.26 M) at 0 °C was added NaH (60% dispersion in oil, 1.2 equiv). The resulting mixture was stirred for 0.5 h at 0 °C, at which time a solution of methanesulfonate <b>7</b> intermediate from a previous step (1 equiv) in DMF (<i>C</i> = 0.26 M) was added into the suspension at 0 °C. The obtained mixture was stirred at 50 °C for 12 h. The solution was cooled, diluted with H<sub>2</sub>O, and extracted with EtOAc. The combined organic layers were washed with H<sub>2</sub>O, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude was purified by silica gel chromatography on a Teledyne ISCO CombiFlash system eluting a gradient of EtOAc in hexane (typically 0–30%) to obtain the desired intermediate in 32–58% yield.</div><div id="sec5_6_3_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i51" class="anchor-spacer"></div><h5 class="article-section__title" id="_i51"> Representative Intermediates</h5></div></div><div id="sec5_6_4" class="NLM_sec NLM_sec_level_3"><div class="NLM_p first last"><b>R<sup>1</sup> = Bn, R<sup>2</sup> = CH<sub>2</sub>-[<i>N</i>-Boc-aniline], R<sup>3</sup> = Ph: <i>tert</i>-Butyl <i>N</i>-({6-Benzyl-2-phenyl-2,6-diazaspiro[3.4]octan-8-yl}methyl)-<i>N</i>-phenylcarbamate (8a) (58%, Yellow Oil)</b>: <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.22–7.30 (m, 6H), 7.16–7.20 (m, 4H), 7.10 (d, 2H, <i>J</i> = 7.6 Hz), 6.70–6.73 (m, 1H), 6.39 (d, 2H, <i>J</i> = 7.9 Hz), 3.78–3.93 (m, 3H), 3.61–3.71 (m, 2H), 3.52–3.56 (m, 3H), 2.98 (d, 1H, <i>J</i> = 9.5 Hz), 2.86 (s, 1H), 2.60–2.67 (m, 1H), 2.30–2.36 (m, 2H), 1.37 (s, 9H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>31</sub>H<sub>37</sub>N<sub>3</sub>O<sub>2</sub>: 483.29, found: <i>m</i>/<i>z</i> 484.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_6_5" class="NLM_sec NLM_sec_level_3"><div class="NLM_p first last"><b>R<sup>1</sup> = Bn, R<sup>2</sup> = CH<sub>2</sub>-[<i>N</i>-Boc, 4F-aniline], R<sup>3</sup> = 3,5-diF-Ph: <i>tert</i>-Butyl <i>N</i>-[[7-Benzyl-2-(3,5-difluorophenyl)-2,7-diazaspiro[3.4]octan-5-yl]methyl]-<i>N</i>-(4-fluorophenyl)carbamate (8c) (32%, Yellow Oil)</b>: <sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.43–7.23 (m, 5H), 7.18 (ddt, <i>J</i> = 8.3, 5.5, 2.8 Hz, 2H), 7.11–6.99 (m, 2H), 6.18 (tt, <i>J</i> = 9.4, 2.2 Hz, 1H), 6.06–5.88 (m, 2H), 4.07–3.95 (m, 2H), 3.84–3.47 (m, 6H), 3.33 (p, <i>J</i> = 1.7 Hz, 2H), 3.01 (d, <i>J</i> = 9.9 Hz, 1H), 2.92–2.81 (m, 1H), 2.75 (d, <i>J</i> = 9.9 Hz, 1H), 2.42–2.21 (m, 2H), 1.38 (s, 9H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>31</sub>H<sub>34</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>: 537.26, found: <i>m</i>/<i>z</i> 538.3 [M + H]<sup>+</sup>.</div></div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> General Procedure for Debenzylation</h3><div class="NLM_p">A stirred solution of benzylated intermediate (1 equiv) in EtOH (<i>C</i> = 0.06 M) was purged with N<sub>2</sub> for 20 min before adding Pd(OH)<sub>2</sub> (0.2 equiv) at 25 °C. The resulting solution was then alternatively purged with N<sub>2</sub> and evacuated (3×) before being stirred under H<sub>2</sub> (balloon) at 25 °C for 16 h (needle, bubbling in the solution). The reaction was monitored by LCMS. After completion of the reaction, the balloon was removed, and the reaction mixture was evacuated and purged with nitrogen (2×). The solution was filtered through a bed of celite and washed with MeOH (with 0.5 M NH<sub>3</sub>) (20 mL × 3). The filtrates were combined and concentrated under reduced pressure. The crude was dried on a freeze-drier and used as is in the following step (84–98% yield).</div><div id="sec5_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> Representative Intermediate</h4><div id="sec5_7_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i54" class="anchor-spacer"></div><h5 class="article-section__title" id="_i54"> R<sup>1</sup> = H, R<sup>2</sup> = CH<sub>2</sub>-[<i>N</i>-Boc, 4F-aniline], R<sup>3</sup> = 3,5-diF-Ph: <i>tert</i>-Butyl <i>N</i>-[[2-(3,5-Difluorophenyl)-2,7-diazaspiro[3.4]octan-5-yl]methyl]-<i>N</i>-(4-fluorophenyl)carbamate Key Intermediate (<b>9c</b>) (84%, Pale-Yellow Foam)</h5><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.33–7.20 (m, 2H), 7.16–7.05 (m, 2H), 6.20 (tt, <i>J</i> = 9.5, 2.2 Hz, 1H), 6.07–5.87 (m, 2H), 4.08–3.91 (m, 2H), 3.84–3.66 (m, 3H), 3.60 (d, <i>J</i> = 7.8 Hz, 1H), 3.13 (s, 2H), 3.05 (dd, <i>J</i> = 11.3, 7.4 Hz, 1H), 2.63 (dd, <i>J</i> = 11.3, 7.5 Hz, 1H), 2.33–2.21 (m, 1H), 1.41 (s, 9H). <sup>13</sup>C NMR (151 MHz, MeOD) δ 164.87 (d, <i>J</i> = 15.7 Hz), 163.25 (d, <i>J</i> = 15.7 Hz), 161.82, 160.20, 155.07, 153.81, 137.99 (d, <i>J</i> = 3.2 Hz), 129.04 (d, <i>J</i> = 8.4 Hz), 115.27 (d, <i>J</i> = 23.0 Hz), 95.26–92.46 (m), 91.65, 80.65, 60.79, 56.72 (d, <i>J</i> = 27.6 Hz), 49.43, 44.82, 43.30, 27.12. LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>24</sub>H<sub>28</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>: 447.21, found: <i>m</i>/<i>z</i> 448.2 [M + H]<sup>+</sup>.</div></div></div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> General Procedure for Amide Coupling at the R<sup>1</sup> Position</h3><div class="NLM_p">To a stirred solution of appropriate pyrrolidine intermediate (1 equiv) in DCM (<i>C</i> = 0.15 M) were added the corresponding carboxylic acid (1.2 equiv), HOPO (1.2 equiv), EDCI·HCl (1.2 equiv), and DIPEA (3 equiv) at 25 °C. The reaction mixture was stirred at this temperature for 16 h. After completion of reaction (monitored by LCMS), the reaction mixture was dissolved in H<sub>2</sub>O and extracted with EtOAc. The organic layers were combined and dried over Na<sub>2</sub>SO<sub>4</sub>, and the solvents were removed under reduced pressure. The residue was purified by silica gel chromatography on a Teledyne ISCO CombiFlash system eluting a gradient of EtOAc in hexane (typically 0–80%) to give the desired compound, which was used as is in the next step (29–85%).</div><div id="sec5_8_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> Representative Intermediate</h4><div id="sec5_8_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i57" class="anchor-spacer"></div><h5 class="article-section__title" id="_i57"> R<sup>1</sup> = (4-Hydroxyphenyl)acetic Acid, R<sup>2</sup> = CH<sub>2</sub>-[<i>N</i>-Boc-aniline], R<sup>3</sup> = Ph: <i>tert</i>-Butyl <i>N</i>-({6-[2-(4-Hydroxyphenyl)acetyl]-2-phenyl-2,6-diazaspiro[3.4]octan-8-yl}methyl)-<i>N</i>-phenylcarbamate <b>(10c</b>) (92%, Off-White Solid)</h5><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, dimethyl sulfoxide (DMSO)-<i>d</i><sub>6</sub>): δ 9.24–9.20 (m, 1H), 7.37–7.33 (m, 2H), 7.26–7.16 (m, 5H), 6.98 (d, 1H, <i>J</i> = 7.8 Hz), 6.91 (d, 1H, <i>J</i> = 8.0 Hz), 6.68–6.66 (m, 3H), 6.40 (d, 2H, <i>J</i> = 7.5 Hz), 3.89–3.83 (m, 2H), 3.76–3.46 (m, 7H), 3.36–3.33 (m, 1H), 2.98–2.94 (m, 1H), 2.48–2.45 (m, 1H), 2.42–2.40 (m, 1H), 1.36–1.34 (m, 9H). LCMS ESI<sup>+</sup>: exact mass calcd for C<sub>32</sub>H<sub>37</sub>N<sub>2</sub>O<sub>4</sub>: 527.28, found: <i>m</i>/<i>z</i> 528.4 [M + H]<sup>+</sup>.</div></div></div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> General Procedure for Final Boc-Deprotection (Route A)</h3><div class="NLM_p">To a solution of corresponding carbamate (1 equiv) in DCM (<i>C</i> = 0.15 M) was added a 4 M HCl solution in dioxane (10 equiv). The resulting mixture was stirred at 25 °C for 24 h, at which time the LCMS showed completion of the reaction.</div><div class="NLM_p">The solvents were removed under reduced pressure, and the residue was dissolved in DCM/MeOH (9:1) and stirred with Amberlyst A21 ion-exchange resin for 30 min. The resin was filtered off and rinsed with methanol, and the filtrate was concentrated.</div><div class="NLM_p">The residue was adsorbed on silica gel and purified on a Teledyne ISCO CombiFlash system eluting a gradient of MeOH in DCM (typically 0–5/10%) to obtain the desired final compounds (40–95%). Enantiomers <b>1-A</b>, <b>1-B</b>, <b>2-A</b>, <b>2-B</b>, <b>68-A</b>, and <b>68-B</b> were separated on chiral columns as described in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf" class="ext-link">Supporting Information File 2</a>.</div><div class="NLM_p">All final compounds are characterized in <a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf" class="ext-link">Supporting Information File 2</a> (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf" class="ext-link">Table S22</a>).</div><div id="sec5_9_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> Representative Compounds</h4><div id="sec5_9_1_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i60" class="anchor-spacer"></div><h5 class="article-section__title" id="_i60"> 2-(4-Hydroxyphenyl)-1-(2-phenyl-8-((phenylamino)methyl)-2,6-diazaspiro[3.4]octan-6-yl)ethan-1-one (<b>1-A</b>) (Single Enantiomer, Stereochemistry Not Determined)</h5><div class="NLM_p"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.19 (s, 1H), 7.16 (t, 2H, <i>J</i> = 7.9 Hz), 7.09–6.96 (m, 4H), 6.67–6.59 (m, 5H), 6.55–6.49 (m, 3H), 5.74–5.71 (m, 1H), 3.85–3.80 (m, 1H), 3.72–3.66 (m, 1H), 3.70–3.42 (m, 5H), 3.38–3.36 (m, 2H), 3.18–3.14 (m, 3H), 2.88–2.81 (m, 1H); LCMS (ESI)<sup>+</sup>: exact mass calcd for C<sub>27</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>: 427.23, <i>m</i>/<i>z</i> found: 428.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">[α]<sub>D</sub> = −2.52° (<i>C</i> = 0.1986 g/100 mL in DMSO, <i>T</i> = 25 °C, path length = 1 dm, wavelength: 589 nm).</div></div><div id="sec5_9_1_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i61" class="anchor-spacer"></div><h5 class="article-section__title" id="_i61"> 4-((2-Phenyl-8-((phenylamino)methyl)-2,6-diazaspiro[3.4]octan-6-yl)methyl)phenol (<b>2-A</b>) (Single Enantiomer, Stereochemistry Not Determined)</h5><div class="NLM_p"><sup>1</sup>H NMR (DMSO-<i>d</i><sub>6</sub>, 400 MHz): δ 9.22 (s, 1H), 7.16 (t, 2H, <i>J</i> = 7.7 Hz), 7.09–7.02 (m, 4H), 6.69–6.63 (m, 5H), 6.58 (d, 2H, <i>J</i> = 8.0 Hz), 6.50 (t, 1H, <i>J</i> = 7.2 Hz), 5.58 (bs, 1H), 3.43–3.32 (m, 3H), 3.21–3.24 (m, 2H), 3.11 (s, 3H), 2.86–2.82 (t, 1H, <i>J</i> = 8.2 Hz), 2.60–2.57 (m, 1H), 2.48–2.44 (m, 2H), 2.36–2.33 (m, 1H); LCMS (ESI)<sup>+</sup>: exact mass calcd for C<sub>26</sub>H<sub>29</sub>N<sub>3</sub>O<sub>2</sub>: 399.23, found: <i>m</i>/<i>z</i> 400.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">[α]<sub>D</sub> = −31.25° (<i>C</i> = 0.3552 g/100 mL in MeOH, <i>T</i> = 25 °C, path length = 1 dm, wavelength: 589 nm).</div></div><div id="sec5_9_1_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i62" class="anchor-spacer"></div><h5 class="article-section__title" id="_i62"> 1-(2-(4-Fluorophenyl)-8-((phenylamino)methyl)-2,6-diazaspiro[3.4]octan-6-yl)-2-(4-hydroxyphenyl)ethan-1-one (<b>68-A</b>) (Single Enantiomer, Stereochemistry Not Determined)</h5><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, chloroform-<i>d</i>) δ 7.27–7.20 (m, 2H), 7.15–7.05 (m, 2H), 6.96–6.85 (m, 2H), 6.83–6.71 (m, 3H), 6.62–6.49 (m, 4H), 5.27 (br s, 1H), 3.96–3.79 (m, 1H), 3.78–3.62 (m, 3H), 3.59 (d, <i>J</i> = 4.8 Hz, 2H), 3.54–3.17 (m, 6H), 2.94–2.72 (m, 1H); LCMS: exact mass calcd for C<sub>27</sub>H<sub>28</sub>FN<sub>3</sub>O<sub>2</sub>: 445.22, found: <i>m</i>/<i>z</i> 446.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">[α]<sub>D</sub> = 8.6° (<i>C</i> = 0.21 g/100 mL, T= 20 °C, path length = 1 dm, wavelength: 589 nm).</div></div><div id="sec5_9_1_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i63" class="anchor-spacer"></div><h5 class="article-section__title" id="_i63"> (2<i>R</i>)-2-Amino-1<b>-</b>[2-(3,5-difluorophenyl)-5-[(4-fluoroanilino)methyl]-2,7-diazaspiro[3.4]octan-7-yl]-2-(4-hydroxyphenyl)ethenone (<b>97</b>)</h5><div class="NLM_p"><sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.24–7.10 (m, 2H), 6.97–6.65 (m, 4H), 6.51 (ddd, <i>J</i> = 9.1, 4.3, 1.9 Hz, 1H), 6.37 (ddd, <i>J</i> = 9.1, 4.3, 1.5 Hz, 1H), 6.27–6.15 (m, 1H), 6.13–5.99 (m, 2H), 4.64–4.50 (m, 1H), 3.90–3.44 (m, 4H), 3.35 (s, 2H), 3.28–2.60 (m, 6H); LCMS: exact mass calcd for C<sub>27</sub>H<sub>27</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>: 496.2, found: <i>m</i>/<i>z</i> 497.2 [M + H]<sup>+</sup>.</div><div class="NLM_p last">[α]<sub>D</sub> = −10.4° (<i>C</i> = 0.28 g/100 mL, <i>T</i> = 20 °C, path length = 1 dm, wavelength: 589 nm).</div></div><div id="sec5_9_1_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i64" class="anchor-spacer"></div><h5 class="article-section__title" id="_i64"> (2<i>S</i>)-2-Amino-1-[2-(3,5-difluorophenyl)-5-[(4-fluoroanilino)methyl]-2,7-diazaspiro[3.4]octan-7-yl]-2-(4-hydroxyphenyl)ethenone (<b>98</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 7.28–7.10 (m, 2H), 6.99–6.71 (m, 4H), 6.59 (ddd, <i>J</i> = 12.6, 8.3, 4.0 Hz, 1H), 6.47 (ddd, <i>J</i> = 19.6, 9.0, 4.8 Hz, 1H), 6.29–5.94 (m, 3H), 4.69–4.54 (m, 1H), 4.12–3.39 (m, 6H), 3.28–2.98 (m, 3H), 2.90–2.76 (m, 1H), 2.72–2.40 (m, 1H); LCMS: exact mass calcd for C<sub>27</sub>H<sub>27</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>: 496.21, found: <i>m</i>/<i>z</i> 497.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_9_1_6" class="NLM_sec NLM_sec_level_4"><div id="ac_i65" class="anchor-spacer"></div><h5 class="article-section__title" id="_i65"> (2<i>R</i>)-2-Amino-3-(4-aminophenyl)-1-[2-(3,5-difluorophenyl)-5-[(4-fluoroanilino)methyl]-2,7-diazaspiro[3.4]octan-7-yl]propan-1-one (<b>106</b>)</h5><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, methanol-<i>d</i><sub>4</sub>) δ 6.97 (ddt, <i>J</i> = 19.7, 17.5, 8.5 Hz, 4H), 6.74 (t, <i>J</i> = 8.2 Hz, 1H), 6.64–6.48 (m, 3H), 6.28–6.12 (m, 2H), 6.12–6.01 (m, 1H), 4.24 (qd, <i>J</i> = 11.5, 10.9, 7.1 Hz, 1H), 3.89–3.33 (m, 5H), 3.24–2.44 (m, 8H); LCMS: exact mass calcd for C<sub>28</sub>H<sub>30</sub>F<sub>3</sub>N<sub>5</sub>O: 509.3, found: <i>m</i>/<i>z</i> 510.2 [M + H]<sup>+</sup>.</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i66"><a href="/doi/suppl/10.1021/acs.jmedchem.1c00034" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23438" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23438" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.1c00034?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00034</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Procedures used for the biological as well as in vitro and in vivo DMPK studies (Supporting Information File 1) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Additional details of the synthetic protocols and compound characterization (Supporting Information File 2) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">SMFA data (Supporting Information File 3) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_003.xlsx" class="ext-link">XLSX</a>)</p></li><li><p class="inline">Excel file with molecular strings (Supporting Information File 4) (<a href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_004.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf">jm1c00034_si_001.pdf (11.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf">jm1c00034_si_002.pdf (1.81 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_003.xlsx">jm1c00034_si_003.xlsx (605.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_004.csv">jm1c00034_si_004.csv (8.79 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/acs.jmedchem.1c00034" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81056" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81056" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kelly Chibale</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">South
African Medical Research Council, Drug Discovery and Development Research
Unit, Department of Chemistry and Institute of Infectious Disease
and Molecular Medicine, University of Cape
Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1327-4727" title="Orcid link">http://orcid.org/0000-0002-1327-4727</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#3f745a535346117c57565d5e535a7f4a5c4b115e5c11455e"><span class="__cf_email__" data-cfemail="dd96b8b1b1a4f39eb5b4bfbcb1b89da8bea9f3bcbef3a7bc">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claire Le Manach</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jean Dam</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John G. Woodland</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gurminder Kaur</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lutete P. Khonde</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christel Brunschwig</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mathew Njoroge</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1276-2224" title="Orcid link">http://orcid.org/0000-0003-1276-2224</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathryn J. Wicht</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">André Horatscheck</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tanya Paquet</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Grant A. Boyle</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Liezl Gibhard</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dale Taylor</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nina Lawrence</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), Division of Clinical Pharmacology,
Department of Medicine, University of Cape
Town, Observatory 7925, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tomas Yeo</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sachel Mok</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-9605-0154" title="Orcid link">http://orcid.org/0000-0002-9605-0154</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard T. Eastman</span> - <span class="hlFld-Affiliation affiliation">Division
of Preclinical Innovation, National Center for Advancing Translational
Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-3580-380X" title="Orcid link">http://orcid.org/0000-0003-3580-380X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dorjbal Dorjsuren</span> - <span class="hlFld-Affiliation affiliation">Division
of Preclinical Innovation, National Center for Advancing Translational
Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel C. Talley</span> - <span class="hlFld-Affiliation affiliation">Division
of Preclinical Innovation, National Center for Advancing Translational
Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hui Guo</span> - <span class="hlFld-Affiliation affiliation">Division
of Preclinical Innovation, National Center for Advancing Translational
Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anton Simeonov</span> - <span class="hlFld-Affiliation affiliation">Division
of Preclinical Innovation, National Center for Advancing Translational
Sciences, National Institutes of Health, Bethesda, Maryland 20892, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janette Reader</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Genetics and Microbiology, Institute for Sustainable
Malaria Control, University of Pretoria, Hatfield, Pretoria 0028, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mariëtte van der Watt</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Genetics and Microbiology, Institute for Sustainable
Malaria Control, University of Pretoria, Hatfield, Pretoria 0028, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Erica Erlank</span> - <span class="hlFld-Affiliation affiliation">Wits Research
Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health
Laboratory Service, Johannesburg 2192, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nelius Venter</span> - <span class="hlFld-Affiliation affiliation">Wits Research
Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health
Laboratory Service, Johannesburg 2192, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jacek W. Zawada</span> - <span class="hlFld-Affiliation affiliation">Wits Research
Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health
Laboratory Service, Johannesburg 2192, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ayesha Aswat</span> - <span class="hlFld-Affiliation affiliation">Wits Research
Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health
Laboratory Service, Johannesburg 2192, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Luisa Nardini</span> - <span class="hlFld-Affiliation affiliation">Wits Research
Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health
Laboratory Service, Johannesburg 2192, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa L. Coetzer</span> - <span class="hlFld-Affiliation affiliation">Wits
Research Institute for Malaria, School of Pathology, Department of
Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sonja B. Lauterbach</span> - <span class="hlFld-Affiliation affiliation">Wits
Research Institute for Malaria, School of Pathology, Department of
Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Belinda C. Bezuidenhout</span> - <span class="hlFld-Affiliation affiliation">Wits
Research Institute for Malaria, School of Pathology, Department of
Molecular Medicine and Haematology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anjo Theron</span> - <span class="hlFld-Affiliation affiliation">Biosciences, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dalu Mancama</span> - <span class="hlFld-Affiliation affiliation">Biosciences, Council for Scientific and Industrial Research, P.O. Box 395, Pretoria 0001, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lizette L. Koekemoer</span> - <span class="hlFld-Affiliation affiliation">Wits Research
Institute for Malaria, School of Pathology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg 2193, South Africa</span>; 
    <span class="hlFld-Affiliation affiliation">Centre
for Emerging Zoonotic and Parasitic Diseases, National Institute for Communicable Diseases of the National Health
Laboratory Service, Johannesburg 2192, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lyn-Marie Birkholtz</span> - <span class="hlFld-Affiliation affiliation">Department
of Biochemistry, Genetics and Microbiology, Institute for Sustainable
Malaria Control, University of Pretoria, Hatfield, Pretoria 0028, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sergio Wittlin</span> - <span class="hlFld-Affiliation affiliation">Swiss
Tropical and Public Health Institute, Socinstrasse 57, 4002 Basel, Switzerland</span>; 
    <span class="hlFld-Affiliation affiliation">University of Basel, 4003 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Delves</span> - <span class="hlFld-Affiliation affiliation">Imperial
College London, South Kensington, London SW7 2AZ, U.K.</span>; 
    <span class="hlFld-Affiliation affiliation">London School of Hygiene and Tropical Medicine, London WC1E 7HT, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sabine Ottilie</span> - <span class="hlFld-Affiliation affiliation">Division
of Host−Microbe Systems & Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093-076, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-9797-2612" title="Orcid link">http://orcid.org/0000-0001-9797-2612</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Elizabeth A. Winzeler</span> - <span class="hlFld-Affiliation affiliation">Division
of Host−Microbe Systems & Therapeutics, Department of Pediatrics, University of California San Diego, La Jolla, California 92093-076, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas W. von Geldern</span> - <span class="hlFld-Affiliation affiliation">Embedded
Consulting, P.O. Box 726, Richmond, Illinois 60071, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis Smith</span> - <span class="hlFld-Affiliation affiliation">4 The Maltings, Walmer CT14 7AR, U.K.</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">David A. Fidock</span> - <span class="hlFld-Affiliation affiliation">Department
of Microbiology and Immunology, Columbia
University Irving Medical Center, New York, New York 10032, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Division
of Infectious Diseases, Department of Medicine, Columbia University Irving Medical Center, New York, New York 10032, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Leslie J. Street</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gregory S. Basarab</span> - <span class="hlFld-Affiliation affiliation">Drug
Discovery and Development Center (H3D), University of Cape Town, Rondebosch 7701, South Africa</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5684-6046" title="Orcid link">http://orcid.org/0000-0001-5684-6046</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">James Duffy</span> - <span class="hlFld-Affiliation affiliation">Medicines
for Malaria Venture, ICC, Route de Pré-Bois 20, P.O.
Box 1826, 1215 Geneva, Switzerland</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br><p class="inlineNote">For the in vivo pharmacokinetics studies, all animal experiments performed in the manuscript were conducted in compliance with institutional guidelines.</p></div></li></ul></div><div class="ack" id="ACK-d7e5951-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i68">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88603" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88603" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Medicines for Malaria Venture (MMV), Strategic Innovation Partnerships (SHIP) unit of the South African Medical Research Council, and the South African Technology Innovation Agency (TIA) for financial support of this research (Project MMV18/0001 to K.C. and MMV08/0015 to D.A.F.). The University of Cape Town, South African Medical Research Council, and South African Research Chairs Initiative of the Department of Science and Innovation, administered through the South African National Research Foundation are gratefully acknowledged for support (K.C. UID: 64767; L.-M.B. UID: 84627; L.L.K. UID: 64763). This research was also supported in part by the Intramural Research Program of the National Center for Advancing Translational Sciences, National Institutes of Health. D.A.F. gratefully acknowledges support from the Department of Defense (W81XWH-15-2-0033). At Swiss TPH, we thank Sibylle Sax and Christian Scheurer for assistance in performing antimalarial cross-resistance assays. At UCT, we thank Virgil Verhoog and Sumaya Salie for running the antiplasmodial assays, Nesia Barnes, Warren Olifant, and Ronald Olckers for running the ADME assays, Zama Ngqumba for the PK sample analysis, and Trevor Finch for assistance with the animal work. We also thank Marwaan Ryland for assisting with structure elucidation and Hong Su for the crystal structure of key intermediate <b>9c</b>. At UP, we thank Phanakosi Moyo for assisting with data analysis for the EIA.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">ABS</td><td class="NLM_def"><p class="first last">asexual blood stage</p></td></tr><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, excretion</p></td></tr><tr><td class="NLM_term">CHO cells</td><td class="NLM_def"><p class="first last">Chinese hamster ovarian cells</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">DGFA</td><td class="NLM_def"><p class="first last">dual gamete formation assay</p></td></tr><tr><td class="NLM_term">DMPK</td><td class="NLM_def"><p class="first last">drug metabolism and pharmacokinetics</p></td></tr><tr><td class="NLM_term">EIA</td><td class="NLM_def"><p class="first last">exflagellation inhibition assay</p></td></tr><tr><td class="NLM_term">EWG</td><td class="NLM_def"><p class="first last">electron-withdrawing groups</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">human</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go related gene</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">iv</td><td class="NLM_def"><p class="first last">intravenous administration</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">m</td><td class="NLM_def"><p class="first last">mouse</p></td></tr><tr><td class="NLM_term">MDA</td><td class="NLM_def"><p class="first last">mass drug administration</p></td></tr><tr><td class="NLM_term">Met ID</td><td class="NLM_def"><p class="first last">metabolite identification</p></td></tr><tr><td class="NLM_term">MMV</td><td class="NLM_def"><p class="first last">Medicines for Malaria Venture</p></td></tr><tr><td class="NLM_term">MoA</td><td class="NLM_def"><p class="first last">mode of action</p></td></tr><tr><td class="NLM_term">MoR</td><td class="NLM_def"><p class="first last">mode of resistance</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">NMR</td><td class="NLM_def"><p class="first last">nuclear magnetic resonance</p></td></tr><tr><td class="NLM_term"><i>Pfcarl</i></td><td class="NLM_def"><p class="first last"><i>Plasmodium falciparum</i> cyclic amine resistance locus</p></td></tr><tr><td class="NLM_term"><i>Pf</i>NSG</td><td class="NLM_def"><p class="first last"><i>Plasmodium falciparum</i> NODscidIL2Rγnull</p></td></tr><tr><td class="NLM_term">PD</td><td class="NLM_def"><p class="first last">pharmacodynamics</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">oral administration</p></td></tr><tr><td class="NLM_term">PPI</td><td class="NLM_def"><p class="first last">protein–protein interaction</p></td></tr><tr><td class="NLM_term">PRR</td><td class="NLM_def"><p class="first last">parasite reduction ratio</p></td></tr><tr><td class="NLM_term">r</td><td class="NLM_def"><p class="first last">rat</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationship</p></td></tr><tr><td class="NLM_term">SMFA</td><td class="NLM_def"><p class="first last">standard membrane feeding assay</p></td></tr><tr><td class="NLM_term">TCP</td><td class="NLM_def"><p class="first last">target compound profile</p></td></tr><tr><td class="NLM_term">TLC</td><td class="NLM_def"><p class="first last">thin-layer chromatography</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">TBA</td><td class="NLM_def"><p class="first last">transmission-blocking activity</p></td></tr><tr><td class="NLM_term">TRA</td><td class="NLM_def"><p class="first last">transmission-reducing activity</p></td></tr><tr><td class="NLM_term"><i>V</i><sub>d</sub></td><td class="NLM_def"><p class="first last">volume of distribution</p></td></tr><tr><td class="NLM_term">WHO</td><td class="NLM_def"><p class="first last">World Health Organization</p></td></tr><tr><td class="NLM_term">WGS</td><td class="NLM_def"><p class="first last">whole-genome sequencing</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80183" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80183" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 37 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>Global
Technical Strategy for Malaria 2016–2030</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=WHO&title=Global%0ATechnical+Strategy+for+Malaria+2016%E2%80%932030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DGlobal%250ATechnical%2520Strategy%2520for%2520Malaria%25202016%25E2%2580%25932030%26pub%3DWorld%2520Health%2520Organization%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">WHO</span>.  <i>World
Malaria Report 2019</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=WHO&title=World%0AMalaria+Report+2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%250AMalaria%2520Report%25202019%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arie, S.</span></span> <span> </span><span class="NLM_article-title">Researchers and WHO Clash over Global Threat of Drug Resistant Malaria</span>. <i>BMJ</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>359</i></span>, <span class="NLM_elocation-id">j5127</span> <span class="refDoi"> DOI: 10.1136/bmj.j5127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1136%2Fbmj.j5127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=29127089" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2017&author=S.+Arie&title=Researchers+and+WHO+Clash+over+Global+Threat+of+Drug+Resistant+Malaria&doi=10.1136%2Fbmj.j5127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1136%2Fbmj.j5127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.j5127%26sid%3Dliteratum%253Aachs%26aulast%3DArie%26aufirst%3DS.%26atitle%3DResearchers%2520and%2520WHO%2520Clash%2520over%2520Global%2520Threat%2520of%2520Drug%2520Resistant%2520Malaria%26jtitle%3DBMJ%26date%3D2017%26volume%3D359%26doi%3D10.1136%2Fbmj.j5127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report 2020</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=WHO&title=World+Malaria+Report+2020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%25202020%26pub%3DWorld%2520Health%2520Organization%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">New Developments in Anti-Malarial Target Candidate and Product Profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1186/s12936-016-1675-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26-54&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+Hooft+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+M%C3%B6hrleauthor=T.+N.+C.+Wells&title=New+Developments+in+Anti-Malarial+Target+Candidate+and+Product+Profiles&doi=10.1186%2Fs12936-016-1675-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0ljYOSoIpy4eDg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DNew%2520Developments%2520in%2520Anti-Malarial%2520Target%2520Candidate%2520and%2520Product%2520Profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26epage%3D54%26doi%3D10.1186%2Fs12936-016-1675-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maetani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit12nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=281-293&author=J.+Swannauthor=V.+Coreyauthor=C.+A.+Schererauthor=N.+Katoauthor=E.+Comerauthor=M.+Maetaniauthor=Y.+Antonova-Kochauthor=C.+Reimerauthor=K.+Gagaringauthor=M.+Ibanezauthor=D.+Plouffeauthor=A.-M.+Zeemanauthor=C.+H.+M.+Kockenauthor=C.+W.+McNamaraauthor=S.+L.+Schreiberauthor=B.+Campoauthor=E.+A.+Winzelerauthor=S.+Meister&title=High-Throughput+Luciferase-Based+Assay+for+the+Discovery+of+Therapeutics+That+Prevent+Malaria&doi=10.1021%2Facsinfecdis.5b00143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria</span></div><div class="casAuthors">Swann, Justine; Corey, Victoria; Scherer, Christina A.; Kato, Nobutaka; Comer, Eamon; Maetani, Micah; Antonova-Koch, Yevgeniya; Reimer, Christin; Gagaring, Kerstin; Ibanez, Maureen; Plouffe, David; Zeeman, Anne-Marie; Kocken, Clemens H. M.; McNamara, Case W.; Schreiber, Stuart L.; Campo, Brice; Winzeler, Elizabeth A.; Meister, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to identify the most attractive starting points for drugs that can be used to prevent malaria, a diverse chem. space comprising tens of thousands to millions of small mols. may need to be examd.  Achieving this throughput necessitates the development of efficient ultra-high-throughput screening methods.  Here, the authors report the development and evaluation of a luciferase-based phenotypic screen of malaria exoerythrocytic-stage parasites optimized for a 1536-well format.  This assay uses the exoerythrocytic stage of the rodent malaria parasite, Plasmodium berghei, and a human hepatoma cell line.  The authors use this assay to evaluate several biased and unbiased compd. libraries, including two small sets of mols. (400 and 89 compds., resp.) with known activity against malaria erythrocytic-stage parasites and a set of 9886 diversity-oriented synthesis (DOS)-derived compds.  Of the compds. screened, the authors obtain hit rates of 12-13 and 0.6% in preselected and naive libraries, resp., and identify 52 compds. with exoerythrocytic-stage activity less than 1 μM and having minimal host cell toxicity.  The data demonstrate the ability of this method to identify compds. known to have causal prophylactic activity in both human and animal models of malaria, as well as novel compds., including some exclusively active against parasite exoerythrocytic stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4sAMW8HfXO7Vg90H21EOLACvtfcHk0lhLWlTmK8BCdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit12nsr4%253D&md5=b9bd0256f0c8e80469a712f2492c6106</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DSwann%26aufirst%3DJ.%26aulast%3DCorey%26aufirst%3DV.%26aulast%3DScherer%26aufirst%3DC.%2BA.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DComer%26aufirst%3DE.%26aulast%3DMaetani%26aufirst%3DM.%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DReimer%26aufirst%3DC.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DMeister%26aufirst%3DS.%26atitle%3DHigh-Throughput%2520Luciferase-Based%2520Assay%2520for%2520the%2520Discovery%2520of%2520Therapeutics%2520That%2520Prevent%2520Malaria%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D281%26epage%3D293%26doi%3D10.1021%2Facsinfecdis.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santo-Tomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> Interaction of Synthetic Peroxide RBx11160 (OZ277) with Piperaquine in Plasmodium Models</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2Fj.exppara.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=17087929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=296-300&author=C.+Snyderauthor=J.+Cholletauthor=J.+Santo-Tomasauthor=C.+Scheurerauthor=S.+Wittlin&title=In+vitro+and+in+vivo+Interaction+of+Synthetic+Peroxide+RBx11160+%28OZ277%29+with+Piperaquine+in+Plasmodium+Models&doi=10.1016%2Fj.exppara.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models</span></div><div class="casAuthors">Snyder, Christopher; Chollet, Jacques; Santo-Tomas, Josefina; Scheurer, Christian; Wittlin, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">296-300</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RBx11160 (OZ277) is a promising antimalarial drug candidate that Ranbaxy Labs. Limited and Medicines for Malaria Venture (MMV) are currently developing as a fixed combination with piperaquine.  Here, we describe the in vitro (Plasmodium falciparum) and in vivo (Plasmodium berghei) activities of piperaquine in combination with RBx11160 and artemether.  In vitro, both combinations demonstrated a slight tendency towards antagonism with mean sums of fractional inhibitory concns. (mean ΣFICs) of 1.5.  In vivo, piperaquine and artemether were borderline antagonistic (mean ΣFIC of 1.4).  However, an additive in vivo interaction of piperaquine and RBx11160 (mean ΣFIC of 1.1) was identified, suggesting that a RBx11160-piperaquine combination therapy in humans should allow each mol. to exert its full antimalarial effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsaEePIfPhrVg90H21EOLACvtfcHk0lhLWlTmK8BCdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ&md5=e1513c45d411887f6e65d7d31a61ad6d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DSanto-Tomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520Interaction%2520of%2520Synthetic%2520Peroxide%2520RBx11160%2520%2528OZ277%2529%2520with%2520Piperaquine%2520in%2520Plasmodium%2520Models%26jtitle%3DExp.%2520Parasitol.%26date%3D2007%26volume%3D115%26spage%3D296%26epage%3D300%26doi%3D10.1016%2Fj.exppara.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucantoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combrinck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santha Kumar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubiano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murithi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veiga, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fid</span></span> <span> </span><span class="NLM_article-title">Hexahydroquinolines Are Antimalarial Candidates with Potent Blood Stage and Transmission-Blocking Activity</span>. <i>Nat. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1403</span>– <span class="NLM_lpage">1414</span>, <span class="refDoi"> DOI: 10.1038/s41564-017-0007-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fs41564-017-0007-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=28808258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2isLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=1403-1414&author=M.+Vanaerschotauthor=L.+Lucantoniauthor=T.+Liauthor=J.+M.+Combrinckauthor=A.+Rueckerauthor=T.+R.+Santha+Kumarauthor=K.+Rubianoauthor=P.+E.+Ferreiraauthor=G.+Sicilianoauthor=S.+Gulatiauthor=P.+P.+Henrichauthor=C.+L.+Ngauthor=J.+M.+Murithiauthor=V.+C.+Coreyauthor=S.+Duffyauthor=O.+J.+Liebermanauthor=M.+I.+Veigaauthor=R.+E.+Sindenauthor=P.+Alanoauthor=M.+J.+Delvesauthor=K.+L.+Simauthor=E.+A.+Winzelerauthor=T.+J.+Eganauthor=S.+L.+Hoffmanauthor=V.+M.+Averyauthor=+Fid&title=Hexahydroquinolines+Are+Antimalarial+Candidates+with+Potent+Blood+Stage+and+Transmission-Blocking+Activity&doi=10.1038%2Fs41564-017-0007-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity</span></div><div class="casAuthors">Vanaerschot, Manu; Lucantoni, Leonardo; Li, Tao; Combrinck, Jill M.; Ruecker, Andrea; Kumar, T. R. Santha; Rubiano, Kelly; Ferreira, Pedro E.; Siciliano, Giulia; Gulati, Sonia; Henrich, Philipp P.; Ng, Caroline L.; Murithi, James M.; Corey, Victoria C.; Duffy, Sandra; Lieberman, Ori J.; Veiga, M. Isabel; Sinden, Robert E.; Alano, Pietro; Delves, Michael J.; Lee Sim, Kim; Winzeler, Elizabeth A.; Egan, Timothy J.; Hoffman, Stephen L.; Avery, Vicky M.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1403-1414</span>CODEN:
                <span class="NLM_cas:coden">NMAICH</span>;
        ISSN:<span class="NLM_cas:issn">2058-5276</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Antimalarial compds. with dual therapeutic and transmission-blocking activity are desired as high-value partners for combination therapies.  Here, we report the identification and characterization of hexahydroquinolines (HHQs) that show low nanomolar potency against both pathogenic and transmissible intra-erythrocytic forms of the malaria parasite Plasmodium falciparum.  This activity translates into potent transmission-blocking potential, as shown by in vitro male gamete formation assays and reduced oocyst infection and prevalence in Anopheles mosquitoes.  In vivo studies illustrated the ability of lead HHQs to suppress Plasmodium berghei blood-stage parasite proliferation.  Resistance selection studies, confirmed by CRISPR-Cas9-based gene editing, identified the digestive vacuole membrane-spanning transporter PfMDR1 (P. falciparum multidrug resistance gene-1) as a determinant of parasite resistance to HHQs.  Hb and haem fractionation assays suggest a mode of action that results in reduced haemozoin levels and might involve inhibition of host Hb uptake into intra-erythrocytic parasites.  Furthermore, parasites resistant to HHQs displayed increased susceptibility to several first-line antimalarial drugs, including lumefantrine, confirming that HHQs have a different mode of action to other antimalarials drugs for which PfMDR1 is known to confer resistance.  This work evokes therapeutic strategies that combine opposing selective pressures on this parasite transporter as an approach to countering the emergence and transmission of multidrug-resistant P. falciparum malaria.  A new class of drugs, hexahydroquinolines, inhibits host Hb endocytosis by Plasmodium falciparum and displays both therapeutic and transmission-blocking activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjCh5di3N1xLVg90H21EOLACvtfcHk0lhLWlTmK8BCdw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2isLnP&md5=7ed38ad319bbc4aaec76fde19abfc047</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41564-017-0007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41564-017-0007-4%26sid%3Dliteratum%253Aachs%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DLucantoni%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DCombrinck%26aufirst%3DJ.%2BM.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DSantha%2BKumar%26aufirst%3DT.%2BR.%26aulast%3DRubiano%26aufirst%3DK.%26aulast%3DFerreira%26aufirst%3DP.%2BE.%26aulast%3DSiciliano%26aufirst%3DG.%26aulast%3DGulati%26aufirst%3DS.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DMurithi%26aufirst%3DJ.%2BM.%26aulast%3DCorey%26aufirst%3DV.%2BC.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DLieberman%26aufirst%3DO.%2BJ.%26aulast%3DVeiga%26aufirst%3DM.%2BI.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DAlano%26aufirst%3DP.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DSim%26aufirst%3DK.%2BL.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BL.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DFid%26atitle%3DHexahydroquinolines%2520Are%2520Antimalarial%2520Candidates%2520with%2520Potent%2520Blood%2520Stage%2520and%2520Transmission-Blocking%2520Activity%26jtitle%3DNat.%2520Microbiol.%26date%3D2017%26volume%3D2%26spage%3D1403%26epage%3D1414%26doi%3D10.1038%2Fs41564-017-0007-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span>; <span class="NLM_string-name">Revesz, L.</span>; <span class="NLM_string-name">Koch, G.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds Useful as MK2 Inhibitors</span>. <span class="NLM_patent">WO2009/010488 A</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+Schlapbach&author=L.+Revesz&author=G.+Koch&title=Heterocyclic+Compounds+Useful+as+MK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26atitle%3DHeterocyclic%2520Compounds%2520Useful%2520as%2520MK2%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chalyk, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isakov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butko, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrebeniuk, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savych, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucher, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilenko, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druzhenko, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmolchuk, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zozulya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mykhailiuk, P. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-Azaspiro[4.3]Alkanes: Innovative Scaffolds for Drug Discovery</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">4530</span>– <span class="NLM_lpage">4542</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201700536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1002%2Fejoc.201700536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFegtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=4530-4542&author=B.+A.+Chalykauthor=A.+A.+Isakovauthor=M.+V.+Butkoauthor=K.+V.+Hrebeniukauthor=O.+V.+Savychauthor=O.+V.+Kucherauthor=K.+S.+Gavrilenkoauthor=T.+V.+Druzhenkoauthor=V.+S.+Yarmolchukauthor=S.+Zozulyaauthor=P.+K.+Mykhailiuk&title=Synthesis+of+6-Azaspiro%5B4.3%5DAlkanes%3A+Innovative+Scaffolds+for+Drug+Discovery&doi=10.1002%2Fejoc.201700536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-Azaspiro[4.3]alkanes: Innovative Scaffolds for Drug Discovery</span></div><div class="casAuthors">Chalyk, Bohdan A.; Isakov, Andrei A.; Butko, Maryna V.; Hrebeniuk, Kateryna V.; Savych, Olena V.; Kucher, Olexandr V.; Gavrilenko, Konstantin S.; Druzhenko, Tetiana V.; Yarmolchuk, Vladimir S.; Zozulya, Sergey; Mykhailiuk, Pavel K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">4530-4542</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New scaffolds for drug discovery, 6-azaspiro[4.3]alkanes, I (R = H, F; A = O, S, SO2, etc.; EWG = COOEt, CN, NO2, etc.) have been synthesized in two steps from four-membered-ring ketones: cyclobutanone, thienone, N-Boc-azetidinone (Boc = tert-butoxycarbonyl), etc.  The key transformation was the reaction between electron-deficient exocyclic alkenes and an in-situ generated N-benzylazomethine ylide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwiPePs6x3rVg90H21EOLACvtfcHk0lht7sy51TFNHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFegtLjL&md5=89dc2e73f978f6f754ed13db0fc04dfb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201700536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201700536%26sid%3Dliteratum%253Aachs%26aulast%3DChalyk%26aufirst%3DB.%2BA.%26aulast%3DIsakov%26aufirst%3DA.%2BA.%26aulast%3DButko%26aufirst%3DM.%2BV.%26aulast%3DHrebeniuk%26aufirst%3DK.%2BV.%26aulast%3DSavych%26aufirst%3DO.%2BV.%26aulast%3DKucher%26aufirst%3DO.%2BV.%26aulast%3DGavrilenko%26aufirst%3DK.%2BS.%26aulast%3DDruzhenko%26aufirst%3DT.%2BV.%26aulast%3DYarmolchuk%26aufirst%3DV.%2BS.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DMykhailiuk%26aufirst%3DP.%2BK.%26atitle%3DSynthesis%2520of%25206-Azaspiro%255B4.3%255DAlkanes%253A%2520Innovative%2520Scaffolds%2520for%2520Drug%2520Discovery%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D4530%26epage%3D4542%26doi%3D10.1002%2Fejoc.201700536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heravi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhtiari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoar, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oskooie, H. A.</span></span> <span> </span><span class="NLM_article-title">DABCO-POCl3, a Mild Dehydrating Agent for the Preparation of Nitriles from Aldoximes</span>. <i>J. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2005</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.3184/030823405774309005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.3184%2F030823405774309005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2005&publication_year=2005&pages=590-591&author=M.+M.+Heraviauthor=K.+Bakhtiariauthor=R.+H.+Shoarauthor=H.+A.+Oskooie&title=DABCO-POCl3%2C+a+Mild+Dehydrating+Agent+for+the+Preparation+of+Nitriles+from+Aldoximes&doi=10.3184%2F030823405774309005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3184%2F030823405774309005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F030823405774309005%26sid%3Dliteratum%253Aachs%26aulast%3DHeravi%26aufirst%3DM.%2BM.%26aulast%3DBakhtiari%26aufirst%3DK.%26aulast%3DShoar%26aufirst%3DR.%2BH.%26aulast%3DOskooie%26aufirst%3DH.%2BA.%26atitle%3DDABCO-POCl3%252C%2520a%2520Mild%2520Dehydrating%2520Agent%2520for%2520the%2520Preparation%2520of%2520Nitriles%2520from%2520Aldoximes%26jtitle%3DJ.%2520Chem.%2520Res.%26date%3D2005%26volume%3D2005%26spage%3D590%26epage%3D591%26doi%3D10.3184%2F030823405774309005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauterbach, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossouw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelbrecht, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wepener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coetzer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span> <span> </span><span class="NLM_article-title">Nowhere to Hide: Interrogating Different Metabolic Parameters of <i>Plasmodium falciparum</i> Gametocytes in a Transmission Blocking Drug Discovery Pipeline towards Malaria Elimination</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">213</span> <span class="refDoi"> DOI: 10.1186/s12936-015-0718-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-015-0718-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=25994518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A280%3ADC%252BC2MfmtVKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&author=J.+Readerauthor=M.+Bothaauthor=A.+Theronauthor=S.+B.+Lauterbachauthor=C.+Rossouwauthor=D.+Engelbrechtauthor=M.+Wepenerauthor=A.+Smitauthor=D.+Leroyauthor=D.+Mancamaauthor=T.+L.+Coetzerauthor=L.-M.+Birkholtz&title=Nowhere+to+Hide%3A+Interrogating+Different+Metabolic+Parameters+of+Plasmodium+falciparum+Gametocytes+in+a+Transmission+Blocking+Drug+Discovery+Pipeline+towards+Malaria+Elimination&doi=10.1186%2Fs12936-015-0718-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination</span></div><div class="casAuthors">Reader Janette; Botha Mariette; Smit Annel; Birkholtz Lyn-Marie; Theron Anjo; Rossouw Claire; Mancama Dalu; Lauterbach Sonja B; Engelbrecht Dewaldt; Wepener Melanie; Coetzer Theresa L; Leroy Didier</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The discovery of malaria transmission-blocking compounds is seen as key to malaria elimination strategies and gametocyte-screening platforms are critical filters to identify active molecules.  However, unlike asexual parasite assays measuring parasite proliferation, greater variability in end-point readout exists between different gametocytocidal assays.  This is compounded by difficulties in routinely producing viable, functional and stage-specific gametocyte populations.  Here, a parallel evaluation of four assay platforms on the same gametocyte populations was performed for the first time.  This allowed the direct comparison of the ability of different assay platforms to detect compounds with gametocytocidal activity and revealed caveats in some assay readouts that interrogate different parasite biological functions.  METHODS:  Gametocytogenesis from Plasmodium falciparum (NF54) was optimized with a robust and standardized protocol.  ATP, pLDH, luciferase reporter and PrestoBlue® assays were compared in context of a set of 10 reference compounds.  The assays were performed in parallel on the same gametocyte preparation (except for luciferase reporter lines) using the same drug preparations (48 h).  The remaining parameters for each assay were all comparable.  RESULTS:  A highly robust method for generating viable and functional gametocytes was developed and comprehensively validated resulting in an average gametocytaemia of 4%.  Subsequent parallel assays for gametocytocidal activity indicated that different assay platforms were not able to screen compounds with variant chemical scaffolds similarly.  Luciferase reporter assays revealed that synchronized stage-specific gametocyte production is essential for drug discovery, as differential susceptibility in various gametocyte developmental populations is evident.  CONCLUSIONS:  With this study, the key parameters for assays aiming at testing the gametocytocidal activity of potential transmission blocking molecules against Plasmodium gametocytes were accurately dissected.  This first and uniquely comparative study emphasizes differential effects seen with the use of different assay platforms interrogating variant biological systems.  Whilst this data is informative from a biological perspective and may provide indications of the drug mode of action, it does highlight the care that must be taken when screening broad-diversity chemotypes with a single assay platform against gametocytes for which the biology is not clearly understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSN-djmAqATdOkdrW1FkXG-fW6udTcc2eYmdJezgZYNtbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfmtVKgtA%253D%253D&md5=aa775c0d4fdf2fc0ef496172de10edfc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-0718-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-0718-z%26sid%3Dliteratum%253Aachs%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBotha%26aufirst%3DM.%26aulast%3DTheron%26aufirst%3DA.%26aulast%3DLauterbach%26aufirst%3DS.%2BB.%26aulast%3DRossouw%26aufirst%3DC.%26aulast%3DEngelbrecht%26aufirst%3DD.%26aulast%3DWepener%26aufirst%3DM.%26aulast%3DSmit%26aufirst%3DA.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DMancama%26aufirst%3DD.%26aulast%3DCoetzer%26aufirst%3DT.%2BL.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26atitle%3DNowhere%2520to%2520Hide%253A%2520Interrogating%2520Different%2520Metabolic%2520Parameters%2520of%2520Plasmodium%2520falciparum%2520Gametocytes%2520in%2520a%2520Transmission%2520Blocking%2520Drug%2520Discovery%2520Pipeline%2520towards%2520Malaria%2520Elimination%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26doi%3D10.1186%2Fs12936-015-0718-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coetzee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Grüning, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opperman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Watt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span> <span> </span><span class="NLM_article-title">Epigenetic Inhibitors Target Multiple Stages of <i>Plasmodium falciparum</i> Parasites</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">2355</span> <span class="refDoi"> DOI: 10.1038/s41598-020-59298-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fs41598-020-59298-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=32047203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVans7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&author=N.+Coetzeeauthor=H.+von+Gr%C3%BCningauthor=D.+Oppermanauthor=M.+van+der+Wattauthor=J.+Readerauthor=L.+M.+Birkholtz&title=Epigenetic+Inhibitors+Target+Multiple+Stages+of+Plasmodium+falciparum+Parasites&doi=10.1038%2Fs41598-020-59298-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites</span></div><div class="casAuthors">Coetzee, Nanika; von Gruning, Hilde; Opperman, Daniel; van der Watt, Mariette; Reader, Janette; Birkholtz, Lyn-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2355</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: The epigenome of the malaria parasite, Plasmodium falciparum, is assocd. with regulation of various essential processes in the parasite including control of proliferation during asexual development as well as control of sexual differentiation.  The unusual nature of the epigenome has prompted investigations into the potential to target epigenetic modulators with novel chemotypes.  Here, we explored the diversity within a library of 95 compds., active against various epigenetic modifiers in cancerous cells, for activity against multiple stages of P. falciparum development.  We show that P. falciparum is differentially susceptible to epigenetic perturbation during both asexual and sexual development, with early stage gametocytes particularly sensitive to epi-drugs targeting both histone and non-histone epigenetic modifiers.  Moreover, 5 compds. targeting histone acetylation and methylation show potent multistage activity against asexual parasites, early and late stage gametocytes, with transmission-blocking potential.  Overall, these results warrant further examn. of the potential antimalarial properties of these hit compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouN6T9Alzu37Vg90H21EOLACvtfcHk0lgVd8mXUYBXBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVans7c%253D&md5=b3878965de5b49c29573acc9d59295cc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-59298-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-59298-4%26sid%3Dliteratum%253Aachs%26aulast%3DCoetzee%26aufirst%3DN.%26aulast%3Dvon%2BGr%25C3%25BCning%26aufirst%3DH.%26aulast%3DOpperman%26aufirst%3DD.%26aulast%3Dvan%2Bder%2BWatt%26aufirst%3DM.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26atitle%3DEpigenetic%2520Inhibitors%2520Target%2520Multiple%2520Stages%2520of%2520Plasmodium%2520falciparum%2520Parasites%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26doi%3D10.1038%2Fs41598-020-59298-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swihart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diouf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, C. A.</span></span> <span> </span><span class="NLM_article-title">Transmission-Blocking Activity Is Determined by Transmission-Reducing Activity and Number of Control Oocysts in <i>Plasmodium falciparum</i> Standard Membrane-Feeding Assay</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">4145</span>– <span class="NLM_lpage">4151</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2016.06.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2Fj.vaccine.2016.06.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=27372156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A280%3ADC%252BC2s7mtlaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=4145-4151&author=K.+Miuraauthor=B.+J.+Swihartauthor=B.+Dengauthor=L.+Zhouauthor=T.+P.+Phamauthor=A.+Dioufauthor=T.+Burtonauthor=M.+P.+Fayauthor=C.+A.+Long&title=Transmission-Blocking+Activity+Is+Determined+by+Transmission-Reducing+Activity+and+Number+of+Control+Oocysts+in+Plasmodium+falciparum+Standard+Membrane-Feeding+Assay&doi=10.1016%2Fj.vaccine.2016.06.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay</span></div><div class="casAuthors">Miura Kazutoyo; Deng Bingbing; Zhou Luwen; Pham Thao P; Diouf Ababacar; Burton Timothy; Long Carole A; Swihart Bruce J; Fay Michael P</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4145-4151</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria transmission-blocking vaccines (TBVs) are potentially helpful tools for malaria eradication.  The standard membrane-feeding assay (SMFA) is considered one of the "gold standard" assays for TBV development.  However, lack of consensus in reporting results from SMFA has made it very challenging to compare results from different studies.  Two main readouts, % inhibition in mean oocyst count per mosquito (TRA) and % inhibition in prevalence of infected mosquitoes (TBA), have been used widely.  In this study, we statistically modeled the oocyst data in SMFA using data from 105 independent feeding experiments including 9804 mosquitoes.  The model was validated using an independent data set that included 10,790 mosquitoes from 110 feeding studies.  The model delineates a relationship between TRA, the mean oocyst count in the control mosquitoes (mo-contl), and TBA.  While TRA was independent from mo-contl, TBA values changed depending on mo-contl.  Regardless of monoclonal or polyclonal antibodies tested, there were strong concordances between observed TBA and predicted TBA based on the model using mo-contl and observed TRA.  Simulations showed that SMFA with lower true control means had increased uncertainty in TRA estimates.  The strong linkage between TBA, TRA and mo-contl inspired creation of a standardized TBA, a model-based TBA standardized to a target control mean, which allows comparison across multiple feeds regardless of mo-contl.  This is the first study showing that the observed TBA can be reasonably predicted by mo-contl and the TRA of the test antibody using independent experimental data.  This study indicates that TRA should be used to compare results from multiple feeds with different levels of mo-contl.  If a measure of TBA is desired, it is better to report standardized TBA rather than observed TBA.  These recommendations support rational comparisons of results from different studies, thus benefiting future TBV development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSDuGyPxLQisjl5L8hwNX0fW6udTcc2eY2lHvYm0C7XLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7mtlaisA%253D%253D&md5=d28280af68a7786ac94e66748064eb8c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2016.06.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2016.06.066%26sid%3Dliteratum%253Aachs%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DSwihart%26aufirst%3DB.%2BJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DPham%26aufirst%3DT.%2BP.%26aulast%3DDiouf%26aufirst%3DA.%26aulast%3DBurton%26aufirst%3DT.%26aulast%3DFay%26aufirst%3DM.%2BP.%26aulast%3DLong%26aufirst%3DC.%2BA.%26atitle%3DTransmission-Blocking%2520Activity%2520Is%2520Determined%2520by%2520Transmission-Reducing%2520Activity%2520and%2520Number%2520of%2520Control%2520Oocysts%2520in%2520Plasmodium%2520falciparum%2520Standard%2520Membrane-Feeding%2520Assay%26jtitle%3DVaccine%26date%3D2016%26volume%3D34%26spage%3D4145%26epage%3D4151%26doi%3D10.1016%2Fj.vaccine.2016.06.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridgland-Taylor, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henthorn, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heapy, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Gerges, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberstson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, C. E.</span></span> <span> </span><span class="NLM_article-title">Optimisation and Validation of a Medium-Throughput Electrophysiology-Based hERG Assay Using IonWorks HT</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2006.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsoauthor=M.+Sullivanauthor=N.+Alberstsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.+P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+Validation+of+a+Medium-Throughput+Electrophysiology-Based+hERG+Assay+Using+IonWorks+HT&doi=10.1016%2Fj.vascn.2006.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0lgVd8mXUYBXBw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobso%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlberstson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.%2BP.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520Validation%2520of%2520a%2520Medium-Throughput%2520Electrophysiology-Based%2520hERG%2520Assay%2520Using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2006.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">The Role of Ligand Efficiency Metrics in Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keser%C3%BCauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+Role+of+Ligand+Efficiency+Metrics+in+Drug+Discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0lhOLzoMfXUr5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520Role%2520of%2520Ligand%2520Efficiency%2520Metrics%2520in%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Manach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sax, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleiferböck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witty, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span> <span> </span><span class="NLM_article-title">Fast <i>in vitro</i> Methods to Determine the Speed of Action and the Stage-Specificity of Anti-Malarials in <i>Plasmodium falciparum</i></span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1186/1475-2875-12-424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2F1475-2875-12-424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=24237770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFehur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=424-430&author=C.+Le%0AManachauthor=C.+Scheurerauthor=S.+Saxauthor=S.+Schleiferb%C3%B6ckauthor=D.+G.+Cabreraauthor=Y.+Younisauthor=T.+Paquetauthor=L.+Streetauthor=P.+Smithauthor=X.+C.+Dingauthor=D.+Watersonauthor=M.+J.+Wittyauthor=D.+Leroyauthor=K.+Chibaleauthor=S.+Wittlin&title=Fast+in+vitro+Methods+to+Determine+the+Speed+of+Action+and+the+Stage-Specificity+of+Anti-Malarials+in+Plasmodium+falciparum&doi=10.1186%2F1475-2875-12-424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum</span></div><div class="casAuthors">Le Manach, Claire; Scheurer, Christian; Sax, Sibylle; Schleiferbock, Sarah; Gonzalez Cabrera, Diego; Younis, Yassir; Paquet, Tanya; Street, Leslie; Smith, Peter; Ding, Xavier C.; Waterson, David; Witty, Michael J.; Leroy, Didier; Chibale, Kelly; Wittlin, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">424/1-424/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Recent whole cell in vitro screening campaigns identified thousands of compds. that are active against asexual blood stages of Plasmodium falciparum at submicromolar concns.  These hits were made available to the public, providing many novel chem. starting points for anti-malarial drug discovery programs.  Knowing which of these hits are fast-acting compds. is of great interest.  Firstly, a fast action will ensure rapid relief of symptoms for the patient.  Secondly, by rapidly reducing the parasitemia, this could minimize the occurrence of mutations leading to new drug resistance mechanisms.  An in vitro assay that provides information about the speed of action of test compds. was developed by researchers at GlaxoSmithKline (GSK) in Spain.  This assay also provides an in vitro measure for the ratio between parasitemia at the onset of drug treatment and after one intra-erythrocytic cycle (parasite redn. ratio, PRR).  Both parameters are needed to det. in vitro killing rates of anti-malarial compds.  A drawback of the killing rate assay is that it takes a month to obtain 1st results.  The approach described in the present study is focused only on the speed of action of anti-malarials.  This has the advantage that initial results can be achieved within 4-7 working days, which helps to distinguish between fast and slow-acting compds. relatively quickly.  It is expected that this new assay can be used as a filter in the early drug discovery phase, which will reduce the no. of compds. progressing to secondary, more time-consuming assays like the killing rate assay.  The speed of action of a selection of 7 anti-malarial compds. was measured with 2 independent exptl. procedures using modifications of the std. [3H]hypoxanthine incorporation assay.  Depending on the outcome of both assays, the tested compds. were classified as either fast or non-fast-acting.  The results obtained for the anti-malarials chloroquine, artesunate, atovaquone, and pyrimethamine are consistent with previous observations, suggesting the methodol. is a valid way to rapidly identify fast-acting anti-malarial compds.  Another advantage of the approach is its ability to discriminate between static or cidal compd. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9DRNQDuAnAbVg90H21EOLACvtfcHk0lhOLzoMfXUr5g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFehur8%253D&md5=6b9faa87181597b607d3b05f88a64c4d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-424%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BManach%26aufirst%3DC.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DSax%26aufirst%3DS.%26aulast%3DSchleiferb%25C3%25B6ck%26aufirst%3DS.%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DPaquet%26aufirst%3DT.%26aulast%3DStreet%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DFast%2520in%2520vitro%2520Methods%2520to%2520Determine%2520the%2520Speed%2520of%2520Action%2520and%2520the%2520Stage-Specificity%2520of%2520Anti-Malarials%2520in%2520Plasmodium%2520falciparum%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D424%26epage%3D430%26doi%3D10.1186%2F1475-2875-12-424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M. H.</span></span> <span> </span><span class="NLM_article-title">The Past, Present and Future of Anti - Malarial Medicines</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="NLM_elocation-id">93</span> <span class="refDoi"> DOI: 10.1186/s12936-019-2724-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-019-2724-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=30902052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=E.+G.+Tseauthor=M.+Korsikauthor=M.+H.+Todd&title=The+Past%2C+Present+and+Future+of+Anti+-+Malarial+Medicines&doi=10.1186%2Fs12936-019-2724-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future of anti-malarial medicines</span></div><div class="casAuthors">Tse Edwin G; Korsik Marat; Todd Matthew H; Todd Matthew H</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide.  Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact.  Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead.  New drugs are needed, particularly those with new mechanisms of action.  Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine.  A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated.  Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAJgQVEudAeqqcneEtCi92fW6udTcc2eb-MaGQK-uSMLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D&md5=b15a2176b672dff36de8c4ea6cfb6a54</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-2724-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-2724-z%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DE.%2BG.%26aulast%3DKorsik%26aufirst%3DM.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DThe%2520Past%252C%2520Present%2520and%2520Future%2520of%2520Anti%2520-%2520Malarial%2520Medicines%26jtitle%3DMalar.%2520J.%26date%3D2019%26doi%3D10.1186%2Fs12936-019-2724-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zdorichenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellanger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurcum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker-milburn, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson-ralph, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span> <span> </span><span class="NLM_article-title">Escaping from Flatland: Antimalarial Activity of Sp 3 - Rich Bridged Pyrrolidine Derivatives</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00486</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00486" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1Kru7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=2497-2503&author=B.+Coxauthor=J.+Duffyauthor=V.+Zdorichenkoauthor=C.+Bellangerauthor=J.+Hurcumauthor=B.+Laleuauthor=K.+I.+Booker-milburnauthor=L.+D.+Elliottauthor=M.+Robertson-ralphauthor=C.+J.+Swainauthor=S.+J.+Bishopauthor=I.+Hallyburtonauthor=M.+Anderson&title=Escaping+from+Flatland%3A+Antimalarial+Activity+of+Sp+3+-+Rich+Bridged+Pyrrolidine+Derivatives&doi=10.1021%2Facsmedchemlett.0c00486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Escaping from Flatland: Antimalarial Activity of sp3-Rich Bridged Pyrrolidine Derivatives</span></div><div class="casAuthors">Cox, Brian; Duffy, James; Zdorichenko, Victor; Bellanger, Corentin; Hurcum, Jessica; Laleu, Benoit; Booker-Milburn, Kevin I.; Elliott, Luke D.; Robertson-Ralph, Michael; Swain, Christopher J.; Bishop, Stephen J.; Hallyburton, Irene; Anderson, Mark</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2497-2503</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic photochem. to generate novel sp3-rich scaffolds and report the design, synthesis, and biol. testing of a diverse series of amides based on the 1-(amino-methyl)-2-benzyl-2-aza-bicyclo[2.1.1]hexane scaffold was utilized .  Preliminary antimalarial screening of the library provided promising compds. with activity in the 1-5μM range with an enhanced hit rate.  Further evaluation (soly., drug metab. and pharmacokinetics (DMPK), and toxicity) of a selected compound (9) suggested that this series represents an excellent opportunity for further optimization with the framework offering multiple opportunities for the addn. of uniquely vectorally positioned extra functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO6ZPqnDNk-7Vg90H21EOLACvtfcHk0liilVtcZpTIsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1Kru7vM&md5=b0226473dd7d0e518a69b4d6d467f3c8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00486%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%26aulast%3DDuffy%26aufirst%3DJ.%26aulast%3DZdorichenko%26aufirst%3DV.%26aulast%3DBellanger%26aufirst%3DC.%26aulast%3DHurcum%26aufirst%3DJ.%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DBooker-milburn%26aufirst%3DK.%2BI.%26aulast%3DElliott%26aufirst%3DL.%2BD.%26aulast%3DRobertson-ralph%26aufirst%3DM.%26aulast%3DSwain%26aufirst%3DC.%2BJ.%26aulast%3DBishop%26aufirst%3DS.%2BJ.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DAnderson%26aufirst%3DM.%26atitle%3DEscaping%2520from%2520Flatland%253A%2520Antimalarial%2520Activity%2520of%2520Sp%25203%2520-%2520Rich%2520Bridged%2520Pyrrolidine%2520Derivatives%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D2497%26epage%3D2503%26doi%3D10.1021%2Facsmedchemlett.0c00486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0liilVtcZpTIsw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span> <span> </span><span class="NLM_article-title">Drugs in Development for Malaria</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">879</span>, <span class="refDoi"> DOI: 10.1007/s40265-018-0911-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1007%2Fs40265-018-0911-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=29802605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=861-879&author=E.+A.+Ashleyauthor=A.+P.+Phyo&title=Drugs+in+Development+for+Malaria&doi=10.1007%2Fs40265-018-0911-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs in Development for Malaria</span></div><div class="casAuthors">Ashley, Elizabeth A.; Phyo, Aung Pyae</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">861-879</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role.  Resistance of Plasmodium falciparum to the artemisinin derivs., piperaquine and mefloquine in Southeast Asia means new antimalarials are needed with some urgency.  There are at least 13 agents in clin. development.  Most of these are blood schizonticides for the treatment of uncomplicated falciparum malaria, under evaluation either singly or as part of two-drug combinations.  Leading candidates progressing through the pipeline are artefenomel-ferroquine and lumefantrine-KAF156, both in Phase 2b.  Treatment of severe malaria continues to rely on two parenteral drugs with ancient forebears: artesunate and quinine, with sevuparin being evaluated as an adjuvant therapy.  Tafenoquine is under review by stringent regulatory authorities for approval as a single-dose treatment for Plasmodium vivax relapse prevention.  This represents an advance over std. 14-day primaquine regimens; however, the risk of acute haemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency remains.  For disease prevention, several of the newer agents show potential but are unlikely to be recommended for use in the main target groups of pregnant women and young children for some years.  Latest predictions are that the malaria burden will continue to be high in the coming decades.  This fact, coupled with the repeated loss of antimalarials to resistance, indicates that new antimalarials will be needed for years to come.  Failure of the artemisinin-based combinations in Southeast Asia has stimulated a reappraisal of current approaches to combination therapy for malaria with incorporation of three or more drugs in a single treatment under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu06hSG2TXLVg90H21EOLACvtfcHk0lhqSRM7Vhu9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK&md5=4cfdcaf7482b5e1d8ed55f3ae126b0e8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs40265-018-0911-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-018-0911-9%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26atitle%3DDrugs%2520in%2520Development%2520for%2520Malaria%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26spage%3D861%26epage%3D879%26doi%3D10.1007%2Fs40265-018-0911-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magistrado, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=816-826&author=P.+A.+Magistradoauthor=V.+C.+Coreyauthor=A.+K.+Lukensauthor=G.+Lamonteauthor=E.+Sasakiauthor=S.+Meisterauthor=M.+Wreeauthor=E.+Winzelerauthor=D.+F.+Wirth&title=Plasmodium+falciparum+Cyclic+Amine+Resistance+Locus+%28PfCARL%29%2C+a+Resistance+Mechanism+for+Two+Distinct+Compound+Classes&doi=10.1021%2Facsinfecdis.6b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes</span></div><div class="casAuthors">Magistrado, Pamela A.; Corey, Victoria C.; Lukens, Amanda K.; LaMonte, Greg; Sasaki, Erika; Meister, Stephan; Wree, Melanie; Winzeler, Elizabeth; Wirth, Dyann F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MMV007564 is a novel antimalarial benzimidazolyl piperidine chemotype identified in cellular screens.  To identify the genetic determinant of MMV007564 resistance, parasites were cultured in the presence of the compd. to generate resistant lines.  Whole genome sequencing revealed distinct mutations in the gene named Plasmodium falciparum cyclic amine resistance locus (pfcarl), encoding a conserved protein of unknown function.  Mutations in pfcarl are strongly assocd. with resistance to a structurally unrelated class of compds., the imidazolopiperazines, including KAF156, currently in clin. trials.  Our data demonstrate that pfcarl mutations confer resistance to two distinct compd. classes, benzimidazolyl piperidines and imidazolopiperazines.  However, MMV007564 and the imidazolopiperazines, KAF156 and GNF179, have different timings of action in the asexual blood stage and different potencies against the liver and sexual blood stages.  These data suggest that pfcarl is a multidrug-resistance gene rather than a common target for benzimidazolyl piperidines and imidazolopiperazines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO2hqloBBVgbVg90H21EOLACvtfcHk0lhqSRM7Vhu9ow"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrsLo%253D&md5=099493350b8b85ee6363c844f9f325cf</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00025%26sid%3Dliteratum%253Aachs%26aulast%3DMagistrado%26aufirst%3DP.%2BA.%26aulast%3DCorey%26aufirst%3DV.%2BC.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DLamonte%26aufirst%3DG.%26aulast%3DSasaki%26aufirst%3DE.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DWinzeler%26aufirst%3DE.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26atitle%3DPlasmodium%2520falciparum%2520Cyclic%2520Amine%2520Resistance%2520Locus%2520%2528PfCARL%2529%252C%2520a%2520Resistance%2520Mechanism%2520for%2520Two%2520Distinct%2520Compound%2520Classes%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D816%26epage%3D826%26doi%3D10.1021%2Facsinfecdis.6b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, M. Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Mutations in the <i>Plasmodium falciparum</i> Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e00696-16</span> <span class="refDoi"> DOI: 10.1128/mBio.00696-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1128%2FmBio.00696-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=27381290" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=G.+Lamonteauthor=M.+Y.+X.+Limauthor=M.+Wreeauthor=C.+Reimerauthor=M.+Nachonauthor=V.+Coreyauthor=P.+Gedeckauthor=D.+Plouffeauthor=A.+Duauthor=N.+Figueroaauthor=B.+Yeungauthor=P.+Bifaniauthor=E.+A.+Winzeler&title=Mutations+in+the+Plasmodium+falciparum+Cyclic+Amine+Resistance+Locus+%28PfCARL%29+Confer+Multidrug+Resistance&doi=10.1128%2FmBio.00696-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FmBio.00696-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00696-16%26sid%3Dliteratum%253Aachs%26aulast%3DLamonte%26aufirst%3DG.%26aulast%3DLim%26aufirst%3DM.%2BY.%2BX.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DReimer%26aufirst%3DC.%26aulast%3DNachon%26aufirst%3DM.%26aulast%3DCorey%26aufirst%3DV.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DA.%26aulast%3DFigueroa%26aufirst%3DN.%26aulast%3DYeung%26aufirst%3DB.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DMutations%2520in%2520the%2520Plasmodium%2520falciparum%2520Cyclic%2520Amine%2520Resistance%2520Locus%2520%2528PfCARL%2529%2520Confer%2520Multidrug%2520Resistance%26jtitle%3DmBio%26date%3D2016%26volume%3D7%26doi%3D10.1128%2FmBio.00696-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberstaller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adapa, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassandra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. H.</span></span> <span> </span><span class="NLM_article-title">Uncovering the Essential Genome of the Human Malaria Parasite <i>Plasmodium falciparum</i> by Saturation Mutagenesis Min</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>, <span class="NLM_elocation-id">eaap7847</span> <span class="refDoi"> DOI: 10.1126/science.aap7847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1126%2Fscience.aap7847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=29724925" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&author=M.+Zhangauthor=C.+Wangauthor=T.+D.+Ottoauthor=J.+Oberstallerauthor=X.+Liaoauthor=S.+R.+Adapaauthor=K.+Udenzeauthor=I.+F.+Bronnerauthor=D.+Cassandraauthor=M.+Mayhoauthor=J.+Brownauthor=S.+Liauthor=J.+Swansonauthor=J.+C.+Raynerauthor=R.+H.+Y.+Jiangauthor=J.+H.+Adams&title=Uncovering+the+Essential+Genome+of+the+Human+Malaria+Parasite+Plasmodium+falciparum+by+Saturation+Mutagenesis+Min&doi=10.1126%2Fscience.aap7847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.aap7847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aap7847%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DOberstaller%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DAdapa%26aufirst%3DS.%2BR.%26aulast%3DUdenze%26aufirst%3DK.%26aulast%3DBronner%26aufirst%3DI.%2BF.%26aulast%3DCassandra%26aufirst%3DD.%26aulast%3DMayho%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSwanson%26aufirst%3DJ.%26aulast%3DRayner%26aufirst%3DJ.%2BC.%26aulast%3DJiang%26aufirst%3DR.%2BH.%2BY.%26aulast%3DAdams%26aufirst%3DJ.%2BH.%26atitle%3DUncovering%2520the%2520Essential%2520Genome%2520of%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520falciparum%2520by%2520Saturation%2520Mutagenesis%2520Min%26jtitle%3DScience%26date%3D2018%26volume%3D360%26doi%3D10.1126%2Fscience.aap7847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaMonte, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocamora, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marapana, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worgall, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgof, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohunlal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santha Kumar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Pan-Active Imidazolopiperazine Antimalarials Target the <i>Plasmodium falciparum</i> Intracellular Secretory Pathway</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">1780</span> <span class="refDoi"> DOI: 10.1038/s41467-020-15440-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fs41467-020-15440-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=32286267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntFOhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=G.+M.+LaMonteauthor=F.+Rocamoraauthor=D.+S.+Marapanaauthor=N.+F.+Gn%C3%A4digauthor=S.+Ottilieauthor=M.+R.+Luthauthor=T.+S.+Worgallauthor=G.+M.+Goldgofauthor=R.+Mohunlalauthor=T.+R.+Santha+Kumarauthor=J.+K.+Thompsonauthor=E.+Vigilauthor=J.+Yangauthor=D.+Hutsonauthor=T.+Johnsonauthor=J.+Huangauthor=R.+M.+Williamsauthor=B.+Y.+Zouauthor=A.+L.+Cheungauthor=P.+Kumarauthor=T.+J.+Eganauthor=M.+C.+S.+Leeauthor=D.+Siegelauthor=A.+F.+Cowmanauthor=D.+A.+Fidockauthor=E.+A.+Winzeler&title=Pan-Active+Imidazolopiperazine+Antimalarials+Target+the+Plasmodium+falciparum+Intracellular+Secretory+Pathway&doi=10.1038%2Fs41467-020-15440-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway</span></div><div class="casAuthors">LaMonte, Gregory M.; Rocamora, Frances; Marapana, Danushka S.; Gnadig, Nina F.; Ottilie, Sabine; Luth, Madeline R.; Worgall, Tilla S.; Goldgof, Gregory M.; Mohunlal, Roxanne; Santha Kumar, T. R.; Thompson, Jennifer K.; Vigil, Edgar; Yang, Jennifer; Hutson, Dylan; Johnson, Trevor; Huang, Jianbo; Williams, Roy M.; Zou, Bing Yu; Cheung, Andrea L.; Kumar, Prianka; Egan, Timothy J.; Lee, Marcus C. S.; Siegel, Dionicio; Cowman, Alan F.; Fidock, David A.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1780</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A promising new compd. class for treating human malaria is the imidazolopiperazines (IZP) class.  IZP compds. KAF156 (Ganaplacide) and GNF179 are effective against Plasmodium symptomatic asexual blood-stage infections, and are able to prevent transmission and block infection in animal models.  But despite the identification of resistance mechanisms in P. falciparum, the mode of action of IZPs remains unknown.  To investigate, we here combine in vitro evolution and genome anal. in Saccharomyces cerevisiae with mol., metabolomic, and chemogenomic methods in P. falciparum.  Our findings reveal that IZP-resistant S. cerevisiae clones carry mutations in genes involved in Endoplasmic Reticulum (ER)-based lipid homeostasis and autophagy.  In Plasmodium, IZPs inhibit protein trafficking, block the establishment of new permeation pathways, and cause ER expansion.  Our data highlight a mechanism for blocking parasite development that is distinct from those of std. compds. used to treat malaria, and demonstrate the potential of IZPs for studying ER-dependent protein processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr2lfZzjtPC7Vg90H21EOLACvtfcHk0liwsvWw1pvBeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntFOhsro%253D&md5=e88068fb9f585db8342036cea951ee30</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15440-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15440-4%26sid%3Dliteratum%253Aachs%26aulast%3DLaMonte%26aufirst%3DG.%2BM.%26aulast%3DRocamora%26aufirst%3DF.%26aulast%3DMarapana%26aufirst%3DD.%2BS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DWorgall%26aufirst%3DT.%2BS.%26aulast%3DGoldgof%26aufirst%3DG.%2BM.%26aulast%3DMohunlal%26aufirst%3DR.%26aulast%3DSantha%2BKumar%26aufirst%3DT.%2BR.%26aulast%3DThompson%26aufirst%3DJ.%2BK.%26aulast%3DVigil%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHutson%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26aulast%3DZou%26aufirst%3DB.%2BY.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DCowman%26aufirst%3DA.%2BF.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DPan-Active%2520Imidazolopiperazine%2520Antimalarials%2520Target%2520the%2520Plasmodium%2520falciparum%2520Intracellular%2520Secretory%2520Pathway%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26doi%3D10.1038%2Fs41467-020-15440-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artavia, G.</span></span> <span> </span><span class="NLM_article-title">Use of the Adamantane Structure in Medicinal Chemistry</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2967</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.2174/092986710792065027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.2174%2F092986710792065027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=20858176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaisr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2967-2978&author=G.+Lamoureuxauthor=G.+Artavia&title=Use+of+the+Adamantane+Structure+in+Medicinal+Chemistry&doi=10.2174%2F092986710792065027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the adamantane structure in medicinal chemistry</span></div><div class="casAuthors">Lamoureux, Guy; Artavia, Graciela</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2967-2978</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review summarizes the importance and recent discoveries of the use of adamantane derivs. in Medicinal Chem.  We have organized the article in 4 sections: 1) Absorption, Distribution, Metab., or Excretion (ADME) properties 2) Hydrophobic Effects 3) Ion Channels and 4) Rigid scaffold.  Within each section, we have provided examples of how the adamantane group changes the properties of known drugs or provides a important pharmacophore for the design of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTyZGBx6L4NrVg90H21EOLACvtfcHk0liwsvWw1pvBeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaisr3I&md5=2515e125ab451790105ced1d354d8369</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F092986710792065027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792065027%26sid%3Dliteratum%253Aachs%26aulast%3DLamoureux%26aufirst%3DG.%26aulast%3DArtavia%26aufirst%3DG.%26atitle%3DUse%2520of%2520the%2520Adamantane%2520Structure%2520in%2520Medicinal%2520Chemistry%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2967%26epage%3D2978%26doi%3D10.2174%2F092986710792065027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorff, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capetta, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallgren, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oborski, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span> <span> </span><span class="NLM_article-title">Application of the Bicyclo[1.1.1]Pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3414</span>– <span class="NLM_lpage">3424</span>, <span class="refDoi"> DOI: 10.1021/jm300094u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300094u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVyntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3414-3424&author=A.+F.+Stepanauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=J.+K.+Dutraauthor=T.+J.+O%E2%80%99Sullivanauthor=K.+J.+Diricoauthor=W.+S.+McDonaldauthor=A.+Wonauthor=P.+H.+Dorffauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=D.+R.+Riddellauthor=G.+W.+Kauffmanauthor=B.+L.+Kormosauthor=L.+Zhangauthor=Y.+Luauthor=S.+H.+Capettaauthor=M.+E.+Greenauthor=K.+Karkiauthor=E.+Sibleyauthor=K.+P.+Atchisonauthor=A.+J.+Hallgrenauthor=C.+E.+Oborskiauthor=A.+E.+Robshawauthor=B.+Sneedauthor=C.+J.+O%E2%80%99Donnell&title=Application+of+the+Bicyclo%5B1.1.1%5DPentane+Motif+as+a+Nonclassical+Phenyl+Ring+Bioisostere+in+the+Design+of+a+Potent+and+Orally+Active+%CE%B3-Secretase+Inhibitor&doi=10.1021%2Fjm300094u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor</span></div><div class="casAuthors">Stepan, Antonia F.; Subramanyam, Chakrapani; Efremov, Ivan V.; Dutra, Jason K.; O'Sullivan, Theresa J.; DiRico, Kenneth J.; McDonald, W. Scott; Won, Annie; Dorff, Peter H.; Nolan, Charles E.; Becker, Stacey L.; Pustilnik, Leslie R.; Riddell, David R.; Kauffman, Gregory W.; Kormos, Bethany L.; Zhang, Liming; Lu, Yasong; Capetta, Steven H.; Green, Michael E.; Karki, Kapil; Sibley, Evelyn; Atchison, Kevin P.; Hallgren, Andrew J.; Oborski, Christine E.; Robshaw, Ashley E.; Sneed, Blossom; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3414-3424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Replacement of the central, para-substituted fluorophenyl ring in the γ-secretase inhibitor BMS-708,163 with the bicyclo[1.1.1]pentane motif led to the discovery of compd. (I), an equipotent enzyme inhibitor with significant improvements in passive permeability and aq. soly.  The modified biopharmaceutical properties of I translated into excellent oral absorption characteristics (∼4-fold ↑ Cmax and AUC values relative to BMS-708,163) in a mouse model of γ-secretase inhibition.  In addn., SAR studies into other fluorophenyl replacements indicate the intrinsic advantages of the bicyclo[1.1.1]pentane moiety over conventional Ph ring replacements with respect to achieving an optimal balance of properties (e.g., γ-secretase inhibition, aq. soly./permeability, in vitro metabolic stability).  Overall, this work enhances the scope of the [1.1.1]-bicycle beyond that of a mere "spacer" unit and presents a compelling case for its broader application as a Ph group replacement in scenarios where the arom. ring count impacts physicochem. parameters and overall drug-likeness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYTrCHjtRbgbVg90H21EOLACvtfcHk0liwsvWw1pvBeg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVyntLo%253D&md5=4bbcac4eb20d974696833df5f86f9c34</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300094u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300094u%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DDirico%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DCapetta%26aufirst%3DS.%2BH.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DAtchison%26aufirst%3DK.%2BP.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DApplication%2520of%2520the%2520Bicyclo%255B1.1.1%255DPentane%2520Motif%2520as%2520a%2520Nonclassical%2520Phenyl%2520Ring%2520Bioisostere%2520in%2520the%2520Design%2520of%2520a%2520Potent%2520and%2520Orally%2520Active%2520%25CE%25B3-Secretase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3414%26epage%3D3424%26doi%3D10.1021%2Fjm300094u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Measom, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Down, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span> <span> </span><span class="NLM_article-title">Investigation of a Bicyclo[1.1.1]Pentane as a Phenyl Replacement within an LpPLA2 Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00281</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCqtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=43-48&author=N.+D.+Measomauthor=K.+D.+Downauthor=D.+J.+Hirstauthor=C.+Jamiesonauthor=E.+S.+Manasauthor=V.+K.+Patelauthor=D.+O.+Somers&title=Investigation+of+a+Bicyclo%5B1.1.1%5DPentane+as+a+Phenyl+Replacement+within+an+LpPLA2+Inhibitor&doi=10.1021%2Facsmedchemlett.6b00281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor</span></div><div class="casAuthors">Measom, Nicholas D.; Down, Kenneth D.; Hirst, David J.; Jamieson, Craig; Manas, Eric S.; Patel, Vipulkumar K.; Somers, Don O.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric Ph replacements.  An efficient synthesis to the target compds. was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation.  Potency, physicochem., and x-ray crystallog. data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and pos. impacted on the physicochem. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQjyZ5QbhWbVg90H21EOLACvtfcHk0lj_BbOL3XE2xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCqtbjK&md5=5d8edc57e03090b6680bd819fc5ed67a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00281%26sid%3Dliteratum%253Aachs%26aulast%3DMeasom%26aufirst%3DN.%2BD.%26aulast%3DDown%26aufirst%3DK.%2BD.%26aulast%3DHirst%26aufirst%3DD.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26atitle%3DInvestigation%2520of%2520a%2520Bicyclo%255B1.1.1%255DPentane%2520as%2520a%2520Phenyl%2520Replacement%2520within%2520an%2520LpPLA2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D43%26epage%3D48%26doi%3D10.1021%2Facsmedchemlett.6b00281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M. H.</span></span> <span> </span><span class="NLM_article-title">Nonclassical Phenyl Bioisosteres as Effective Replacements in a Series of Novel Open-Source Antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">11585</span>– <span class="NLM_lpage">11601</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWiu7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=11585-11601&author=E.+G.+Tseauthor=S.+D.+Houstonauthor=C.+M.+Williamsauthor=G.+P.+Savageauthor=L.+M.+Rendinaauthor=I.+Hallyburtonauthor=M.+Andersonauthor=R.+Sharmaauthor=G.+S.+Walkerauthor=R.+S.+Obachauthor=M.+H.+Todd&title=Nonclassical+Phenyl+Bioisosteres+as+Effective+Replacements+in+a+Series+of+Novel+Open-Source+Antimalarials&doi=10.1021%2Facs.jmedchem.0c00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclassical Phenyl Bioisosteres as Effective Replacements in a Series of Novel Open-Source Antimalarials</span></div><div class="casAuthors">Tse, Edwin G.; Houston, Sevan D.; Williams, Craig M.; Savage, G. Paul; Rendina, Louis M.; Hallyburton, Irene; Anderson, Mark; Sharma, Raman; Walker, Gregory S.; Obach, R. Scott; Todd, Matthew H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11585-11601</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of one chem. motif with another that is broadly similar is a common method in medicinal chem. to modulate the phys. and biol. properties of a mol. (i.e., bioisosterism).  In recent years, bioisosteres such as cubane and bicyclo[1.1.1]pentane (BCP) have been used as highly effective Ph mimics.  Herein, we show the successful incorporation of a range of Ph bioisosteres during the open-source optimization of an antimalarial series.  Cubane (19) and closo-carborane (23) analogs exhibited improved in vitro potency against Plasmodium falciparum compared to the parent Ph compd.; however, these changes resulted in a redn. in metabolic stability; unusually, enzyme-mediated oxidn. was found to take place on the cubane core.  A BCP analog (22) was found to be equipotent to its parent Ph compd. and showed significantly improved metabolic properties.  While these results demonstrate the utility of these atypical bioisosteres when used in a medicinal chem. program, the search to find a suitable bioisostere may well require the prepn. of many candidates, in our case, 32 compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjGWeFZfQlLVg90H21EOLACvtfcHk0lj_BbOL3XE2xQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWiu7zJ&md5=f369e96ecb6f1dc14e2d739ced836c78</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00746%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DE.%2BG.%26aulast%3DHouston%26aufirst%3DS.%2BD.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%26aulast%3DSavage%26aufirst%3DG.%2BP.%26aulast%3DRendina%26aufirst%3DL.%2BM.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DNonclassical%2520Phenyl%2520Bioisosteres%2520as%2520Effective%2520Replacements%2520in%2520a%2520Series%2520of%2520Novel%2520Open-Source%2520Antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D11585%26epage%3D11601%26doi%3D10.1021%2Facs.jmedchem.0c00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, P. M. S.</span></span> <span> </span><span class="NLM_article-title">Syntheses of Novel Antimycobacterial Combinatorial Libraries of Structurally Diverse Substituted Pyrimidines by Three-Component Solid-Phase Reactions</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)00829-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2FS0960-894X%2801%2900829-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=11844696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=667-669&author=A.+Kumarauthor=S.+Sinhaauthor=P.+M.+S.+Chauhan&title=Syntheses+of+Novel+Antimycobacterial+Combinatorial+Libraries+of+Structurally+Diverse+Substituted+Pyrimidines+by+Three-Component+Solid-Phase+Reactions&doi=10.1016%2FS0960-894X%2801%2900829-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of novel antimycobacterial combinatorial libraries of structurally diverse substituted pyrimidines by three-component solid-phase reactions</span></div><div class="casAuthors">Kumar, Arun; Sinha, Sudhir; Chauhan, Prem M. S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-669</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new pyrimidine based scaffold has been developed by three-component solid-phase syntheses.  The utility of scaffolds was demonstrated by synthesizing libraries of 80 substituted pyrimidines.  Among 80 compds. screened, six compds. showed in vitro activity against Mycobacterium tuberculosis(MABA) at a concn. of 50 and 25 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyg6_HbXxcC7Vg90H21EOLACvtfcHk0liAczweyGNmRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFKqtbw%253D&md5=c0e341c244ea576630f82525260bca0d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900829-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900829-0%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DP.%2BM.%2BS.%26atitle%3DSyntheses%2520of%2520Novel%2520Antimycobacterial%2520Combinatorial%2520Libraries%2520of%2520Structurally%2520Diverse%2520Substituted%2520Pyrimidines%2520by%2520Three-Component%2520Solid-Phase%2520Reactions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D667%26epage%3D669%26doi%3D10.1016%2FS0960-894X%2801%2900829-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zafrani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeffet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sod-Moriah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berliner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amir, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershonov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saphier, S.</span></span> <span> </span><span class="NLM_article-title">Difluoromethyl Bioisostere: Examining the “Lipophilic Hydrogen Bond Donor” Concept</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01691</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01691" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis12jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=797-804&author=Y.+Zafraniauthor=D.+Yeffetauthor=G.+Sod-Moriahauthor=A.+Berlinerauthor=D.+Amirauthor=D.+Marcianoauthor=E.+Gershonovauthor=S.+Saphier&title=Difluoromethyl+Bioisostere%3A+Examining+the+%E2%80%9CLipophilic+Hydrogen+Bond+Donor%E2%80%9D+Concept&doi=10.1021%2Facs.jmedchem.6b01691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Difluoromethyl Bioisostere: Examining the "Lipophilic Hydrogen Bond Donor" Concept</span></div><div class="casAuthors">Zafrani, Yossi; Yeffet, Dina; Sod-Moriah, Gali; Berliner, Anat; Amir, Dafna; Marciano, Daniele; Gershonov, Eytan; Saphier, Sigal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a growing interest in org. compds. contg. the difluoromethyl group, as it is considered a lipophilic hydrogen bond donor that may act as a bioisostere of hydroxyl, thiol, or amine groups.  A series of difluoromethyl anisoles and thioanisoles was prepd. and their drug-like properties, hydrogen bonding, and lipophilicity were studied.  The hydrogen bond acidity parameters A (0.085-0.126) were detd. using Abraham's solute 1H NMR anal.  The difluoromethyl group acts as a hydrogen bond donor on a scale similar to that of thiophenol, aniline, and amine groups but not as that of hydroxyl.  Although difluoromethyl is considered a lipophilicity enhancing group, the range of the exptl. Δlog P(water-octanol) values (log P(XCF2H) - log P(XCH3)) spanned from -0.1 to +0.4.  For both parameters, a linear correlation was found between the measured values and Hammett σ consts.  These results may aid in the rational design of drugs contg. the difluoromethyl moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJEzcH0xPatbVg90H21EOLACvtfcHk0liAczweyGNmRg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis12jtw%253D%253D&md5=36159f57b99aa812693f32ff38e88406</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01691%26sid%3Dliteratum%253Aachs%26aulast%3DZafrani%26aufirst%3DY.%26aulast%3DYeffet%26aufirst%3DD.%26aulast%3DSod-Moriah%26aufirst%3DG.%26aulast%3DBerliner%26aufirst%3DA.%26aulast%3DAmir%26aufirst%3DD.%26aulast%3DMarciano%26aufirst%3DD.%26aulast%3DGershonov%26aufirst%3DE.%26aulast%3DSaphier%26aufirst%3DS.%26atitle%3DDifluoromethyl%2520Bioisostere%253A%2520Examining%2520the%2520%25E2%2580%259CLipophilic%2520Hydrogen%2520Bond%2520Donor%25E2%2580%259D%2520Concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D797%26epage%3D804%26doi%3D10.1021%2Facs.jmedchem.6b01691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Manach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagborough, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakutansky, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanachayangkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witty, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Díaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Efficacy of MMV390048, an Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaad9735</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1126%2Fscitranslmed.aad9735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=28446690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=T.+Paquetauthor=C.+Le+Manachauthor=D.+G.+Cabreraauthor=Y.+Younisauthor=P.+P.+Henrichauthor=T.+S.+Abrahamauthor=M.+C.+S.+Leeauthor=R.+Basakauthor=S.+Ghidelli-Disseauthor=M.+J.+Lafuente-Monasterioauthor=M.+Bantscheffauthor=A.+Rueckerauthor=A.+M.+Blagboroughauthor=S.+E.+Zakutanskyauthor=A.-M.+Zeemanauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=J.+Mannilaauthor=J.+Morizziauthor=C.+Scheurerauthor=I.+Angulo-Barturenauthor=M.+S.+Mart%C3%ADnezauthor=S.+Ferrerauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=J.+Readerauthor=M.+Bothaauthor=K.+J.+Decheringauthor=R.+W.+Sauerweinauthor=A.+Tungtaengauthor=P.+Vanachayangkulauthor=C.+S.+Limauthor=J.+Burrowsauthor=M.+J.+Wittyauthor=K.+C.+Marshauthor=C.+Bodenreiderauthor=R.+Rochfordauthor=S.+M.+Solapureauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=C.+Doniniauthor=B.+Campoauthor=L.-M.+Birkholtzauthor=K.+K.+Hansonauthor=G.+Drewesauthor=C.+H.+M.+Kockenauthor=M.+J.+Delvesauthor=D.+Leroyauthor=D.+A.+Fidockauthor=D.+Watersonauthor=L.+J.+Streetauthor=K.+Chibale&title=Antimalarial+Efficacy+of+MMV390048%2C+an+Inhibitor+of+Plasmodium+Phosphatidylinositol+4-Kinase&doi=10.1126%2Fscitranslmed.aad9735"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9735%26sid%3Dliteratum%253Aachs%26aulast%3DPaquet%26aufirst%3DT.%26aulast%3DLe%2BManach%26aufirst%3DC.%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DAbraham%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DBasak%26aufirst%3DR.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DBlagborough%26aufirst%3DA.%2BM.%26aulast%3DZakutansky%26aufirst%3DS.%2BE.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DMannila%26aufirst%3DJ.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBotha%26aufirst%3DM.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DVanachayangkul%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DSolapure%26aufirst%3DS.%2BM.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonini%26aufirst%3DC.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26aulast%3DHanson%26aufirst%3DK.%2BK.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAntimalarial%2520Efficacy%2520of%2520MMV390048%252C%2520an%2520Inhibitor%2520of%2520Plasmodium%2520Phosphatidylinositol%25204-Kinase%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aad9735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenviaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graumans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Vegte-Bolmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattabongkot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinetz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5060</span>– <span class="NLM_lpage">5067</span>, <span class="refDoi"> DOI: 10.1128/AAC.02727-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1128%2FAAC.02727-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=24913172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5060-5067&author=K.+L.+Kuhenauthor=A.+K.+Chatterjeeauthor=M.+Rottmannauthor=K.+Gagaringauthor=R.+Borboaauthor=J.+Buenviajeauthor=Z.+Chenauthor=C.+Francekauthor=T.+Wuauthor=A.+Nagleauthor=S.+W.+Barnesauthor=D.+Plouffeauthor=M.+C.+S.+Leeauthor=D.+A.+Fidockauthor=W.+Graumansauthor=M.+Van+De+Vegte-Bolmerauthor=G.+J.+Van+Gemertauthor=G.+Wirjanataauthor=B.+Sebayangauthor=J.+Marfurtauthor=B.+Russellauthor=R.+Suwanaruskauthor=R.+N.+Priceauthor=F.+Nostenauthor=A.+Tungtaengauthor=M.+Gettayacaminauthor=J.+Sattabongkotauthor=J.+Taylorauthor=J.+R.+Walkerauthor=D.+Tullyauthor=K.+P.+Patraauthor=E.+L.+Flanneryauthor=J.+M.+Vinetzauthor=L.+Reniaauthor=R.+W.+Sauerweinauthor=E.+A.+Winzelerauthor=R.+J.+Glynneauthor=T.+T.+Diagana&title=KAF156+Is+an+Antimalarial+Clinical+Candidate+with+Potential+for+Use+in+Prophylaxis%2C+Treatment%2C+and+Prevention+of+Disease+Transmission&doi=10.1128%2FAAC.02727-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">KAf156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission</span></div><div class="casAuthors">Kuhen, Kelli L.; Chatterjee, Arnab K.; Rottmann, Matthias; Gagaring, Kerstin; Borboa, Rachel; Buenviaje, Jennifer; Chen, Zhong; Francek, Carolyn; Wu, Tao; Nagle, Advait; Barnes, S. Whitney; Plouffe, David; Lee, Marcus C. S.; Fidock, David A.; Graumans, Wouter; van de Vegte-Bolmer, Marga; van Gemert, Geert J.; Wirjanata, Grennady; Sebayang, Boni; Marfurt, Jutta; Russell, Bruce; Suwanarusk, Rossarin; Price, Ric N.; Nosten, Francois; Tungtaeng, Anchalee; Gettayacamin, Montip; Sattabongkot, Jetsumon; Taylor, Jennifer; Walker, John R.; Tully, David; Patra, Kailash P.; Flannery, Erika L.; Vinetz, Joseph M.; Renia, Laurent; Sauerwein, Robert W.; Winzeler, Elizabeth A.; Glynne, Richard J.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5060-5067, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Renewed global efforts toward malaria eradication have highlighted the need for novel antimalarial agents with activity against multiple stages of the parasite life cycle.  We have previously reported the discovery of a novel class of antimalarial compds. in the imidazolopiperazine series that have activity in the prevention and treatment of blood stage infection in a mouse model of malaria.  Consistent with the previously reported activity profile of this series, the clin. candidate KAF156 shows blood schizonticidal activity with 50% inhibitory concns. of 6 to 17.4 nM against P. falciparum drug-sensitive and drug-resistant strains, as well as potent therapeutic activity in a mouse models of malaria with 50, 90, and 99 % EDs of 0.6, 0.9, and 1.4 mg/kg, resp.  When administered prophylactically in a sporozoite challenge mouse model, KAF156 is completely protective as a single oral dose of 10 mg/kg.  Finally, KAF156 displays potent Plasmodium transmission blocking activities both in vitro and in vivo.  Collectively, our data suggest that KAF156, currently under evaluation in clin. trials, has the potential to treat, prevent, and block the transmission of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4QluxrWtdq7Vg90H21EOLACvtfcHk0lizZtlWZgI2Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK&md5=c97e07e4832e871885546880084be5ca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FAAC.02727-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02727-13%26sid%3Dliteratum%253Aachs%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBuenviaje%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DGraumans%26aufirst%3DW.%26aulast%3DVan%2BDe%2BVegte-Bolmer%26aufirst%3DM.%26aulast%3DVan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DSebayang%26aufirst%3DB.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTully%26aufirst%3DD.%26aulast%3DPatra%26aufirst%3DK.%2BP.%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DVinetz%26aufirst%3DJ.%2BM.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DKAF156%2520Is%2520an%2520Antimalarial%2520Clinical%2520Candidate%2520with%2520Potential%2520for%2520Use%2520in%2520Prophylaxis%252C%2520Treatment%252C%2520and%2520Prevention%2520of%2520Disease%2520Transmission%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5060%26epage%3D5067%26doi%3D10.1128%2FAAC.02727-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4244</span>– <span class="NLM_lpage">4273</span>, <span class="refDoi"> DOI: 10.1021/jm300041e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300041e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4244-4273&author=A.+Nagleauthor=T.+Wuauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=B.+Liuauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=T.+Chuanauthor=P.+B.+Alperauthor=C.+Fischliauthor=R.+Brunauthor=S.+B.+Lakshminarayanaauthor=M.+Rottmannauthor=T.+T.+Diaganaauthor=E.+A.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+Lead+Optimization+of+the+Second-Generation+Antimalarial+Agents&doi=10.1021%2Fjm300041e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents</span></div><div class="casAuthors">Nagle, Advait; Wu, Tao; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Liu, Bo; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Chuan, Tiffany; Alper, Philip B.; Fischli, Christoph; Brun, Reto; Lakshminarayana, Suresh B.; Rottmann, Matthias; Diagana, Thierry T.; Winzeler, Elizabeth A.; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4244-4273</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the initial success of optimization of a novel series of imidazolopiperazines, a second generation of compds. involving changes in the core piperazine ring was synthesized to improve antimalarial properties.  These changes were carried out to further improve the potency and metabolic stability of the compds. by leveraging the outcome of a set of in vitro metabolic identification studies.  The optimized 8,8-di-Me imidazolopiperazine analogs I(R = 4-F, 4-Me, 3,4-F2) and II(R = 4-Me, 3-Cl-4-F) III(R = Me, F) exhibited improved potency, in vitro metabolic stability profile and, as a result, enhanced oral exposure in vivo in mice.  The optimized compds. were found to be more efficacious than the current antimalarials in a malaria mouse model.  They exhibit moderate oral exposure in rat pharmacokinetic studies to achieve sufficient multiples of the oral exposure at the efficacious dose in toxicol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonl3aXJKMqObVg90H21EOLACvtfcHk0lizZtlWZgI2Gg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D&md5=6c46f2f5ca76ae5a5089b542ec15e2ac</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm300041e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300041e%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DChuan%26aufirst%3DT.%26aulast%3DAlper%26aufirst%3DP.%2BB.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520Lead%2520Optimization%2520of%2520the%2520Second-Generation%2520Antimalarial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4244%26epage%3D4273%26doi%3D10.1021%2Fjm300041e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crighton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katneni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moehrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abla, N.</span></span> <span> </span><span class="NLM_article-title">An i<i>n vitro</i> Toolbox to Accelerate Anti - Malarial Drug Discovery and Development</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span>, <span class="NLM_elocation-id">1</span> <span class="refDoi"> DOI: 10.1186/s12936-019-3075-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-019-3075-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=31898492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&author=S.+A.+Charmanauthor=A.+Andreuauthor=H.+Barkerauthor=S.+Blundellauthor=A.+Campbellauthor=M.+Campbellauthor=G.+Chenauthor=F.+C.+K.+Chiuauthor=E.+Crightonauthor=K.+Katneniauthor=J.+Morizziauthor=R.+Patilauthor=T.+Phamauthor=E.+Ryanauthor=J.+Saundersauthor=D.+M.+Shacklefordauthor=K.+L.+Whiteauthor=L.+Almondauthor=M.+Dickinsauthor=D.+A.+Smithauthor=J.+J.+Moehrleauthor=J.+N.+Burrowsauthor=N.+Abla&title=An+in+vitro+Toolbox+to+Accelerate+Anti+-+Malarial+Drug+Discovery+and+Development&doi=10.1186%2Fs12936-019-3075-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro toolbox to accelerate anti-malarial drug discovery and development</span></div><div class="casAuthors">Charman, Susan A.; Andreu, Alice; Barker, Helena; Blundell, Scott; Campbell, Anna; Campbell, Michael; Chen, Gong; Chiu, Francis C. K.; Crighton, Elly; Katneni, Kasiram; Morizzi, Julia; Patil, Rahul; Pham, Thao; Ryan, Eileen; Saunders, Jessica; Shackleford, David M.; White, Karen L.; Almond, Lisa; Dickins, Maurice; Smith, Dennis A.; Moehrle, Joerg J.; Burrows, Jeremy N.; Abla, Nada</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Modeling and simulation are being increasingly utilized to support the discovery and development of new anti-malarial drugs.  These approaches require reliable in vitro data for physicochem. properties, permeability, binding, intrinsic clearance and cytochrome P 450 inhibition.  This work was conducted to generate an in vitro data toolbox using standardized methods for a set of 45 anti-malarial drugs and to assess changes in physicochem. properties in relation to changing target product and candidate profiles.  Methods: Ionization consts. were detd. by potentiometric titrn. and partition coeffs. were measured using a shake-flask method.  Soly. was assessed in biorelevant media and permeability coeffs. and efflux ratios were detd. using Caco-2 cell monolayers.  Binding to plasma and media proteins was measured using either ultracentrifugation or rapid equil. dialysis.  Metabolic stability and cytochrome P 450 inhibition were assessed using human liver microsomes.  Sample anal. was conducted by LC-MS/MS.  Results: Both soly. and fraction unbound decreased, and permeability and unbound intrinsic clearance increased, with increasing Log D7.4.  In general, development compds. were somewhat more lipophilic than legacy drugs.  For many compds., permeability and protein binding were challenging to assess and both required the use of exptl. conditions that minimized the impact of non-specific binding.  Intrinsic clearance in human liver microsomes was varied across the data set and several compds. exhibited no measurable substrate loss under the conditions used.  Inhibition of cytochrome P 450 enzymes was minimal for most compds.  Conclusions: This is the first data set to describe in vitro properties for 45 legacy and development anti-malarial drugs.  The studies identified several practical methodol. issues common to many of the more lipophilic compds. and highlighted areas which require more work to customize exptl. conditions for compds. being designed to meet the new target product profiles.  The dataset will be a valuable tool for malaria researchers aiming to develop PBPK models for the prediction of human PK properties and/or drug-drug interactions.  Furthermore, generation of this comprehensive data set within a single lab. allows direct comparison of properties across a large dataset and evaluation of changing property trends that have occurred over time with changing target product and candidate profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz-G7Yo6U877Vg90H21EOLACvtfcHk0lj8LGqdp4-Ztw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D&md5=a996cd5a032c9042bc957d0bddecbd3b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-3075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-3075-5%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DAndreu%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DBlundell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DCrighton%26aufirst%3DE.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DAlmond%26aufirst%3DL.%26aulast%3DDickins%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DMoehrle%26aufirst%3DJ.%2BJ.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DAbla%26aufirst%3DN.%26atitle%3DAn%2520in%2520vitro%2520Toolbox%2520to%2520Accelerate%2520Anti%2520-%2520Malarial%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DMalar.%2520J.%26date%3D2020%26volume%3D19%26doi%3D10.1186%2Fs12936-019-3075-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. Z.</span></span> <span> </span><span class="NLM_article-title">PfCRT and PfMDR1 Modulate Interactions of Artemisinin Derivatives and Ion Channel Blockers</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">25379</span> <span class="refDoi"> DOI: 10.1038/srep25379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fsrep25379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=27147113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVeltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=R.+T.+Eastmanauthor=P.+Khineauthor=R.+Huangauthor=C.+J.+Thomasauthor=X.+Z.+Su&title=PfCRT+and+PfMDR1+Modulate+Interactions+of+Artemisinin+Derivatives+and+Ion+Channel+Blockers&doi=10.1038%2Fsrep25379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers</span></div><div class="casAuthors">Eastman, Richard T.; Khine, Pwint; Huang, Ruili; Thomas, Craig J.; Su, Xin-zhuan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25379</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment of the symptomatic asexual stage of Plasmodium falciparum relies almost exclusively on artemisinin (ART) combination therapies (ACTs) in endemic regions.  ACTs combine ART or its deriv. with a long-acting partner drug to maximize efficacy during the typical three-day regimen.  Both lab. and clin. studies have previously demonstrated that the common drug resistance determinants P. falciparum chloroquine resistance transporter (PfCRT) and multidrug resistance transporter (PfMDR1) can modulate the susceptibility to many current antimalarial drugs and chem. compds.  Here we investigated the parasite responses to dihydroartemisinin (DHA) and various Ca2+ and Na+ channel blockers and showed pos. correlated responses between DHA and several channel blockers, suggesting potential shared transport pathways or mode of action.  Addnl., we demonstrated that PfCRT and PfMDR1 could also significantly modulate the pharmacodynamic interactions of the compds. and that the interactions were influenced by the parasite genetic backgrounds.  These results provide important information for better understanding of drug resistance and for assessing the overall impact of drug resistance markers on parasite response to ACTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWn-9cZTLVRbVg90H21EOLACvtfcHk0lj8LGqdp4-Ztw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVeltrs%253D&md5=b6cda0676f8281caf56185dc9d3d1fa2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsrep25379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep25379%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DKhine%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSu%26aufirst%3DX.%2BZ.%26atitle%3DPfCRT%2520and%2520PfMDR1%2520Modulate%2520Interactions%2520of%2520Artemisinin%2520Derivatives%2520and%2520Ion%2520Channel%2520Blockers%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep25379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansbro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itkin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahoranszky-Kohalmi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peryea, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sá, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Pluijm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, R.</span></span> <span> </span><span class="NLM_article-title">Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by <i>Plasmodium falciparum</i> Genotype</span>. <i>ACS Pharmacol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1157</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.0c00110</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.0c00110" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1SgtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=1144-1157&author=M.+Ansbroauthor=Z.+Itkinauthor=L.+Chenauthor=G.+Zahoranszky-Kohalmiauthor=C.+Amaratungaauthor=O.+Miottoauthor=T.+Peryeaauthor=C.+Hobbsauthor=S.+Suonauthor=J.+S%C3%A1author=A.+Dondorpauthor=R.+van+der%0APluijmauthor=T.+Wellemsauthor=A.+Simeonovauthor=R.+Eastman&title=Modulation+of+Triple+Artemisinin-Based+Combination+Therapy+Pharmacodynamics+by+Plasmodium+falciparum+Genotype&doi=10.1021%2Facsptsci.0c00110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by Plasmodium falciparum Genotype</span></div><div class="casAuthors">Ansbro, Megan R.; Itkin, Zina; Chen, Lu; Zahoranszky-Kohalmi, Gergely; Amaratunga, Chanaki; Miotto, Olivo; Peryea, Tyler; Hobbs, Charlotte V.; Suon, Seila; Sa, Juliana M.; Dondorp, Arjen M.; van der Pluijm, Rob W.; Wellems, Thomas E.; Simeonov, Anton; Eastman, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Pharmacology & Translational Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1144-1157</span>CODEN:
                <span class="NLM_cas:coden">APTSFN</span>;
        ISSN:<span class="NLM_cas:issn">2575-9108</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first-line treatments for uncomplicated Plasmodium falciparum malaria are artemisinin-based combination therapies (ACTs), consisting of an artemisinin deriv. combined with a longer acting partner drug.  However, the spread of P. falciparum with decreased susceptibility to artemisinin and partner drugs presents a significant challenge to malaria control efforts.  To stem the spread of drug resistant parasites, novel chemotherapeutic strategies are being evaluated, including the implementation of triple artemisinin-based combination therapies (TACTs).  Currently, there is limited knowledge on the pharmacodynamic and pharmacogenetic interactions of proposed TACT drug combinations.  To evaluate these interactions, we established an in vitro high-throughput process for measuring the drug concn.-response to three distinct antimalarial drugs present in a TACT.  Sixteen different TACT combinations were screened against 15 parasite lines from Cambodia, with a focus on parasites with differential susceptibilities to piperaquine and artemisinins.  Anal. revealed drug-drug interactions unique to specific genetic backgrounds, including antagonism between piperaquine and pyronaridine assocd. with gene amplification of plasmepsin II/III, two aspartic proteases that localize to the parasite digestive vacuole.  From this initial study, we identified parasite genotypes with decreased susceptibility to specific TACTs, as well as potential TACTs that display antagonism in a genotype-dependent manner.  Our assay and anal. platform can be further leveraged to inform drug implementation decisions and evaluate next-generation TACTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNxlcR_dyz0LVg90H21EOLACvtfcHk0lhOjpLZAxgXlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1SgtbjN&md5=32061e3a74e8faed980d5c1afbb0e937</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.0c00110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.0c00110%26sid%3Dliteratum%253Aachs%26aulast%3DAnsbro%26aufirst%3DM.%26aulast%3DItkin%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZahoranszky-Kohalmi%26aufirst%3DG.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DPeryea%26aufirst%3DT.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DS%25C3%25A1%26aufirst%3DJ.%26aulast%3DDondorp%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DR.%26aulast%3DWellems%26aufirst%3DT.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DEastman%26aufirst%3DR.%26atitle%3DModulation%2520of%2520Triple%2520Artemisinin-Based%2520Combination%2520Therapy%2520Pharmacodynamics%2520by%2520Plasmodium%2520falciparum%2520Genotype%26jtitle%3DACS%2520Pharmacol.%2520Transl.%2520Sci.%26date%3D2020%26volume%3D3%26spage%3D1144%26epage%3D1157%26doi%3D10.1021%2Facsptsci.0c00110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 1 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Neha Sharma, Mohammad Kashif, Vigyasa Singh, Diana Fontinha, Budhaditya Mukherjee, Dhruv Kumar, Shailja Singh, Miguel Prudencio, Agam P. Singh, <span class="NLM_string-name hlFld-ContribAuthor">Brijesh Rathi</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Antiplasmodial Compounds Leveraged with Multistage Potency against the Parasite Plasmodium falciparum: In Vitro and In Vivo Evaluations and Pharmacokinetic Studies. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8666-8683. <a href="https://doi.org/10.1021/acs.jmedchem.1c00659" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00659</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00659&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00659%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BAntiplasmodial%252BCompounds%252BLeveraged%252Bwith%252BMultistage%252BPotency%252Bagainst%252Bthe%252BParasite%252BPlasmodium%252Bfalciparum%25253A%252BIn%252BVitro%252Band%252BIn%252BVivo%252BEvaluations%252Band%252BPharmacokinetic%252BStudies%26aulast%3DSharma%26aufirst%3DNeha%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12042021%26date%3D14062021%26volume%3D64%26issue%3D12%26spage%3D8666%26epage%3D8683" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0012.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0002.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. PPI28 generic structure and structures of the two hit compounds <b>1</b> and <b>2</b> (racemic mixtures).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0007.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. (A) Route A: Preparation of Compounds <b>11</b>–<b>27</b>, <b>84</b>–<b>106</b>, and <b>S1</b>–<b>S19</b> with R<sup>1</sup> Variations and Preparation of the Phenoxy Derivative <b>29</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (0) toluene, 110 °C, 3 h, 96%; (a) LiF (4 equiv), CH<sub>3</sub>CN, 60 °C, 67%; (b) trifluoroacetic acid (TFA) (30 equiv), dichloromethane (DCM), 0–25 °C, 16 h, 83–100%; (c) Ar-X (1 equiv), RuPhos (0.06 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.08 equiv), Cs<sub>2</sub>CO<sub>3</sub> (3 equiv), <i>t-</i>BuOH, 110 °C, sealed tube, 16 h, 29–99%; (d) LAH (3 equiv), tetrahydrofuran (THF), 0 °C to rt, 12 h, 64–77%; (e) MsCl (1.2 equiv), Et<sub>3</sub>N (1.5 equiv), DCM, 25 °C, 3 h, 74–78%; (f) BocNHAr (1 equiv), NaH (1.2 equiv), dimethylformamide (DMF), 0–50 °C, 12 h, 32–58%; (g) Pd(OH)<sub>2</sub> (0.2 equiv), H<sub>2</sub> (balloon), EtOH, 25 °C, 16 h, 84–98%; (h) R-COOH (1.2 equiv), 2-hydroxypyridine-<i>N</i>-oxide (HOPO) (1.2 equiv), 1-ethyl-3-(3′-dimethylaminopropyl)carbodiimide hydrochloride (EDCI·HCl) (1.2 equiv), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA) (3 equiv), DCM, 25 °C, 12 h, 29–85%; (i) HCl (4 M in dioxane) (5 equiv), DCM, 25 °C, 16 h, 40–95%; (j) PhOH (1.1 equiv), K<sub>2</sub>CO<sub>3</sub> (1.5 equiv), 90 °C, 4 h, 34%. (B) Asymmetric unit of <b>9c</b>. Displacement ellipsoids are shown at the 50% probability level. Hydrogen and salt atoms were omitted for clarity.</p></p></figure><figure data-id="sch2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0008.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Route B: Preparation of Compounds <b>35</b>–<b>60</b> with R<sup>2</sup> Variations<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(OH)<sub>2</sub>, H<sub>2</sub> (balloon), EtOH, 25 °C, 12 h, 84–98%; (b) R-COOH (1.2 equiv), HOPO (1.2 equiv), EDCI·HCl (1.2 equiv), DIPEA (3 equiv), DCM, 25 °C, 12 h, 29–85%; (c) NaBH<sub>4</sub> (10 equiv), MeOH, 0–25 °C, 3 h, 71–93%; (d) Dess–Martin periodinane (1 equiv), wet DCM, 25 °C, 2 h, 50–67%; (e) NH<sub>2</sub>OH (1.15 equiv), NaHCO<sub>3</sub> (1.15 equiv), Na<sub>2</sub>SO<sub>4</sub> (1.15 equiv), DCM, 12 h, 25 °C, 84%; (f) POCl<sub>3</sub> (2 equiv), 1,4-diazabicyclo[2.2. 2]octane (DABCO) (2 equiv), DCM, 25 °C, 1 h, 91%; (g) tetra-<i>n</i>-butylammonium fluoride (TBAF) (1.1 equiv), AcOH (1.1 equiv), 25 °C, 48–86%; or Cs<sub>2</sub>CO<sub>3</sub> (1 equiv), DMF/H<sub>2</sub>O (10:1), 25 °C, 18 h, 56%; (h) LiOH·H<sub>2</sub>O (3 equiv), MeOH/THF/H<sub>2</sub>O (1:1:1), 0–25 °C, 2 h, 66%; (i) Mg (2.2 equiv), R-Br (2 equiv), THF, 0 °C, 1 h, 58–69%; (j) R-NH<sub>2</sub> (1.1 equiv), NaBH<sub>3</sub>CN (3 equiv), MeOH, AcOH, 25 °C, 12 h, 30–70%; (k) PPh<sub>3</sub>, diisopropyl azodicarboxylate (DIAD), NaN<sub>3</sub>, H<sub>2</sub>SO<sub>4</sub>, DCM, 0–25 °C; (l) ethynyltrimethylsilane (1 equiv), Cu(I)I (0.02 equiv), DIPEA (0.02 equiv), AcOH (0.02 equiv), DMF/H<sub>2</sub>O (1:1), 80 °C, 16, 52%; (m) PPh<sub>3</sub> (1.4 equiv), THF, H<sub>2</sub>O (5:1), 0 °C, 15 min, 80 °C, 2 h, 72%; (n) R-COOH (1.5 equiv), hexafluorophosphate azabenzotriazole tetramethyl uronium (HATU) (1.3 equiv), DIPEA (2 equiv), DMF, 25 °C, 16 h, 61–65%.</p></p></figure><figure data-id="sch3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0009.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Route C: Preparation of Compounds <b>68</b>–<b>83</b> with R<sup>3</sup> Variations<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Pd(OH)<sub>2</sub> (0.2 equiv), H<sub>2</sub> (balloon), EtOH, 16 h, 25 °C, 84–98%; (b) acid (1.2 equiv), HOPO (1.2 equiv), EDCI·HCl (1.2 equiv), DIPEA (3 equiv), DCM, 25 °C, 16 h, 29–85%; (c) (c1) TFA (30 equiv), DCM, 0–25 °C, 16 h, 88%, (c2) Cbz-Cl (2 equiv), Et<sub>3</sub>N (2 equiv), DCM, 0 °C, 1 h, 65%; (d) NaBH<sub>4</sub> (10 equiv), MeOH, 0 °C and then 25 °C, 3 h, 71–93%; (e) Dess–Martin periodinane (1 equiv), wet DCM, 0–25 °C, 2 h; (f) (f1) Ph-NH<sub>2</sub> (1.1 equiv), AcOH (trace), NaBH<sub>3</sub>CN (3 equiv), MeOH, 25 °C, 12 h, 30–70%, (f2) Boc<sub>2</sub>O (2.5 equiv), 1,2-dichloroethane (DCE), 80 °C, sealed tube, 18 h, 49%; (g) 10% Pd/C (20 mass %), EtOH, 25 °C, 16 h, 86%; (h) (h1) Ar-X (1.2 equiv), RuPhos (0.04 equiv), Pd<sub>2</sub>(dba)<sub>3</sub> (0.06 equiv), K<sub>2</sub>CO<sub>3</sub> (3 equiv), <i>t-</i>BuOH, 110 °C, sealed tube, 16 h; (h2) HCl (4 M in dioxane) (15 equiv), MeOH, 0–25 °C, 16 h, 26–50% over two steps; or (i) (i1) R-CHO (1.1 equiv), NaBH<sub>3</sub>CN (3 equiv), MeOH, 25 °C, 16 h, followed by TBAF (1.1 equiv), THF, 2 h, 25 °C, 35–44%; (i2) TFA (35 equiv), DCM, 25 °C, 16 h, 61–64%.</p></p></figure><figure data-id="fig2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0003.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Chemical space and clusters of the hit compounds. (A) Chemical space of the compounds with >70% inhibition of ABS Dd2 parasite growth. Hits with ABS Dd2 IC<sub>50</sub> < 2 μM are represented by a bigger circle and colored according to their activity (green to red, 0.1–2 μM). (B) Chemical clusters of hits with ABS Dd2 IC<sub>50</sub> < 2 μM. Compounds are colored according to their activity and sized according to their LLE (logIC<sub>50</sub> – log <i>P</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0004.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Summary of the main findings from the initial SAR studies.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0005.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Biotransformations of <b>1-A</b>, <b>49</b>, and <b>68</b> in mouse liver microsomes. Sites of oxidation assigned from fragmentation patterns are indicated in red. +, minor; ++, moderate; +++, major.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/medium/jm1c00034_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0006.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. High degree of antagonism observed in L1108W and M1050I PfCARL mutant parasites (MMV692834-resistant clone Fl3-A8 and MMV910804-resistant clone 3G3, respectively) and to a lesser degree in V1053G mutant parasite (MMV010804-resistant clone 3F3), compared to the parental line Dd2 for combinations that include <b>S14</b>. Shown are representative matrix blocks (of three independent experiments), normalized proliferation responses over 72 h assays, as determined by SYBR Green I fluorescence intensity. Black represents uninhibited parasite proliferation; red represents inhibited parasite growth.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-4/acs.jmedchem.1c00034/20210218/images/large/jm1c00034_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.1c00034&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i70">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_56235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_56235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 37 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">WHO</span>.  <i>Global
Technical Strategy for Malaria 2016–2030</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=WHO&title=Global%0ATechnical+Strategy+for+Malaria+2016%E2%80%932030"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DGlobal%250ATechnical%2520Strategy%2520for%2520Malaria%25202016%25E2%2580%25932030%26pub%3DWorld%2520Health%2520Organization%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">WHO</span>.  <i>World
Malaria Report 2019</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2019</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=WHO&title=World%0AMalaria+Report+2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%250AMalaria%2520Report%25202019%26pub%3DWorld%2520Health%2520Organization%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arie, S.</span></span> <span> </span><span class="NLM_article-title">Researchers and WHO Clash over Global Threat of Drug Resistant Malaria</span>. <i>BMJ</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>359</i></span>, <span class="NLM_elocation-id">j5127</span> <span class="refDoi"> DOI: 10.1136/bmj.j5127</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1136%2Fbmj.j5127" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=29127089" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=359&publication_year=2017&author=S.+Arie&title=Researchers+and+WHO+Clash+over+Global+Threat+of+Drug+Resistant+Malaria&doi=10.1136%2Fbmj.j5127"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1136%2Fbmj.j5127&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.j5127%26sid%3Dliteratum%253Aachs%26aulast%3DArie%26aufirst%3DS.%26atitle%3DResearchers%2520and%2520WHO%2520Clash%2520over%2520Global%2520Threat%2520of%2520Drug%2520Resistant%2520Malaria%26jtitle%3DBMJ%26date%3D2017%26volume%3D359%26doi%3D10.1136%2Fbmj.j5127" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">WHO</span>.  <i>World Malaria Report 2020</i>; <span class="NLM_publisher-name">World Health Organization</span>: <span class="NLM_publisher-loc">Geneva</span>, <span class="NLM_year">2020</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=WHO&title=World+Malaria+Report+2020"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dreport%26sid%3Dliteratum%253Aachs%26aulast%3D%26jtitle%3DWorld%2520Malaria%2520Report%25202020%26pub%3DWorld%2520Health%2520Organization%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duparc, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gutteridge, W. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hooft van Huijsduijnen, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaszubska, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Macintyre, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mazzuri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möhrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wells, T. N. C.</span></span> <span> </span><span class="NLM_article-title">New Developments in Anti-Malarial Target Candidate and Product Profiles</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">26</span>– <span class="NLM_lpage">54</span>, <span class="refDoi"> DOI: 10.1186/s12936-016-1675-x</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-016-1675-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=28086874" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2017&pages=26-54&author=J.+N.+Burrowsauthor=S.+Duparcauthor=W.+E.+Gutteridgeauthor=R.+Hooft+van+Huijsduijnenauthor=W.+Kaszubskaauthor=F.+Macintyreauthor=S.+Mazzuriauthor=J.+J.+M%C3%B6hrleauthor=T.+N.+C.+Wells&title=New+Developments+in+Anti-Malarial+Target+Candidate+and+Product+Profiles&doi=10.1186%2Fs12936-016-1675-x"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">New developments in anti-malarial target candidate and product profiles</span></div><div class="casAuthors">Burrows, Jeremy N.; Duparc, Stephan; Gutteridge, Winston E.; Hooft van Huijsduijnen, Rob; Kaszubska, Wiweka; MacIntyre, Fiona; Mazzuri, Sebastien; Mohrle, Jorg J.; Wells, Timothy N. C.</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">26/1-26/29</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">A review.  A decade of discovery and development of new anti-malarial medicines has led to a renewed focus on malaria elimination and eradication.  Changes in the way new anti-malarial drugs are discovered and developed have led to a dramatic increase in the no. and diversity of new mols. presently in pre-clin. and early clin. development.  The twin challenges faced can be summarized by multi-drug resistant malaria from the Greater Mekong Subregion, and the need to provide simplified medicines.  This review lists changes in anti-malarial target candidate and target product profiles over the last 4 years.  As well as new medicines to treat disease and prevent transmission, there has been increased focus on the longer term goal of finding new medicines for chemoprotection, potentially with long-acting mols., or parenteral formulations.  Other gaps in the malaria armamentarium, such as drugs to treat severe malaria and endectocides (that kill mosquitoes which feed on people who have taken the drug), are defined here.  Ultimately the elimination of malaria requires medicines that are safe and well-tolerated to be used in vulnerable populations: in pregnancy, esp. the first trimester, and in those suffering from malnutrition or co-infection with other pathogens.  These updates reflect the maturing of an understanding of the key challenges in producing the next generation of medicines to control, eliminate and ultimately eradicate malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjgdhMYAylM7Vg90H21EOLACvtfcHk0ljje5ymPoATiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXjsFCqu7g%253D&md5=17984994f7a29c9fb184faa5214d4d35</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1186%2Fs12936-016-1675-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-016-1675-x%26sid%3Dliteratum%253Aachs%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DDuparc%26aufirst%3DS.%26aulast%3DGutteridge%26aufirst%3DW.%2BE.%26aulast%3DHooft%2Bvan%2BHuijsduijnen%26aufirst%3DR.%26aulast%3DKaszubska%26aufirst%3DW.%26aulast%3DMacintyre%26aufirst%3DF.%26aulast%3DMazzuri%26aufirst%3DS.%26aulast%3DM%25C3%25B6hrle%26aufirst%3DJ.%2BJ.%26aulast%3DWells%26aufirst%3DT.%2BN.%2BC.%26atitle%3DNew%2520Developments%2520in%2520Anti-Malarial%2520Target%2520Candidate%2520and%2520Product%2520Profiles%26jtitle%3DMalar.%2520J.%26date%3D2017%26volume%3D16%26spage%3D26%26epage%3D54%26doi%3D10.1186%2Fs12936-016-1675-x" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Swann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scherer, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kato, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Comer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maetani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Antonova-Koch, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ibanez, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McNamara, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schreiber, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span> <span> </span><span class="NLM_article-title">High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">293</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.5b00143</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.5b00143" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28Xit12nsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=281-293&author=J.+Swannauthor=V.+Coreyauthor=C.+A.+Schererauthor=N.+Katoauthor=E.+Comerauthor=M.+Maetaniauthor=Y.+Antonova-Kochauthor=C.+Reimerauthor=K.+Gagaringauthor=M.+Ibanezauthor=D.+Plouffeauthor=A.-M.+Zeemanauthor=C.+H.+M.+Kockenauthor=C.+W.+McNamaraauthor=S.+L.+Schreiberauthor=B.+Campoauthor=E.+A.+Winzelerauthor=S.+Meister&title=High-Throughput+Luciferase-Based+Assay+for+the+Discovery+of+Therapeutics+That+Prevent+Malaria&doi=10.1021%2Facsinfecdis.5b00143"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">High-Throughput Luciferase-Based Assay for the Discovery of Therapeutics That Prevent Malaria</span></div><div class="casAuthors">Swann, Justine; Corey, Victoria; Scherer, Christina A.; Kato, Nobutaka; Comer, Eamon; Maetani, Micah; Antonova-Koch, Yevgeniya; Reimer, Christin; Gagaring, Kerstin; Ibanez, Maureen; Plouffe, David; Zeeman, Anne-Marie; Kocken, Clemens H. M.; McNamara, Case W.; Schreiber, Stuart L.; Campo, Brice; Winzeler, Elizabeth A.; Meister, Stephan</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">281-293</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">In order to identify the most attractive starting points for drugs that can be used to prevent malaria, a diverse chem. space comprising tens of thousands to millions of small mols. may need to be examd.  Achieving this throughput necessitates the development of efficient ultra-high-throughput screening methods.  Here, the authors report the development and evaluation of a luciferase-based phenotypic screen of malaria exoerythrocytic-stage parasites optimized for a 1536-well format.  This assay uses the exoerythrocytic stage of the rodent malaria parasite, Plasmodium berghei, and a human hepatoma cell line.  The authors use this assay to evaluate several biased and unbiased compd. libraries, including two small sets of mols. (400 and 89 compds., resp.) with known activity against malaria erythrocytic-stage parasites and a set of 9886 diversity-oriented synthesis (DOS)-derived compds.  Of the compds. screened, the authors obtain hit rates of 12-13 and 0.6% in preselected and naive libraries, resp., and identify 52 compds. with exoerythrocytic-stage activity less than 1 μM and having minimal host cell toxicity.  The data demonstrate the ability of this method to identify compds. known to have causal prophylactic activity in both human and animal models of malaria, as well as novel compds., including some exclusively active against parasite exoerythrocytic stages.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr4sAMW8HfXO7Vg90H21EOLACvtfcHk0lj4t3ts0u4i5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xit12nsr4%253D&md5=b9bd0256f0c8e80469a712f2492c6106</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.5b00143&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.5b00143%26sid%3Dliteratum%253Aachs%26aulast%3DSwann%26aufirst%3DJ.%26aulast%3DCorey%26aufirst%3DV.%26aulast%3DScherer%26aufirst%3DC.%2BA.%26aulast%3DKato%26aufirst%3DN.%26aulast%3DComer%26aufirst%3DE.%26aulast%3DMaetani%26aufirst%3DM.%26aulast%3DAntonova-Koch%26aufirst%3DY.%26aulast%3DReimer%26aufirst%3DC.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DIbanez%26aufirst%3DM.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DMcNamara%26aufirst%3DC.%2BW.%26aulast%3DSchreiber%26aufirst%3DS.%2BL.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DMeister%26aufirst%3DS.%26atitle%3DHigh-Throughput%2520Luciferase-Based%2520Assay%2520for%2520the%2520Discovery%2520of%2520Therapeutics%2520That%2520Prevent%2520Malaria%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D281%26epage%3D293%26doi%3D10.1021%2Facsinfecdis.5b00143" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Snyder, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chollet, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santo-Tomas, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span> <span> </span><span class="NLM_article-title"><i>In vitro</i> and <i>in vivo</i> Interaction of Synthetic Peroxide RBx11160 (OZ277) with Piperaquine in Plasmodium Models</span>. <i>Exp. Parasitol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>115</i></span>,  <span class="NLM_fpage">296</span>– <span class="NLM_lpage">300</span>, <span class="refDoi"> DOI: 10.1016/j.exppara.2006.09.016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2Fj.exppara.2006.09.016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=17087929" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=115&publication_year=2007&pages=296-300&author=C.+Snyderauthor=J.+Cholletauthor=J.+Santo-Tomasauthor=C.+Scheurerauthor=S.+Wittlin&title=In+vitro+and+in+vivo+Interaction+of+Synthetic+Peroxide+RBx11160+%28OZ277%29+with+Piperaquine+in+Plasmodium+Models&doi=10.1016%2Fj.exppara.2006.09.016"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro and in vivo interaction of synthetic peroxide RBx11160 (OZ277) with piperaquine in Plasmodium models</span></div><div class="casAuthors">Snyder, Christopher; Chollet, Jacques; Santo-Tomas, Josefina; Scheurer, Christian; Wittlin, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Parasitology</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">115</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">296-300</span>CODEN:
                <span class="NLM_cas:coden">EXPAAA</span>;
        ISSN:<span class="NLM_cas:issn">0014-4894</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">RBx11160 (OZ277) is a promising antimalarial drug candidate that Ranbaxy Labs. Limited and Medicines for Malaria Venture (MMV) are currently developing as a fixed combination with piperaquine.  Here, we describe the in vitro (Plasmodium falciparum) and in vivo (Plasmodium berghei) activities of piperaquine in combination with RBx11160 and artemether.  In vitro, both combinations demonstrated a slight tendency towards antagonism with mean sums of fractional inhibitory concns. (mean ΣFICs) of 1.5.  In vivo, piperaquine and artemether were borderline antagonistic (mean ΣFIC of 1.4).  However, an additive in vivo interaction of piperaquine and RBx11160 (mean ΣFIC of 1.1) was identified, suggesting that a RBx11160-piperaquine combination therapy in humans should allow each mol. to exert its full antimalarial effect.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbsaEePIfPhrVg90H21EOLACvtfcHk0lj4t3ts0u4i5w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1Krt7vJ&md5=e1513c45d411887f6e65d7d31a61ad6d</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2Fj.exppara.2006.09.016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.exppara.2006.09.016%26sid%3Dliteratum%253Aachs%26aulast%3DSnyder%26aufirst%3DC.%26aulast%3DChollet%26aufirst%3DJ.%26aulast%3DSanto-Tomas%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DIn%2520vitro%2520and%2520in%2520vivo%2520Interaction%2520of%2520Synthetic%2520Peroxide%2520RBx11160%2520%2528OZ277%2529%2520with%2520Piperaquine%2520in%2520Plasmodium%2520Models%26jtitle%3DExp.%2520Parasitol.%26date%3D2007%26volume%3D115%26spage%3D296%26epage%3D300%26doi%3D10.1016%2Fj.exppara.2006.09.016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vanaerschot, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucantoni, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Combrinck, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santha Kumar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rubiano, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferreira, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siciliano, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gulati, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ng, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murithi, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lieberman, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Veiga, M. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinden, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alano, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sim, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffman, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Avery, V. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fid</span></span> <span> </span><span class="NLM_article-title">Hexahydroquinolines Are Antimalarial Candidates with Potent Blood Stage and Transmission-Blocking Activity</span>. <i>Nat. Microbiol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1403</span>– <span class="NLM_lpage">1414</span>, <span class="refDoi"> DOI: 10.1038/s41564-017-0007-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fs41564-017-0007-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=28808258" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvV2isLnP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2017&pages=1403-1414&author=M.+Vanaerschotauthor=L.+Lucantoniauthor=T.+Liauthor=J.+M.+Combrinckauthor=A.+Rueckerauthor=T.+R.+Santha+Kumarauthor=K.+Rubianoauthor=P.+E.+Ferreiraauthor=G.+Sicilianoauthor=S.+Gulatiauthor=P.+P.+Henrichauthor=C.+L.+Ngauthor=J.+M.+Murithiauthor=V.+C.+Coreyauthor=S.+Duffyauthor=O.+J.+Liebermanauthor=M.+I.+Veigaauthor=R.+E.+Sindenauthor=P.+Alanoauthor=M.+J.+Delvesauthor=K.+L.+Simauthor=E.+A.+Winzelerauthor=T.+J.+Eganauthor=S.+L.+Hoffmanauthor=V.+M.+Averyauthor=+Fid&title=Hexahydroquinolines+Are+Antimalarial+Candidates+with+Potent+Blood+Stage+and+Transmission-Blocking+Activity&doi=10.1038%2Fs41564-017-0007-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Hexahydroquinolines are antimalarial candidates with potent blood-stage and transmission-blocking activity</span></div><div class="casAuthors">Vanaerschot, Manu; Lucantoni, Leonardo; Li, Tao; Combrinck, Jill M.; Ruecker, Andrea; Kumar, T. R. Santha; Rubiano, Kelly; Ferreira, Pedro E.; Siciliano, Giulia; Gulati, Sonia; Henrich, Philipp P.; Ng, Caroline L.; Murithi, James M.; Corey, Victoria C.; Duffy, Sandra; Lieberman, Ori J.; Veiga, M. Isabel; Sinden, Robert E.; Alano, Pietro; Delves, Michael J.; Lee Sim, Kim; Winzeler, Elizabeth A.; Egan, Timothy J.; Hoffman, Stephen L.; Avery, Vicky M.; Fidock, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Microbiology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1403-1414</span>CODEN:
                <span class="NLM_cas:coden">NMAICH</span>;
        ISSN:<span class="NLM_cas:issn">2058-5276</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Antimalarial compds. with dual therapeutic and transmission-blocking activity are desired as high-value partners for combination therapies.  Here, we report the identification and characterization of hexahydroquinolines (HHQs) that show low nanomolar potency against both pathogenic and transmissible intra-erythrocytic forms of the malaria parasite Plasmodium falciparum.  This activity translates into potent transmission-blocking potential, as shown by in vitro male gamete formation assays and reduced oocyst infection and prevalence in Anopheles mosquitoes.  In vivo studies illustrated the ability of lead HHQs to suppress Plasmodium berghei blood-stage parasite proliferation.  Resistance selection studies, confirmed by CRISPR-Cas9-based gene editing, identified the digestive vacuole membrane-spanning transporter PfMDR1 (P. falciparum multidrug resistance gene-1) as a determinant of parasite resistance to HHQs.  Hb and haem fractionation assays suggest a mode of action that results in reduced haemozoin levels and might involve inhibition of host Hb uptake into intra-erythrocytic parasites.  Furthermore, parasites resistant to HHQs displayed increased susceptibility to several first-line antimalarial drugs, including lumefantrine, confirming that HHQs have a different mode of action to other antimalarials drugs for which PfMDR1 is known to confer resistance.  This work evokes therapeutic strategies that combine opposing selective pressures on this parasite transporter as an approach to countering the emergence and transmission of multidrug-resistant P. falciparum malaria.  A new class of drugs, hexahydroquinolines, inhibits host Hb endocytosis by Plasmodium falciparum and displays both therapeutic and transmission-blocking activities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrjCh5di3N1xLVg90H21EOLACvtfcHk0lgzVHcbryoPuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvV2isLnP&md5=7ed38ad319bbc4aaec76fde19abfc047</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1038%2Fs41564-017-0007-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41564-017-0007-4%26sid%3Dliteratum%253Aachs%26aulast%3DVanaerschot%26aufirst%3DM.%26aulast%3DLucantoni%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DT.%26aulast%3DCombrinck%26aufirst%3DJ.%2BM.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DSantha%2BKumar%26aufirst%3DT.%2BR.%26aulast%3DRubiano%26aufirst%3DK.%26aulast%3DFerreira%26aufirst%3DP.%2BE.%26aulast%3DSiciliano%26aufirst%3DG.%26aulast%3DGulati%26aufirst%3DS.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DNg%26aufirst%3DC.%2BL.%26aulast%3DMurithi%26aufirst%3DJ.%2BM.%26aulast%3DCorey%26aufirst%3DV.%2BC.%26aulast%3DDuffy%26aufirst%3DS.%26aulast%3DLieberman%26aufirst%3DO.%2BJ.%26aulast%3DVeiga%26aufirst%3DM.%2BI.%26aulast%3DSinden%26aufirst%3DR.%2BE.%26aulast%3DAlano%26aufirst%3DP.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DSim%26aufirst%3DK.%2BL.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DHoffman%26aufirst%3DS.%2BL.%26aulast%3DAvery%26aufirst%3DV.%2BM.%26aulast%3DFid%26atitle%3DHexahydroquinolines%2520Are%2520Antimalarial%2520Candidates%2520with%2520Potent%2520Blood%2520Stage%2520and%2520Transmission-Blocking%2520Activity%26jtitle%3DNat.%2520Microbiol.%26date%3D2017%26volume%3D2%26spage%3D1403%26epage%3D1414%26doi%3D10.1038%2Fs41564-017-0007-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Schlapbach, A.</span>; <span class="NLM_string-name">Revesz, L.</span>; <span class="NLM_string-name">Koch, G.</span></span> <span> </span><span class="NLM_article-title">Heterocyclic Compounds Useful as MK2 Inhibitors</span>. <span class="NLM_patent">WO2009/010488 A</span>, <span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=A.+Schlapbach&author=L.+Revesz&author=G.+Koch&title=Heterocyclic+Compounds+Useful+as+MK2+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSchlapbach%26aufirst%3DA.%26atitle%3DHeterocyclic%2520Compounds%2520Useful%2520as%2520MK2%2520Inhibitors%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chalyk, B. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isakov, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butko, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hrebeniuk, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savych, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kucher, O. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gavrilenko, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Druzhenko, T. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yarmolchuk, V. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zozulya, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mykhailiuk, P. K.</span></span> <span> </span><span class="NLM_article-title">Synthesis of 6-Azaspiro[4.3]Alkanes: Innovative Scaffolds for Drug Discovery</span>. <i>Eur. J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>2017</i></span>,  <span class="NLM_fpage">4530</span>– <span class="NLM_lpage">4542</span>, <span class="refDoi"> DOI: 10.1002/ejoc.201700536</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1002%2Fejoc.201700536" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFegtLjL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2017&publication_year=2017&pages=4530-4542&author=B.+A.+Chalykauthor=A.+A.+Isakovauthor=M.+V.+Butkoauthor=K.+V.+Hrebeniukauthor=O.+V.+Savychauthor=O.+V.+Kucherauthor=K.+S.+Gavrilenkoauthor=T.+V.+Druzhenkoauthor=V.+S.+Yarmolchukauthor=S.+Zozulyaauthor=P.+K.+Mykhailiuk&title=Synthesis+of+6-Azaspiro%5B4.3%5DAlkanes%3A+Innovative+Scaffolds+for+Drug+Discovery&doi=10.1002%2Fejoc.201700536"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of 6-Azaspiro[4.3]alkanes: Innovative Scaffolds for Drug Discovery</span></div><div class="casAuthors">Chalyk, Bohdan A.; Isakov, Andrei A.; Butko, Maryna V.; Hrebeniuk, Kateryna V.; Savych, Olena V.; Kucher, Olexandr V.; Gavrilenko, Konstantin S.; Druzhenko, Tetiana V.; Yarmolchuk, Vladimir S.; Zozulya, Sergey; Mykhailiuk, Pavel K.</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">2017</span>
        (<span class="NLM_cas:issue">31</span>),
    <span class="NLM_cas:pages">4530-4542</span>CODEN:
                <span class="NLM_cas:coden">EJOCFK</span>;
        ISSN:<span class="NLM_cas:issn">1099-0690</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">New scaffolds for drug discovery, 6-azaspiro[4.3]alkanes, I (R = H, F; A = O, S, SO2, etc.; EWG = COOEt, CN, NO2, etc.) have been synthesized in two steps from four-membered-ring ketones: cyclobutanone, thienone, N-Boc-azetidinone (Boc = tert-butoxycarbonyl), etc.  The key transformation was the reaction between electron-deficient exocyclic alkenes and an in-situ generated N-benzylazomethine ylide.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdwiPePs6x3rVg90H21EOLACvtfcHk0lgzVHcbryoPuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFegtLjL&md5=89dc2e73f978f6f754ed13db0fc04dfb</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1002%2Fejoc.201700536&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fejoc.201700536%26sid%3Dliteratum%253Aachs%26aulast%3DChalyk%26aufirst%3DB.%2BA.%26aulast%3DIsakov%26aufirst%3DA.%2BA.%26aulast%3DButko%26aufirst%3DM.%2BV.%26aulast%3DHrebeniuk%26aufirst%3DK.%2BV.%26aulast%3DSavych%26aufirst%3DO.%2BV.%26aulast%3DKucher%26aufirst%3DO.%2BV.%26aulast%3DGavrilenko%26aufirst%3DK.%2BS.%26aulast%3DDruzhenko%26aufirst%3DT.%2BV.%26aulast%3DYarmolchuk%26aufirst%3DV.%2BS.%26aulast%3DZozulya%26aufirst%3DS.%26aulast%3DMykhailiuk%26aufirst%3DP.%2BK.%26atitle%3DSynthesis%2520of%25206-Azaspiro%255B4.3%255DAlkanes%253A%2520Innovative%2520Scaffolds%2520for%2520Drug%2520Discovery%26jtitle%3DEur.%2520J.%2520Org.%2520Chem.%26date%3D2017%26volume%3D2017%26spage%3D4530%26epage%3D4542%26doi%3D10.1002%2Fejoc.201700536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heravi, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bakhtiari, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shoar, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oskooie, H. A.</span></span> <span> </span><span class="NLM_article-title">DABCO-POCl3, a Mild Dehydrating Agent for the Preparation of Nitriles from Aldoximes</span>. <i>J. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>2005</i></span>,  <span class="NLM_fpage">590</span>– <span class="NLM_lpage">591</span>, <span class="refDoi"> DOI: 10.3184/030823405774309005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.3184%2F030823405774309005" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2005&publication_year=2005&pages=590-591&author=M.+M.+Heraviauthor=K.+Bakhtiariauthor=R.+H.+Shoarauthor=H.+A.+Oskooie&title=DABCO-POCl3%2C+a+Mild+Dehydrating+Agent+for+the+Preparation+of+Nitriles+from+Aldoximes&doi=10.3184%2F030823405774309005"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.3184%2F030823405774309005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3184%252F030823405774309005%26sid%3Dliteratum%253Aachs%26aulast%3DHeravi%26aufirst%3DM.%2BM.%26aulast%3DBakhtiari%26aufirst%3DK.%26aulast%3DShoar%26aufirst%3DR.%2BH.%26aulast%3DOskooie%26aufirst%3DH.%2BA.%26atitle%3DDABCO-POCl3%252C%2520a%2520Mild%2520Dehydrating%2520Agent%2520for%2520the%2520Preparation%2520of%2520Nitriles%2520from%2520Aldoximes%26jtitle%3DJ.%2520Chem.%2520Res.%26date%3D2005%26volume%3D2005%26spage%3D590%26epage%3D591%26doi%3D10.3184%2F030823405774309005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Theron, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lauterbach, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rossouw, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Engelbrecht, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wepener, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mancama, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coetzer, T. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span> <span> </span><span class="NLM_article-title">Nowhere to Hide: Interrogating Different Metabolic Parameters of <i>Plasmodium falciparum</i> Gametocytes in a Transmission Blocking Drug Discovery Pipeline towards Malaria Elimination</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>14</i></span>, <span class="NLM_elocation-id">213</span> <span class="refDoi"> DOI: 10.1186/s12936-015-0718-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-015-0718-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=25994518" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A280%3ADC%252BC2MfmtVKgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2015&author=J.+Readerauthor=M.+Bothaauthor=A.+Theronauthor=S.+B.+Lauterbachauthor=C.+Rossouwauthor=D.+Engelbrechtauthor=M.+Wepenerauthor=A.+Smitauthor=D.+Leroyauthor=D.+Mancamaauthor=T.+L.+Coetzerauthor=L.-M.+Birkholtz&title=Nowhere+to+Hide%3A+Interrogating+Different+Metabolic+Parameters+of+Plasmodium+falciparum+Gametocytes+in+a+Transmission+Blocking+Drug+Discovery+Pipeline+towards+Malaria+Elimination&doi=10.1186%2Fs12936-015-0718-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Nowhere to hide: interrogating different metabolic parameters of Plasmodium falciparum gametocytes in a transmission blocking drug discovery pipeline towards malaria elimination</span></div><div class="casAuthors">Reader Janette; Botha Mariette; Smit Annel; Birkholtz Lyn-Marie; Theron Anjo; Rossouw Claire; Mancama Dalu; Lauterbach Sonja B; Engelbrecht Dewaldt; Wepener Melanie; Coetzer Theresa L; Leroy Didier</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">213</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  The discovery of malaria transmission-blocking compounds is seen as key to malaria elimination strategies and gametocyte-screening platforms are critical filters to identify active molecules.  However, unlike asexual parasite assays measuring parasite proliferation, greater variability in end-point readout exists between different gametocytocidal assays.  This is compounded by difficulties in routinely producing viable, functional and stage-specific gametocyte populations.  Here, a parallel evaluation of four assay platforms on the same gametocyte populations was performed for the first time.  This allowed the direct comparison of the ability of different assay platforms to detect compounds with gametocytocidal activity and revealed caveats in some assay readouts that interrogate different parasite biological functions.  METHODS:  Gametocytogenesis from Plasmodium falciparum (NF54) was optimized with a robust and standardized protocol.  ATP, pLDH, luciferase reporter and PrestoBlue® assays were compared in context of a set of 10 reference compounds.  The assays were performed in parallel on the same gametocyte preparation (except for luciferase reporter lines) using the same drug preparations (48 h).  The remaining parameters for each assay were all comparable.  RESULTS:  A highly robust method for generating viable and functional gametocytes was developed and comprehensively validated resulting in an average gametocytaemia of 4%.  Subsequent parallel assays for gametocytocidal activity indicated that different assay platforms were not able to screen compounds with variant chemical scaffolds similarly.  Luciferase reporter assays revealed that synchronized stage-specific gametocyte production is essential for drug discovery, as differential susceptibility in various gametocyte developmental populations is evident.  CONCLUSIONS:  With this study, the key parameters for assays aiming at testing the gametocytocidal activity of potential transmission blocking molecules against Plasmodium gametocytes were accurately dissected.  This first and uniquely comparative study emphasizes differential effects seen with the use of different assay platforms interrogating variant biological systems.  Whilst this data is informative from a biological perspective and may provide indications of the drug mode of action, it does highlight the care that must be taken when screening broad-diversity chemotypes with a single assay platform against gametocytes for which the biology is not clearly understood.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSN-djmAqATdOkdrW1FkXG-fW6udTcc2eZT8yNoV3OADbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2MfmtVKgtA%253D%253D&md5=aa775c0d4fdf2fc0ef496172de10edfc</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1186%2Fs12936-015-0718-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-015-0718-z%26sid%3Dliteratum%253Aachs%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBotha%26aufirst%3DM.%26aulast%3DTheron%26aufirst%3DA.%26aulast%3DLauterbach%26aufirst%3DS.%2BB.%26aulast%3DRossouw%26aufirst%3DC.%26aulast%3DEngelbrecht%26aufirst%3DD.%26aulast%3DWepener%26aufirst%3DM.%26aulast%3DSmit%26aufirst%3DA.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DMancama%26aufirst%3DD.%26aulast%3DCoetzer%26aufirst%3DT.%2BL.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26atitle%3DNowhere%2520to%2520Hide%253A%2520Interrogating%2520Different%2520Metabolic%2520Parameters%2520of%2520Plasmodium%2520falciparum%2520Gametocytes%2520in%2520a%2520Transmission%2520Blocking%2520Drug%2520Discovery%2520Pipeline%2520towards%2520Malaria%2520Elimination%26jtitle%3DMalar.%2520J.%26date%3D2015%26volume%3D14%26doi%3D10.1186%2Fs12936-015-0718-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Coetzee, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">von Grüning, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Opperman, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der Watt, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L. M.</span></span> <span> </span><span class="NLM_article-title">Epigenetic Inhibitors Target Multiple Stages of <i>Plasmodium falciparum</i> Parasites</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>, <span class="NLM_elocation-id">2355</span> <span class="refDoi"> DOI: 10.1038/s41598-020-59298-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fs41598-020-59298-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=32047203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXkvVans7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&author=N.+Coetzeeauthor=H.+von+Gr%C3%BCningauthor=D.+Oppermanauthor=M.+van+der+Wattauthor=J.+Readerauthor=L.+M.+Birkholtz&title=Epigenetic+Inhibitors+Target+Multiple+Stages+of+Plasmodium+falciparum+Parasites&doi=10.1038%2Fs41598-020-59298-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Epigenetic inhibitors target multiple stages of Plasmodium falciparum parasites</span></div><div class="casAuthors">Coetzee, Nanika; von Gruning, Hilde; Opperman, Daniel; van der Watt, Mariette; Reader, Janette; Birkholtz, Lyn-Marie</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2355</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: The epigenome of the malaria parasite, Plasmodium falciparum, is assocd. with regulation of various essential processes in the parasite including control of proliferation during asexual development as well as control of sexual differentiation.  The unusual nature of the epigenome has prompted investigations into the potential to target epigenetic modulators with novel chemotypes.  Here, we explored the diversity within a library of 95 compds., active against various epigenetic modifiers in cancerous cells, for activity against multiple stages of P. falciparum development.  We show that P. falciparum is differentially susceptible to epigenetic perturbation during both asexual and sexual development, with early stage gametocytes particularly sensitive to epi-drugs targeting both histone and non-histone epigenetic modifiers.  Moreover, 5 compds. targeting histone acetylation and methylation show potent multistage activity against asexual parasites, early and late stage gametocytes, with transmission-blocking potential.  Overall, these results warrant further examn. of the potential antimalarial properties of these hit compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouN6T9Alzu37Vg90H21EOLACvtfcHk0lhh7mZt_OQYkg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXkvVans7c%253D&md5=b3878965de5b49c29573acc9d59295cc</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-59298-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-59298-4%26sid%3Dliteratum%253Aachs%26aulast%3DCoetzee%26aufirst%3DN.%26aulast%3Dvon%2BGr%25C3%25BCning%26aufirst%3DH.%26aulast%3DOpperman%26aufirst%3DD.%26aulast%3Dvan%2Bder%2BWatt%26aufirst%3DM.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBirkholtz%26aufirst%3DL.%2BM.%26atitle%3DEpigenetic%2520Inhibitors%2520Target%2520Multiple%2520Stages%2520of%2520Plasmodium%2520falciparum%2520Parasites%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26doi%3D10.1038%2Fs41598-020-59298-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Miura, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swihart, B. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diouf, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fay, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, C. A.</span></span> <span> </span><span class="NLM_article-title">Transmission-Blocking Activity Is Determined by Transmission-Reducing Activity and Number of Control Oocysts in <i>Plasmodium falciparum</i> Standard Membrane-Feeding Assay</span>. <i>Vaccine</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">4145</span>– <span class="NLM_lpage">4151</span>, <span class="refDoi"> DOI: 10.1016/j.vaccine.2016.06.066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2Fj.vaccine.2016.06.066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=27372156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A280%3ADC%252BC2s7mtlaisA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2016&pages=4145-4151&author=K.+Miuraauthor=B.+J.+Swihartauthor=B.+Dengauthor=L.+Zhouauthor=T.+P.+Phamauthor=A.+Dioufauthor=T.+Burtonauthor=M.+P.+Fayauthor=C.+A.+Long&title=Transmission-Blocking+Activity+Is+Determined+by+Transmission-Reducing+Activity+and+Number+of+Control+Oocysts+in+Plasmodium+falciparum+Standard+Membrane-Feeding+Assay&doi=10.1016%2Fj.vaccine.2016.06.066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Transmission-blocking activity is determined by transmission-reducing activity and number of control oocysts in Plasmodium falciparum standard membrane-feeding assay</span></div><div class="casAuthors">Miura Kazutoyo; Deng Bingbing; Zhou Luwen; Pham Thao P; Diouf Ababacar; Burton Timothy; Long Carole A; Swihart Bruce J; Fay Michael P</div><div class="citationInfo"><span class="NLM_cas:title">Vaccine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">35</span>),
    <span class="NLM_cas:pages">4145-4151</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Malaria transmission-blocking vaccines (TBVs) are potentially helpful tools for malaria eradication.  The standard membrane-feeding assay (SMFA) is considered one of the "gold standard" assays for TBV development.  However, lack of consensus in reporting results from SMFA has made it very challenging to compare results from different studies.  Two main readouts, % inhibition in mean oocyst count per mosquito (TRA) and % inhibition in prevalence of infected mosquitoes (TBA), have been used widely.  In this study, we statistically modeled the oocyst data in SMFA using data from 105 independent feeding experiments including 9804 mosquitoes.  The model was validated using an independent data set that included 10,790 mosquitoes from 110 feeding studies.  The model delineates a relationship between TRA, the mean oocyst count in the control mosquitoes (mo-contl), and TBA.  While TRA was independent from mo-contl, TBA values changed depending on mo-contl.  Regardless of monoclonal or polyclonal antibodies tested, there were strong concordances between observed TBA and predicted TBA based on the model using mo-contl and observed TRA.  Simulations showed that SMFA with lower true control means had increased uncertainty in TRA estimates.  The strong linkage between TBA, TRA and mo-contl inspired creation of a standardized TBA, a model-based TBA standardized to a target control mean, which allows comparison across multiple feeds regardless of mo-contl.  This is the first study showing that the observed TBA can be reasonably predicted by mo-contl and the TRA of the test antibody using independent experimental data.  This study indicates that TRA should be used to compare results from multiple feeds with different levels of mo-contl.  If a measure of TBA is desired, it is better to report standardized TBA rather than observed TBA.  These recommendations support rational comparisons of results from different studies, thus benefiting future TBV development.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTSDuGyPxLQisjl5L8hwNX0fW6udTcc2eZFzGaxsoVjtLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2s7mtlaisA%253D%253D&md5=d28280af68a7786ac94e66748064eb8c</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.vaccine.2016.06.066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vaccine.2016.06.066%26sid%3Dliteratum%253Aachs%26aulast%3DMiura%26aufirst%3DK.%26aulast%3DSwihart%26aufirst%3DB.%2BJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DPham%26aufirst%3DT.%2BP.%26aulast%3DDiouf%26aufirst%3DA.%26aulast%3DBurton%26aufirst%3DT.%26aulast%3DFay%26aufirst%3DM.%2BP.%26aulast%3DLong%26aufirst%3DC.%2BA.%26atitle%3DTransmission-Blocking%2520Activity%2520Is%2520Determined%2520by%2520Transmission-Reducing%2520Activity%2520and%2520Number%2520of%2520Control%2520Oocysts%2520in%2520Plasmodium%2520falciparum%2520Standard%2520Membrane-Feeding%2520Assay%26jtitle%3DVaccine%26date%3D2016%26volume%3D34%26spage%3D4145%26epage%3D4151%26doi%3D10.1016%2Fj.vaccine.2016.06.066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bridgland-Taylor, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Easter, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Orme, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henthorn, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Small, B. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heapy, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abi-Gerges, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Persson, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jacobso, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alberstson, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammond, T. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sullivan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valentin, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollard, C. E.</span></span> <span> </span><span class="NLM_article-title">Optimisation and Validation of a Medium-Throughput Electrophysiology-Based hERG Assay Using IonWorks HT</span>. <i>J. Pharmacol. Toxicol. Methods</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>54</i></span>,  <span class="NLM_fpage">189</span>– <span class="NLM_lpage">199</span>, <span class="refDoi"> DOI: 10.1016/j.vascn.2006.02.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2Fj.vascn.2006.02.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=16563806" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2006&pages=189-199&author=M.+H.+Bridgland-Taylorauthor=A.+C.+Hargreavesauthor=A.+Easterauthor=A.+Ormeauthor=D.+C.+Henthornauthor=M.+Dingauthor=A.+M.+Davisauthor=B.+G.+Smallauthor=C.+G.+Heapyauthor=N.+Abi-Gergesauthor=F.+Perssonauthor=I.+Jacobsoauthor=M.+Sullivanauthor=N.+Alberstsonauthor=T.+G.+Hammondauthor=E.+Sullivanauthor=J.+P.+Valentinauthor=C.+E.+Pollard&title=Optimisation+and+Validation+of+a+Medium-Throughput+Electrophysiology-Based+hERG+Assay+Using+IonWorks+HT&doi=10.1016%2Fj.vascn.2006.02.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Optimization and validation of a medium-throughput electrophysiology-based hERG assay using IonWorks HT</span></div><div class="casAuthors">Bridgland-Taylor, M. H.; Hargreaves, A. C.; Easter, A.; Orme, A.; Henthorn, D. C.; Ding, M.; Davis, A. M.; Small, B. G.; Heapy, C. G.; Abi-Gerges, N.; Persson, F.; Jacobson, I.; Sullivan, M.; Albertson, N.; Hammond, T. G.; Sullivan, E.; Valentin, J.-P.; Pollard, C. E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacological and Toxicological Methods</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">189-199</span>CODEN:
                <span class="NLM_cas:coden">JPTMEZ</span>;
        ISSN:<span class="NLM_cas:issn">1056-8719</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Introduction: Regulatory and competitive pressure to reduce the QT interval prolongation risk of potential new drugs has led to focus on methods to test for inhibition of the human ether-a-go-go-related gene (hERG)-encoded K+ channel, the primary mol. target underlying this safety issue.  Here we describe the validation of a method that combines medium-throughput with direct assessment of channel function.  Methods: The electrophysiol. and pharmacol. properties of hERG were compared using two methods: conventional, low-throughput electrophysiol. and planar-array-based, medium-throughput electrophysiol. (IonWorks HT).  A pharmacol. comparison was also made between IonWorks HT and an indirect assay (Rb+ efflux).  Results: Basic electrophysiol. properties of hERG were similar whether recorded conventionally (HEK cells) or using IonWorks HT (CHO cells): for example, tail current V1/2 - 12.1 ± 5.0 mV (32) for conventional and - 9.5 ± 6.0 mV (46) for IonWorks HT (mean ± S.D. (n)).  A key finding was that as the no. of cells per well was increased in IonWorks HT, the potency reported for a given compd. decreased.  Using the lowest possible cell concn. (250,000 cells/mL) and 89 compds. spanning a broad potency range, the pIC50 values from IonWorks HT (CHO-hERG) were found to correlate well with those obtained using conventional methodol. (HEK-hERG)(r = 0.90; p < 0.001).  Further validation using CHO-hERG cells with both methods confirmed the correlation (r = 0.94; p < 0.001).  In contrast, a comparison of IonWorks HT and Rb+ efflux data with 649 compds. using CHO-hERG cells showed that the indirect assay consistently reported compds. as being, on av., 6-fold less potent, though the differences varied depending on chem. series.  Discussion: The main finding of this work is that providing a relatively low cell concn. is used in IonWorks HT, the potency information generated correlates well with that detd. using conventional electrophysiol.  The effect on potency of increasing cell concn. may relate to a reduced free concn. of test compd. owing to partitioning into cell membranes.  In summary, the IonWorks HT hERG assay can generate pIC50 values based on a direct assessment of channel function in a timeframe short enough to influence chem. design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqTcBXhwRw0nLVg90H21EOLACvtfcHk0ljtsAf8qVkZ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XptFChtbw%253D&md5=730258a42517947c0b972ca87cef46b6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.vascn.2006.02.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.vascn.2006.02.003%26sid%3Dliteratum%253Aachs%26aulast%3DBridgland-Taylor%26aufirst%3DM.%2BH.%26aulast%3DHargreaves%26aufirst%3DA.%2BC.%26aulast%3DEaster%26aufirst%3DA.%26aulast%3DOrme%26aufirst%3DA.%26aulast%3DHenthorn%26aufirst%3DD.%2BC.%26aulast%3DDing%26aufirst%3DM.%26aulast%3DDavis%26aufirst%3DA.%2BM.%26aulast%3DSmall%26aufirst%3DB.%2BG.%26aulast%3DHeapy%26aufirst%3DC.%2BG.%26aulast%3DAbi-Gerges%26aufirst%3DN.%26aulast%3DPersson%26aufirst%3DF.%26aulast%3DJacobso%26aufirst%3DI.%26aulast%3DSullivan%26aufirst%3DM.%26aulast%3DAlberstson%26aufirst%3DN.%26aulast%3DHammond%26aufirst%3DT.%2BG.%26aulast%3DSullivan%26aufirst%3DE.%26aulast%3DValentin%26aufirst%3DJ.%2BP.%26aulast%3DPollard%26aufirst%3DC.%2BE.%26atitle%3DOptimisation%2520and%2520Validation%2520of%2520a%2520Medium-Throughput%2520Electrophysiology-Based%2520hERG%2520Assay%2520Using%2520IonWorks%2520HT%26jtitle%3DJ.%2520Pharmacol.%2520Toxicol.%2520Methods%26date%3D2006%26volume%3D54%26spage%3D189%26epage%3D199%26doi%3D10.1016%2Fj.vascn.2006.02.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hopkins, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keserü, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leeson, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rees, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reynolds, C. H.</span></span> <span> </span><span class="NLM_article-title">The Role of Ligand Efficiency Metrics in Drug Discovery</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">105</span>– <span class="NLM_lpage">121</span>, <span class="refDoi"> DOI: 10.1038/nrd4163</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fnrd4163" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=24481311" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2014&pages=105-121&author=A.+L.+Hopkinsauthor=G.+M.+Keser%C3%BCauthor=P.+D.+Leesonauthor=D.+C.+Reesauthor=C.+H.+Reynolds&title=The+Role+of+Ligand+Efficiency+Metrics+in+Drug+Discovery&doi=10.1038%2Fnrd4163"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">The role of ligand efficiency metrics in drug discovery</span></div><div class="casAuthors">Hopkins, Andrew L.; Keserue, Gyoergy M.; Leeson, Paul D.; Rees, David C.; Reynolds, Charles H.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">105-121</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The judicious application of ligand or binding efficiency metrics, which quantify the mol. properties required to obtain binding affinity for a drug target, is gaining traction in the selection and optimization of fragments, hits and leads.  Retrospective anal. of recently marketed oral drugs shows that they frequently have highly optimized ligand efficiency values for their targets.  Optimizing ligand efficiency metrics based on both mol. mass and lipophilicity, when set in the context of the specific target, has the potential to ameliorate the inflation of these properties that has been obsd. in current medicinal chem. practice, and to increase the quality of drug candidates.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq96uhvE1OZ5LVg90H21EOLACvtfcHk0ljtsAf8qVkZ-A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1SmtLk%253D&md5=344030e59f499180f79d311302a27532</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1038%2Fnrd4163&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd4163%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DKeser%25C3%25BC%26aufirst%3DG.%2BM.%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DRees%26aufirst%3DD.%2BC.%26aulast%3DReynolds%26aufirst%3DC.%2BH.%26atitle%3DThe%2520Role%2520of%2520Ligand%2520Efficiency%2520Metrics%2520in%2520Drug%2520Discovery%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2014%26volume%3D13%26spage%3D105%26epage%3D121%26doi%3D10.1038%2Fnrd4163" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Le
Manach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sax, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schleiferböck, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ding, X. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witty, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span> <span> </span><span class="NLM_article-title">Fast <i>in vitro</i> Methods to Determine the Speed of Action and the Stage-Specificity of Anti-Malarials in <i>Plasmodium falciparum</i></span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">424</span>– <span class="NLM_lpage">430</span>, <span class="refDoi"> DOI: 10.1186/1475-2875-12-424</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2F1475-2875-12-424" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=24237770" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvFehur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=424-430&author=C.+Le%0AManachauthor=C.+Scheurerauthor=S.+Saxauthor=S.+Schleiferb%C3%B6ckauthor=D.+G.+Cabreraauthor=Y.+Younisauthor=T.+Paquetauthor=L.+Streetauthor=P.+Smithauthor=X.+C.+Dingauthor=D.+Watersonauthor=M.+J.+Wittyauthor=D.+Leroyauthor=K.+Chibaleauthor=S.+Wittlin&title=Fast+in+vitro+Methods+to+Determine+the+Speed+of+Action+and+the+Stage-Specificity+of+Anti-Malarials+in+Plasmodium+falciparum&doi=10.1186%2F1475-2875-12-424"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Fast in vitro methods to determine the speed of action and the stage-specificity of anti-malarials in Plasmodium falciparum</span></div><div class="casAuthors">Le Manach, Claire; Scheurer, Christian; Sax, Sibylle; Schleiferbock, Sarah; Gonzalez Cabrera, Diego; Younis, Yassir; Paquet, Tanya; Street, Leslie; Smith, Peter; Ding, Xavier C.; Waterson, David; Witty, Michael J.; Leroy, Didier; Chibale, Kelly; Wittlin, Sergio</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">424/1-424/7, 7 pp.</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Recent whole cell in vitro screening campaigns identified thousands of compds. that are active against asexual blood stages of Plasmodium falciparum at submicromolar concns.  These hits were made available to the public, providing many novel chem. starting points for anti-malarial drug discovery programs.  Knowing which of these hits are fast-acting compds. is of great interest.  Firstly, a fast action will ensure rapid relief of symptoms for the patient.  Secondly, by rapidly reducing the parasitemia, this could minimize the occurrence of mutations leading to new drug resistance mechanisms.  An in vitro assay that provides information about the speed of action of test compds. was developed by researchers at GlaxoSmithKline (GSK) in Spain.  This assay also provides an in vitro measure for the ratio between parasitemia at the onset of drug treatment and after one intra-erythrocytic cycle (parasite redn. ratio, PRR).  Both parameters are needed to det. in vitro killing rates of anti-malarial compds.  A drawback of the killing rate assay is that it takes a month to obtain 1st results.  The approach described in the present study is focused only on the speed of action of anti-malarials.  This has the advantage that initial results can be achieved within 4-7 working days, which helps to distinguish between fast and slow-acting compds. relatively quickly.  It is expected that this new assay can be used as a filter in the early drug discovery phase, which will reduce the no. of compds. progressing to secondary, more time-consuming assays like the killing rate assay.  The speed of action of a selection of 7 anti-malarial compds. was measured with 2 independent exptl. procedures using modifications of the std. [3H]hypoxanthine incorporation assay.  Depending on the outcome of both assays, the tested compds. were classified as either fast or non-fast-acting.  The results obtained for the anti-malarials chloroquine, artesunate, atovaquone, and pyrimethamine are consistent with previous observations, suggesting the methodol. is a valid way to rapidly identify fast-acting anti-malarial compds.  Another advantage of the approach is its ability to discriminate between static or cidal compd. effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr9DRNQDuAnAbVg90H21EOLACvtfcHk0liu1Wtl6ra1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvFehur8%253D&md5=6b9faa87181597b607d3b05f88a64c4d</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1186%2F1475-2875-12-424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1475-2875-12-424%26sid%3Dliteratum%253Aachs%26aulast%3DLe%2BManach%26aufirst%3DC.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DSax%26aufirst%3DS.%26aulast%3DSchleiferb%25C3%25B6ck%26aufirst%3DS.%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DPaquet%26aufirst%3DT.%26aulast%3DStreet%26aufirst%3DL.%26aulast%3DSmith%26aufirst%3DP.%26aulast%3DDing%26aufirst%3DX.%2BC.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DChibale%26aufirst%3DK.%26aulast%3DWittlin%26aufirst%3DS.%26atitle%3DFast%2520in%2520vitro%2520Methods%2520to%2520Determine%2520the%2520Speed%2520of%2520Action%2520and%2520the%2520Stage-Specificity%2520of%2520Anti-Malarials%2520in%2520Plasmodium%2520falciparum%26jtitle%3DMalar.%2520J.%26date%3D2013%26volume%3D12%26spage%3D424%26epage%3D430%26doi%3D10.1186%2F1475-2875-12-424" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korsik, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M. H.</span></span> <span> </span><span class="NLM_article-title">The Past, Present and Future of Anti - Malarial Medicines</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>, <span class="NLM_elocation-id">93</span> <span class="refDoi"> DOI: 10.1186/s12936-019-2724-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-019-2724-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=30902052" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2019&author=E.+G.+Tseauthor=M.+Korsikauthor=M.+H.+Todd&title=The+Past%2C+Present+and+Future+of+Anti+-+Malarial+Medicines&doi=10.1186%2Fs12936-019-2724-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">The past, present and future of anti-malarial medicines</span></div><div class="casAuthors">Tse Edwin G; Korsik Marat; Todd Matthew H; Todd Matthew H</div><div class="citationInfo"><span class="NLM_cas:title">Malaria journal</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">93</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Great progress has been made in recent years to reduce the high level of suffering caused by malaria worldwide.  Notably, the use of insecticide-treated mosquito nets for malaria prevention and the use of artemisinin-based combination therapy (ACT) for malaria treatment have made a significant impact.  Nevertheless, the development of resistance to the past and present anti-malarial drugs highlights the need for continued research to stay one step ahead.  New drugs are needed, particularly those with new mechanisms of action.  Here the range of anti-malarial medicines developed over the years are reviewed, beginning with the discovery of quinine in the early 1800s, through to modern day ACT and the recently-approved tafenoquine.  A number of new potential anti-malarial drugs currently in development are outlined, along with a description of the hit to lead campaign from which it originated.  Finally, promising novel mechanisms of action for these and future anti-malarial medicines are outlined.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRAJgQVEudAeqqcneEtCi92fW6udTcc2eZelvo3eGEK_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3cbntFylug%253D%253D&md5=b15a2176b672dff36de8c4ea6cfb6a54</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-2724-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-2724-z%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DE.%2BG.%26aulast%3DKorsik%26aufirst%3DM.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DThe%2520Past%252C%2520Present%2520and%2520Future%2520of%2520Anti%2520-%2520Malarial%2520Medicines%26jtitle%3DMalar.%2520J.%26date%3D2019%26doi%3D10.1186%2Fs12936-019-2724-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cox, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duffy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zdorichenko, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bellanger, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurcum, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laleu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Booker-milburn, K. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elliott, L. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robertson-ralph, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swain, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bishop, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span> <span> </span><span class="NLM_article-title">Escaping from Flatland: Antimalarial Activity of Sp 3 - Rich Bridged Pyrrolidine Derivatives</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">2497</span>– <span class="NLM_lpage">2503</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.0c00486</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.0c00486" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1Kru7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&pages=2497-2503&author=B.+Coxauthor=J.+Duffyauthor=V.+Zdorichenkoauthor=C.+Bellangerauthor=J.+Hurcumauthor=B.+Laleuauthor=K.+I.+Booker-milburnauthor=L.+D.+Elliottauthor=M.+Robertson-ralphauthor=C.+J.+Swainauthor=S.+J.+Bishopauthor=I.+Hallyburtonauthor=M.+Anderson&title=Escaping+from+Flatland%3A+Antimalarial+Activity+of+Sp+3+-+Rich+Bridged+Pyrrolidine+Derivatives&doi=10.1021%2Facsmedchemlett.0c00486"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Escaping from Flatland: Antimalarial Activity of sp3-Rich Bridged Pyrrolidine Derivatives</span></div><div class="casAuthors">Cox, Brian; Duffy, James; Zdorichenko, Victor; Bellanger, Corentin; Hurcum, Jessica; Laleu, Benoit; Booker-Milburn, Kevin I.; Elliott, Luke D.; Robertson-Ralph, Michael; Swain, Christopher J.; Bishop, Stephen J.; Hallyburton, Irene; Anderson, Mark</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2497-2503</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Synthetic photochem. to generate novel sp3-rich scaffolds and report the design, synthesis, and biol. testing of a diverse series of amides based on the 1-(amino-methyl)-2-benzyl-2-aza-bicyclo[2.1.1]hexane scaffold was utilized .  Preliminary antimalarial screening of the library provided promising compds. with activity in the 1-5μM range with an enhanced hit rate.  Further evaluation (soly., drug metab. and pharmacokinetics (DMPK), and toxicity) of a selected compound (9) suggested that this series represents an excellent opportunity for further optimization with the framework offering multiple opportunities for the addn. of uniquely vectorally positioned extra functionality.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO6ZPqnDNk-7Vg90H21EOLACvtfcHk0liu1Wtl6ra1lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1Kru7vM&md5=b0226473dd7d0e518a69b4d6d467f3c8</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.0c00486&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.0c00486%26sid%3Dliteratum%253Aachs%26aulast%3DCox%26aufirst%3DB.%26aulast%3DDuffy%26aufirst%3DJ.%26aulast%3DZdorichenko%26aufirst%3DV.%26aulast%3DBellanger%26aufirst%3DC.%26aulast%3DHurcum%26aufirst%3DJ.%26aulast%3DLaleu%26aufirst%3DB.%26aulast%3DBooker-milburn%26aufirst%3DK.%2BI.%26aulast%3DElliott%26aufirst%3DL.%2BD.%26aulast%3DRobertson-ralph%26aufirst%3DM.%26aulast%3DSwain%26aufirst%3DC.%2BJ.%26aulast%3DBishop%26aufirst%3DS.%2BJ.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DAnderson%26aufirst%3DM.%26atitle%3DEscaping%2520from%2520Flatland%253A%2520Antimalarial%2520Activity%2520of%2520Sp%25203%2520-%2520Rich%2520Bridged%2520Pyrrolidine%2520Derivatives%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2020%26volume%3D11%26spage%3D2497%26epage%3D2503%26doi%3D10.1021%2Facsmedchemlett.0c00486" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lgkimmvCUMsvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ashley, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phyo, A. P.</span></span> <span> </span><span class="NLM_article-title">Drugs in Development for Malaria</span>. <i>Drugs</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">879</span>, <span class="refDoi"> DOI: 10.1007/s40265-018-0911-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1007%2Fs40265-018-0911-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=29802605" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2018&pages=861-879&author=E.+A.+Ashleyauthor=A.+P.+Phyo&title=Drugs+in+Development+for+Malaria&doi=10.1007%2Fs40265-018-0911-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">Drugs in Development for Malaria</span></div><div class="casAuthors">Ashley, Elizabeth A.; Phyo, Aung Pyae</div><div class="citationInfo"><span class="NLM_cas:title">Drugs</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">861-879</span>CODEN:
                <span class="NLM_cas:coden">DRUGAY</span>;
        ISSN:<span class="NLM_cas:issn">0012-6667</span>.
    
            (<span class="NLM_cas:orgname">Springer International Publishing AG</span>)
        </div><div class="casAbstract">The last two decades have seen a surge in antimalarial drug development with product development partnerships taking a leading role.  Resistance of Plasmodium falciparum to the artemisinin derivs., piperaquine and mefloquine in Southeast Asia means new antimalarials are needed with some urgency.  There are at least 13 agents in clin. development.  Most of these are blood schizonticides for the treatment of uncomplicated falciparum malaria, under evaluation either singly or as part of two-drug combinations.  Leading candidates progressing through the pipeline are artefenomel-ferroquine and lumefantrine-KAF156, both in Phase 2b.  Treatment of severe malaria continues to rely on two parenteral drugs with ancient forebears: artesunate and quinine, with sevuparin being evaluated as an adjuvant therapy.  Tafenoquine is under review by stringent regulatory authorities for approval as a single-dose treatment for Plasmodium vivax relapse prevention.  This represents an advance over std. 14-day primaquine regimens; however, the risk of acute haemolytic anemia in patients with glucose-6-phosphate dehydrogenase deficiency remains.  For disease prevention, several of the newer agents show potential but are unlikely to be recommended for use in the main target groups of pregnant women and young children for some years.  Latest predictions are that the malaria burden will continue to be high in the coming decades.  This fact, coupled with the repeated loss of antimalarials to resistance, indicates that new antimalarials will be needed for years to come.  Failure of the artemisinin-based combinations in Southeast Asia has stimulated a reappraisal of current approaches to combination therapy for malaria with incorporation of three or more drugs in a single treatment under consideration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrbu06hSG2TXLVg90H21EOLACvtfcHk0lgkimmvCUMsvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtVOmurnK&md5=4cfdcaf7482b5e1d8ed55f3ae126b0e8</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs40265-018-0911-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs40265-018-0911-9%26sid%3Dliteratum%253Aachs%26aulast%3DAshley%26aufirst%3DE.%2BA.%26aulast%3DPhyo%26aufirst%3DA.%2BP.%26atitle%3DDrugs%2520in%2520Development%2520for%2520Malaria%26jtitle%3DDrugs%26date%3D2018%26volume%3D78%26spage%3D861%26epage%3D879%26doi%3D10.1007%2Fs40265-018-0911-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Magistrado, P. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lukens, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sasaki, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meister, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirth, D. F.</span></span> <span> </span><span class="NLM_article-title"><i>Plasmodium falciparum</i> Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes</span>. <i>ACS Infect. Dis.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">816</span>– <span class="NLM_lpage">826</span>, <span class="refDoi"> DOI: 10.1021/acsinfecdis.6b00025</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsinfecdis.6b00025" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28XkvFCrsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2016&pages=816-826&author=P.+A.+Magistradoauthor=V.+C.+Coreyauthor=A.+K.+Lukensauthor=G.+Lamonteauthor=E.+Sasakiauthor=S.+Meisterauthor=M.+Wreeauthor=E.+Winzelerauthor=D.+F.+Wirth&title=Plasmodium+falciparum+Cyclic+Amine+Resistance+Locus+%28PfCARL%29%2C+a+Resistance+Mechanism+for+Two+Distinct+Compound+Classes&doi=10.1021%2Facsinfecdis.6b00025"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Plasmodium falciparum Cyclic Amine Resistance Locus (PfCARL), a Resistance Mechanism for Two Distinct Compound Classes</span></div><div class="casAuthors">Magistrado, Pamela A.; Corey, Victoria C.; Lukens, Amanda K.; LaMonte, Greg; Sasaki, Erika; Meister, Stephan; Wree, Melanie; Winzeler, Elizabeth; Wirth, Dyann F.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Infectious Diseases</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">816-826</span>CODEN:
                <span class="NLM_cas:coden">AIDCBC</span>;
        ISSN:<span class="NLM_cas:issn">2373-8227</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">MMV007564 is a novel antimalarial benzimidazolyl piperidine chemotype identified in cellular screens.  To identify the genetic determinant of MMV007564 resistance, parasites were cultured in the presence of the compd. to generate resistant lines.  Whole genome sequencing revealed distinct mutations in the gene named Plasmodium falciparum cyclic amine resistance locus (pfcarl), encoding a conserved protein of unknown function.  Mutations in pfcarl are strongly assocd. with resistance to a structurally unrelated class of compds., the imidazolopiperazines, including KAF156, currently in clin. trials.  Our data demonstrate that pfcarl mutations confer resistance to two distinct compd. classes, benzimidazolyl piperidines and imidazolopiperazines.  However, MMV007564 and the imidazolopiperazines, KAF156 and GNF179, have different timings of action in the asexual blood stage and different potencies against the liver and sexual blood stages.  These data suggest that pfcarl is a multidrug-resistance gene rather than a common target for benzimidazolyl piperidines and imidazolopiperazines.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpO2hqloBBVgbVg90H21EOLACvtfcHk0lgkimmvCUMsvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XkvFCrsLo%253D&md5=099493350b8b85ee6363c844f9f325cf</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1021%2Facsinfecdis.6b00025&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsinfecdis.6b00025%26sid%3Dliteratum%253Aachs%26aulast%3DMagistrado%26aufirst%3DP.%2BA.%26aulast%3DCorey%26aufirst%3DV.%2BC.%26aulast%3DLukens%26aufirst%3DA.%2BK.%26aulast%3DLamonte%26aufirst%3DG.%26aulast%3DSasaki%26aufirst%3DE.%26aulast%3DMeister%26aufirst%3DS.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DWinzeler%26aufirst%3DE.%26aulast%3DWirth%26aufirst%3DD.%2BF.%26atitle%3DPlasmodium%2520falciparum%2520Cyclic%2520Amine%2520Resistance%2520Locus%2520%2528PfCARL%2529%252C%2520a%2520Resistance%2520Mechanism%2520for%2520Two%2520Distinct%2520Compound%2520Classes%26jtitle%3DACS%2520Infect.%2520Dis.%26date%3D2016%26volume%3D2%26spage%3D816%26epage%3D826%26doi%3D10.1021%2Facsinfecdis.6b00025" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamonte, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, M. Y. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wree, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reimer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nachon, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corey, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gedeck, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Figueroa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeung, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bifani, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Mutations in the <i>Plasmodium falciparum</i> Cyclic Amine Resistance Locus (PfCARL) Confer Multidrug Resistance</span>. <i>mBio</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>, <span class="NLM_elocation-id">e00696-16</span> <span class="refDoi"> DOI: 10.1128/mBio.00696-16</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1128%2FmBio.00696-16" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=27381290" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&author=G.+Lamonteauthor=M.+Y.+X.+Limauthor=M.+Wreeauthor=C.+Reimerauthor=M.+Nachonauthor=V.+Coreyauthor=P.+Gedeckauthor=D.+Plouffeauthor=A.+Duauthor=N.+Figueroaauthor=B.+Yeungauthor=P.+Bifaniauthor=E.+A.+Winzeler&title=Mutations+in+the+Plasmodium+falciparum+Cyclic+Amine+Resistance+Locus+%28PfCARL%29+Confer+Multidrug+Resistance&doi=10.1128%2FmBio.00696-16"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1128%2FmBio.00696-16&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FmBio.00696-16%26sid%3Dliteratum%253Aachs%26aulast%3DLamonte%26aufirst%3DG.%26aulast%3DLim%26aufirst%3DM.%2BY.%2BX.%26aulast%3DWree%26aufirst%3DM.%26aulast%3DReimer%26aufirst%3DC.%26aulast%3DNachon%26aufirst%3DM.%26aulast%3DCorey%26aufirst%3DV.%26aulast%3DGedeck%26aufirst%3DP.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DDu%26aufirst%3DA.%26aulast%3DFigueroa%26aufirst%3DN.%26aulast%3DYeung%26aufirst%3DB.%26aulast%3DBifani%26aufirst%3DP.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DMutations%2520in%2520the%2520Plasmodium%2520falciparum%2520Cyclic%2520Amine%2520Resistance%2520Locus%2520%2528PfCARL%2529%2520Confer%2520Multidrug%2520Resistance%26jtitle%3DmBio%26date%3D2016%26volume%3D7%26doi%3D10.1128%2FmBio.00696-16" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Otto, T. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberstaller, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adapa, S. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udenze, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bronner, I. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassandra, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mayho, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swanson, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rayner, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, R. H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J. H.</span></span> <span> </span><span class="NLM_article-title">Uncovering the Essential Genome of the Human Malaria Parasite <i>Plasmodium falciparum</i> by Saturation Mutagenesis Min</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>360</i></span>, <span class="NLM_elocation-id">eaap7847</span> <span class="refDoi"> DOI: 10.1126/science.aap7847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1126%2Fscience.aap7847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=29724925" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=360&publication_year=2018&author=M.+Zhangauthor=C.+Wangauthor=T.+D.+Ottoauthor=J.+Oberstallerauthor=X.+Liaoauthor=S.+R.+Adapaauthor=K.+Udenzeauthor=I.+F.+Bronnerauthor=D.+Cassandraauthor=M.+Mayhoauthor=J.+Brownauthor=S.+Liauthor=J.+Swansonauthor=J.+C.+Raynerauthor=R.+H.+Y.+Jiangauthor=J.+H.+Adams&title=Uncovering+the+Essential+Genome+of+the+Human+Malaria+Parasite+Plasmodium+falciparum+by+Saturation+Mutagenesis+Min&doi=10.1126%2Fscience.aap7847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1126%2Fscience.aap7847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.aap7847%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DM.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DOtto%26aufirst%3DT.%2BD.%26aulast%3DOberstaller%26aufirst%3DJ.%26aulast%3DLiao%26aufirst%3DX.%26aulast%3DAdapa%26aufirst%3DS.%2BR.%26aulast%3DUdenze%26aufirst%3DK.%26aulast%3DBronner%26aufirst%3DI.%2BF.%26aulast%3DCassandra%26aufirst%3DD.%26aulast%3DMayho%26aufirst%3DM.%26aulast%3DBrown%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DSwanson%26aufirst%3DJ.%26aulast%3DRayner%26aufirst%3DJ.%2BC.%26aulast%3DJiang%26aufirst%3DR.%2BH.%2BY.%26aulast%3DAdams%26aufirst%3DJ.%2BH.%26atitle%3DUncovering%2520the%2520Essential%2520Genome%2520of%2520the%2520Human%2520Malaria%2520Parasite%2520Plasmodium%2520falciparum%2520by%2520Saturation%2520Mutagenesis%2520Min%26jtitle%3DScience%26date%3D2018%26volume%3D360%26doi%3D10.1126%2Fscience.aap7847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">LaMonte, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rocamora, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marapana, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gnädig, N. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ottilie, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luth, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Worgall, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldgof, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohunlal, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Santha Kumar, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thompson, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vigil, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zou, B. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheung, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowman, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span> <span> </span><span class="NLM_article-title">Pan-Active Imidazolopiperazine Antimalarials Target the <i>Plasmodium falciparum</i> Intracellular Secretory Pathway</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>11</i></span>, <span class="NLM_elocation-id">1780</span> <span class="refDoi"> DOI: 10.1038/s41467-020-15440-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fs41467-020-15440-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=32286267" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXntFOhsro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2020&author=G.+M.+LaMonteauthor=F.+Rocamoraauthor=D.+S.+Marapanaauthor=N.+F.+Gn%C3%A4digauthor=S.+Ottilieauthor=M.+R.+Luthauthor=T.+S.+Worgallauthor=G.+M.+Goldgofauthor=R.+Mohunlalauthor=T.+R.+Santha+Kumarauthor=J.+K.+Thompsonauthor=E.+Vigilauthor=J.+Yangauthor=D.+Hutsonauthor=T.+Johnsonauthor=J.+Huangauthor=R.+M.+Williamsauthor=B.+Y.+Zouauthor=A.+L.+Cheungauthor=P.+Kumarauthor=T.+J.+Eganauthor=M.+C.+S.+Leeauthor=D.+Siegelauthor=A.+F.+Cowmanauthor=D.+A.+Fidockauthor=E.+A.+Winzeler&title=Pan-Active+Imidazolopiperazine+Antimalarials+Target+the+Plasmodium+falciparum+Intracellular+Secretory+Pathway&doi=10.1038%2Fs41467-020-15440-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Pan-active imidazolopiperazine antimalarials target the Plasmodium falciparum intracellular secretory pathway</span></div><div class="casAuthors">LaMonte, Gregory M.; Rocamora, Frances; Marapana, Danushka S.; Gnadig, Nina F.; Ottilie, Sabine; Luth, Madeline R.; Worgall, Tilla S.; Goldgof, Gregory M.; Mohunlal, Roxanne; Santha Kumar, T. R.; Thompson, Jennifer K.; Vigil, Edgar; Yang, Jennifer; Hutson, Dylan; Johnson, Trevor; Huang, Jianbo; Williams, Roy M.; Zou, Bing Yu; Cheung, Andrea L.; Kumar, Prianka; Egan, Timothy J.; Lee, Marcus C. S.; Siegel, Dionicio; Cowman, Alan F.; Fidock, David A.; Winzeler, Elizabeth A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1780</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Abstr.: A promising new compd. class for treating human malaria is the imidazolopiperazines (IZP) class.  IZP compds. KAF156 (Ganaplacide) and GNF179 are effective against Plasmodium symptomatic asexual blood-stage infections, and are able to prevent transmission and block infection in animal models.  But despite the identification of resistance mechanisms in P. falciparum, the mode of action of IZPs remains unknown.  To investigate, we here combine in vitro evolution and genome anal. in Saccharomyces cerevisiae with mol., metabolomic, and chemogenomic methods in P. falciparum.  Our findings reveal that IZP-resistant S. cerevisiae clones carry mutations in genes involved in Endoplasmic Reticulum (ER)-based lipid homeostasis and autophagy.  In Plasmodium, IZPs inhibit protein trafficking, block the establishment of new permeation pathways, and cause ER expansion.  Our data highlight a mechanism for blocking parasite development that is distinct from those of std. compds. used to treat malaria, and demonstrate the potential of IZPs for studying ER-dependent protein processing.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr2lfZzjtPC7Vg90H21EOLACvtfcHk0lhtQRsL-wzGRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXntFOhsro%253D&md5=e88068fb9f585db8342036cea951ee30</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1038%2Fs41467-020-15440-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-020-15440-4%26sid%3Dliteratum%253Aachs%26aulast%3DLaMonte%26aufirst%3DG.%2BM.%26aulast%3DRocamora%26aufirst%3DF.%26aulast%3DMarapana%26aufirst%3DD.%2BS.%26aulast%3DGn%25C3%25A4dig%26aufirst%3DN.%2BF.%26aulast%3DOttilie%26aufirst%3DS.%26aulast%3DLuth%26aufirst%3DM.%2BR.%26aulast%3DWorgall%26aufirst%3DT.%2BS.%26aulast%3DGoldgof%26aufirst%3DG.%2BM.%26aulast%3DMohunlal%26aufirst%3DR.%26aulast%3DSantha%2BKumar%26aufirst%3DT.%2BR.%26aulast%3DThompson%26aufirst%3DJ.%2BK.%26aulast%3DVigil%26aufirst%3DE.%26aulast%3DYang%26aufirst%3DJ.%26aulast%3DHutson%26aufirst%3DD.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DHuang%26aufirst%3DJ.%26aulast%3DWilliams%26aufirst%3DR.%2BM.%26aulast%3DZou%26aufirst%3DB.%2BY.%26aulast%3DCheung%26aufirst%3DA.%2BL.%26aulast%3DKumar%26aufirst%3DP.%26aulast%3DEgan%26aufirst%3DT.%2BJ.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DCowman%26aufirst%3DA.%2BF.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26atitle%3DPan-Active%2520Imidazolopiperazine%2520Antimalarials%2520Target%2520the%2520Plasmodium%2520falciparum%2520Intracellular%2520Secretory%2520Pathway%26jtitle%3DNat.%2520Commun.%26date%3D2020%26volume%3D11%26doi%3D10.1038%2Fs41467-020-15440-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamoureux, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Artavia, G.</span></span> <span> </span><span class="NLM_article-title">Use of the Adamantane Structure in Medicinal Chemistry</span>. <i>Curr. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">2967</span>– <span class="NLM_lpage">2978</span>, <span class="refDoi"> DOI: 10.2174/092986710792065027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.2174%2F092986710792065027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=20858176" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtFaisr3I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2010&pages=2967-2978&author=G.+Lamoureuxauthor=G.+Artavia&title=Use+of+the+Adamantane+Structure+in+Medicinal+Chemistry&doi=10.2174%2F092986710792065027"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Use of the adamantane structure in medicinal chemistry</span></div><div class="casAuthors">Lamoureux, Guy; Artavia, Graciela</div><div class="citationInfo"><span class="NLM_cas:title">Current Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">26</span>),
    <span class="NLM_cas:pages">2967-2978</span>CODEN:
                <span class="NLM_cas:coden">CMCHE7</span>;
        ISSN:<span class="NLM_cas:issn">0929-8673</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  This review summarizes the importance and recent discoveries of the use of adamantane derivs. in Medicinal Chem.  We have organized the article in 4 sections: 1) Absorption, Distribution, Metab., or Excretion (ADME) properties 2) Hydrophobic Effects 3) Ion Channels and 4) Rigid scaffold.  Within each section, we have provided examples of how the adamantane group changes the properties of known drugs or provides a important pharmacophore for the design of new drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTyZGBx6L4NrVg90H21EOLACvtfcHk0lhtQRsL-wzGRw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtFaisr3I&md5=2515e125ab451790105ced1d354d8369</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.2174%2F092986710792065027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F092986710792065027%26sid%3Dliteratum%253Aachs%26aulast%3DLamoureux%26aufirst%3DG.%26aulast%3DArtavia%26aufirst%3DG.%26atitle%3DUse%2520of%2520the%2520Adamantane%2520Structure%2520in%2520Medicinal%2520Chemistry%26jtitle%3DCurr.%2520Med.%2520Chem.%26date%3D2010%26volume%3D17%26spage%3D2967%26epage%3D2978%26doi%3D10.2174%2F092986710792065027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Stepan, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Subramanyam, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Efremov, I. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dutra, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Sullivan, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirico, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Won, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dorff, P. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Becker, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pustilnik, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riddell, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauffman, G. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kormos, B. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capetta, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sibley, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Atchison, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallgren, A. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oborski, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robshaw, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sneed, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’Donnell, C. J.</span></span> <span> </span><span class="NLM_article-title">Application of the Bicyclo[1.1.1]Pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3414</span>– <span class="NLM_lpage">3424</span>, <span class="refDoi"> DOI: 10.1021/jm300094u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300094u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC38XktVyntLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=3414-3424&author=A.+F.+Stepanauthor=C.+Subramanyamauthor=I.+V.+Efremovauthor=J.+K.+Dutraauthor=T.+J.+O%E2%80%99Sullivanauthor=K.+J.+Diricoauthor=W.+S.+McDonaldauthor=A.+Wonauthor=P.+H.+Dorffauthor=C.+E.+Nolanauthor=S.+L.+Beckerauthor=L.+R.+Pustilnikauthor=D.+R.+Riddellauthor=G.+W.+Kauffmanauthor=B.+L.+Kormosauthor=L.+Zhangauthor=Y.+Luauthor=S.+H.+Capettaauthor=M.+E.+Greenauthor=K.+Karkiauthor=E.+Sibleyauthor=K.+P.+Atchisonauthor=A.+J.+Hallgrenauthor=C.+E.+Oborskiauthor=A.+E.+Robshawauthor=B.+Sneedauthor=C.+J.+O%E2%80%99Donnell&title=Application+of+the+Bicyclo%5B1.1.1%5DPentane+Motif+as+a+Nonclassical+Phenyl+Ring+Bioisostere+in+the+Design+of+a+Potent+and+Orally+Active+%CE%B3-Secretase+Inhibitor&doi=10.1021%2Fjm300094u"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Application of the Bicyclo[1.1.1]pentane Motif as a Nonclassical Phenyl Ring Bioisostere in the Design of a Potent and Orally Active γ-Secretase Inhibitor</span></div><div class="casAuthors">Stepan, Antonia F.; Subramanyam, Chakrapani; Efremov, Ivan V.; Dutra, Jason K.; O'Sullivan, Theresa J.; DiRico, Kenneth J.; McDonald, W. Scott; Won, Annie; Dorff, Peter H.; Nolan, Charles E.; Becker, Stacey L.; Pustilnik, Leslie R.; Riddell, David R.; Kauffman, Gregory W.; Kormos, Bethany L.; Zhang, Liming; Lu, Yasong; Capetta, Steven H.; Green, Michael E.; Karki, Kapil; Sibley, Evelyn; Atchison, Kevin P.; Hallgren, Andrew J.; Oborski, Christine E.; Robshaw, Ashley E.; Sneed, Blossom; O'Donnell, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3414-3424</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Replacement of the central, para-substituted fluorophenyl ring in the γ-secretase inhibitor BMS-708,163 with the bicyclo[1.1.1]pentane motif led to the discovery of compd. (I), an equipotent enzyme inhibitor with significant improvements in passive permeability and aq. soly.  The modified biopharmaceutical properties of I translated into excellent oral absorption characteristics (∼4-fold ↑ Cmax and AUC values relative to BMS-708,163) in a mouse model of γ-secretase inhibition.  In addn., SAR studies into other fluorophenyl replacements indicate the intrinsic advantages of the bicyclo[1.1.1]pentane moiety over conventional Ph ring replacements with respect to achieving an optimal balance of properties (e.g., γ-secretase inhibition, aq. soly./permeability, in vitro metabolic stability).  Overall, this work enhances the scope of the [1.1.1]-bicycle beyond that of a mere "spacer" unit and presents a compelling case for its broader application as a Ph group replacement in scenarios where the arom. ring count impacts physicochem. parameters and overall drug-likeness.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoYTrCHjtRbgbVg90H21EOLACvtfcHk0lgclkrkcwl5vQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XktVyntLo%253D&md5=4bbcac4eb20d974696833df5f86f9c34</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm300094u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300094u%26sid%3Dliteratum%253Aachs%26aulast%3DStepan%26aufirst%3DA.%2BF.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DEfremov%26aufirst%3DI.%2BV.%26aulast%3DDutra%26aufirst%3DJ.%2BK.%26aulast%3DO%25E2%2580%2599Sullivan%26aufirst%3DT.%2BJ.%26aulast%3DDirico%26aufirst%3DK.%2BJ.%26aulast%3DMcDonald%26aufirst%3DW.%2BS.%26aulast%3DWon%26aufirst%3DA.%26aulast%3DDorff%26aufirst%3DP.%2BH.%26aulast%3DNolan%26aufirst%3DC.%2BE.%26aulast%3DBecker%26aufirst%3DS.%2BL.%26aulast%3DPustilnik%26aufirst%3DL.%2BR.%26aulast%3DRiddell%26aufirst%3DD.%2BR.%26aulast%3DKauffman%26aufirst%3DG.%2BW.%26aulast%3DKormos%26aufirst%3DB.%2BL.%26aulast%3DZhang%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DY.%26aulast%3DCapetta%26aufirst%3DS.%2BH.%26aulast%3DGreen%26aufirst%3DM.%2BE.%26aulast%3DKarki%26aufirst%3DK.%26aulast%3DSibley%26aufirst%3DE.%26aulast%3DAtchison%26aufirst%3DK.%2BP.%26aulast%3DHallgren%26aufirst%3DA.%2BJ.%26aulast%3DOborski%26aufirst%3DC.%2BE.%26aulast%3DRobshaw%26aufirst%3DA.%2BE.%26aulast%3DSneed%26aufirst%3DB.%26aulast%3DO%25E2%2580%2599Donnell%26aufirst%3DC.%2BJ.%26atitle%3DApplication%2520of%2520the%2520Bicyclo%255B1.1.1%255DPentane%2520Motif%2520as%2520a%2520Nonclassical%2520Phenyl%2520Ring%2520Bioisostere%2520in%2520the%2520Design%2520of%2520a%2520Potent%2520and%2520Orally%2520Active%2520%25CE%25B3-Secretase%2520Inhibitor%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D3414%26epage%3D3424%26doi%3D10.1021%2Fjm300094u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Measom, N. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Down, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirst, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jamieson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manas, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, V. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Somers, D. O.</span></span> <span> </span><span class="NLM_article-title">Investigation of a Bicyclo[1.1.1]Pentane as a Phenyl Replacement within an LpPLA2 Inhibitor</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">43</span>– <span class="NLM_lpage">48</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.6b00281</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.6b00281" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28XhvVCqtbjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=43-48&author=N.+D.+Measomauthor=K.+D.+Downauthor=D.+J.+Hirstauthor=C.+Jamiesonauthor=E.+S.+Manasauthor=V.+K.+Patelauthor=D.+O.+Somers&title=Investigation+of+a+Bicyclo%5B1.1.1%5DPentane+as+a+Phenyl+Replacement+within+an+LpPLA2+Inhibitor&doi=10.1021%2Facsmedchemlett.6b00281"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor</span></div><div class="casAuthors">Measom, Nicholas D.; Down, Kenneth D.; Hirst, David J.; Jamieson, Craig; Manas, Eric S.; Patel, Vipulkumar K.; Somers, Don O.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">43-48</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The authors describe the incorporation of a bicyclo[1.1.1]pentane moiety within two known LpPLA2 inhibitors to act as bioisosteric Ph replacements.  An efficient synthesis to the target compds. was enabled with a dichlorocarbene insertion into a bicyclo[1.1.0]butane system being the key transformation.  Potency, physicochem., and x-ray crystallog. data were obtained to compare the known inhibitors to their bioisosteric counterparts, which showed the isostere was well tolerated and pos. impacted on the physicochem. profile.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGouQjyZ5QbhWbVg90H21EOLACvtfcHk0lg0W5wWWYgxlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhvVCqtbjK&md5=5d8edc57e03090b6680bd819fc5ed67a</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.6b00281&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.6b00281%26sid%3Dliteratum%253Aachs%26aulast%3DMeasom%26aufirst%3DN.%2BD.%26aulast%3DDown%26aufirst%3DK.%2BD.%26aulast%3DHirst%26aufirst%3DD.%2BJ.%26aulast%3DJamieson%26aufirst%3DC.%26aulast%3DManas%26aufirst%3DE.%2BS.%26aulast%3DPatel%26aufirst%3DV.%2BK.%26aulast%3DSomers%26aufirst%3DD.%2BO.%26atitle%3DInvestigation%2520of%2520a%2520Bicyclo%255B1.1.1%255DPentane%2520as%2520a%2520Phenyl%2520Replacement%2520within%2520an%2520LpPLA2%2520Inhibitor%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2017%26volume%3D8%26spage%3D43%26epage%3D48%26doi%3D10.1021%2Facsmedchemlett.6b00281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tse, E. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Houston, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, C. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Savage, G. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rendina, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hallyburton, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, G. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Obach, R. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Todd, M. H.</span></span> <span> </span><span class="NLM_article-title">Nonclassical Phenyl Bioisosteres as Effective Replacements in a Series of Novel Open-Source Antimalarials</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">11585</span>– <span class="NLM_lpage">11601</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.0c00746</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.0c00746" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhsVWiu7zJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=11585-11601&author=E.+G.+Tseauthor=S.+D.+Houstonauthor=C.+M.+Williamsauthor=G.+P.+Savageauthor=L.+M.+Rendinaauthor=I.+Hallyburtonauthor=M.+Andersonauthor=R.+Sharmaauthor=G.+S.+Walkerauthor=R.+S.+Obachauthor=M.+H.+Todd&title=Nonclassical+Phenyl+Bioisosteres+as+Effective+Replacements+in+a+Series+of+Novel+Open-Source+Antimalarials&doi=10.1021%2Facs.jmedchem.0c00746"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Nonclassical Phenyl Bioisosteres as Effective Replacements in a Series of Novel Open-Source Antimalarials</span></div><div class="casAuthors">Tse, Edwin G.; Houston, Sevan D.; Williams, Craig M.; Savage, G. Paul; Rendina, Louis M.; Hallyburton, Irene; Anderson, Mark; Sharma, Raman; Walker, Gregory S.; Obach, R. Scott; Todd, Matthew H.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">11585-11601</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The replacement of one chem. motif with another that is broadly similar is a common method in medicinal chem. to modulate the phys. and biol. properties of a mol. (i.e., bioisosterism).  In recent years, bioisosteres such as cubane and bicyclo[1.1.1]pentane (BCP) have been used as highly effective Ph mimics.  Herein, we show the successful incorporation of a range of Ph bioisosteres during the open-source optimization of an antimalarial series.  Cubane (19) and closo-carborane (23) analogs exhibited improved in vitro potency against Plasmodium falciparum compared to the parent Ph compd.; however, these changes resulted in a redn. in metabolic stability; unusually, enzyme-mediated oxidn. was found to take place on the cubane core.  A BCP analog (22) was found to be equipotent to its parent Ph compd. and showed significantly improved metabolic properties.  While these results demonstrate the utility of these atypical bioisosteres when used in a medicinal chem. program, the search to find a suitable bioisostere may well require the prepn. of many candidates, in our case, 32 compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUjGWeFZfQlLVg90H21EOLACvtfcHk0lg0W5wWWYgxlQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhsVWiu7zJ&md5=f369e96ecb6f1dc14e2d739ced836c78</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.0c00746&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.0c00746%26sid%3Dliteratum%253Aachs%26aulast%3DTse%26aufirst%3DE.%2BG.%26aulast%3DHouston%26aufirst%3DS.%2BD.%26aulast%3DWilliams%26aufirst%3DC.%2BM.%26aulast%3DSavage%26aufirst%3DG.%2BP.%26aulast%3DRendina%26aufirst%3DL.%2BM.%26aulast%3DHallyburton%26aufirst%3DI.%26aulast%3DAnderson%26aufirst%3DM.%26aulast%3DSharma%26aufirst%3DR.%26aulast%3DWalker%26aufirst%3DG.%2BS.%26aulast%3DObach%26aufirst%3DR.%2BS.%26aulast%3DTodd%26aufirst%3DM.%2BH.%26atitle%3DNonclassical%2520Phenyl%2520Bioisosteres%2520as%2520Effective%2520Replacements%2520in%2520a%2520Series%2520of%2520Novel%2520Open-Source%2520Antimalarials%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26spage%3D11585%26epage%3D11601%26doi%3D10.1021%2Facs.jmedchem.0c00746" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sinha, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chauhan, P. M. S.</span></span> <span> </span><span class="NLM_article-title">Syntheses of Novel Antimycobacterial Combinatorial Libraries of Structurally Diverse Substituted Pyrimidines by Three-Component Solid-Phase Reactions</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">667</span>– <span class="NLM_lpage">669</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(01)00829-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1016%2FS0960-894X%2801%2900829-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=11844696" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BD38XhtFKqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=667-669&author=A.+Kumarauthor=S.+Sinhaauthor=P.+M.+S.+Chauhan&title=Syntheses+of+Novel+Antimycobacterial+Combinatorial+Libraries+of+Structurally+Diverse+Substituted+Pyrimidines+by+Three-Component+Solid-Phase+Reactions&doi=10.1016%2FS0960-894X%2801%2900829-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Syntheses of novel antimycobacterial combinatorial libraries of structurally diverse substituted pyrimidines by three-component solid-phase reactions</span></div><div class="casAuthors">Kumar, Arun; Sinha, Sudhir; Chauhan, Prem M. S.</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">667-669</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">A new pyrimidine based scaffold has been developed by three-component solid-phase syntheses.  The utility of scaffolds was demonstrated by synthesizing libraries of 80 substituted pyrimidines.  Among 80 compds. screened, six compds. showed in vitro activity against Mycobacterium tuberculosis(MABA) at a concn. of 50 and 25 μg/mL.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpyg6_HbXxcC7Vg90H21EOLACvtfcHk0lgurecpj4lLJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XhtFKqtbw%253D&md5=c0e341c244ea576630f82525260bca0d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2801%2900829-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252801%252900829-0%26sid%3Dliteratum%253Aachs%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DSinha%26aufirst%3DS.%26aulast%3DChauhan%26aufirst%3DP.%2BM.%2BS.%26atitle%3DSyntheses%2520of%2520Novel%2520Antimycobacterial%2520Combinatorial%2520Libraries%2520of%2520Structurally%2520Diverse%2520Substituted%2520Pyrimidines%2520by%2520Three-Component%2520Solid-Phase%2520Reactions%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26spage%3D667%26epage%3D669%26doi%3D10.1016%2FS0960-894X%2801%2900829-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zafrani, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeffet, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sod-Moriah, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berliner, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amir, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marciano, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gershonov, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saphier, S.</span></span> <span> </span><span class="NLM_article-title">Difluoromethyl Bioisostere: Examining the “Lipophilic Hydrogen Bond Donor” Concept</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">797</span>– <span class="NLM_lpage">804</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.6b01691</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.6b01691" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2sXis12jtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2017&pages=797-804&author=Y.+Zafraniauthor=D.+Yeffetauthor=G.+Sod-Moriahauthor=A.+Berlinerauthor=D.+Amirauthor=D.+Marcianoauthor=E.+Gershonovauthor=S.+Saphier&title=Difluoromethyl+Bioisostere%3A+Examining+the+%E2%80%9CLipophilic+Hydrogen+Bond+Donor%E2%80%9D+Concept&doi=10.1021%2Facs.jmedchem.6b01691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Difluoromethyl Bioisostere: Examining the "Lipophilic Hydrogen Bond Donor" Concept</span></div><div class="casAuthors">Zafrani, Yossi; Yeffet, Dina; Sod-Moriah, Gali; Berliner, Anat; Amir, Dafna; Marciano, Daniele; Gershonov, Eytan; Saphier, Sigal</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">60</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">797-804</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a growing interest in org. compds. contg. the difluoromethyl group, as it is considered a lipophilic hydrogen bond donor that may act as a bioisostere of hydroxyl, thiol, or amine groups.  A series of difluoromethyl anisoles and thioanisoles was prepd. and their drug-like properties, hydrogen bonding, and lipophilicity were studied.  The hydrogen bond acidity parameters A (0.085-0.126) were detd. using Abraham's solute 1H NMR anal.  The difluoromethyl group acts as a hydrogen bond donor on a scale similar to that of thiophenol, aniline, and amine groups but not as that of hydroxyl.  Although difluoromethyl is considered a lipophilicity enhancing group, the range of the exptl. Δlog P(water-octanol) values (log P(XCF2H) - log P(XCH3)) spanned from -0.1 to +0.4.  For both parameters, a linear correlation was found between the measured values and Hammett σ consts.  These results may aid in the rational design of drugs contg. the difluoromethyl moiety.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrJEzcH0xPatbVg90H21EOLACvtfcHk0lgurecpj4lLJg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXis12jtw%253D%253D&md5=36159f57b99aa812693f32ff38e88406</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.6b01691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.6b01691%26sid%3Dliteratum%253Aachs%26aulast%3DZafrani%26aufirst%3DY.%26aulast%3DYeffet%26aufirst%3DD.%26aulast%3DSod-Moriah%26aufirst%3DG.%26aulast%3DBerliner%26aufirst%3DA.%26aulast%3DAmir%26aufirst%3DD.%26aulast%3DMarciano%26aufirst%3DD.%26aulast%3DGershonov%26aufirst%3DE.%26aulast%3DSaphier%26aufirst%3DS.%26atitle%3DDifluoromethyl%2520Bioisostere%253A%2520Examining%2520the%2520%25E2%2580%259CLipophilic%2520Hydrogen%2520Bond%2520Donor%25E2%2580%259D%2520Concept%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2017%26volume%3D60%26spage%3D797%26epage%3D804%26doi%3D10.1021%2Facs.jmedchem.6b01691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Paquet, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le Manach, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cabrera, D. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Younis, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrich, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abraham, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basak, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ghidelli-Disse, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lafuente-Monasterio, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bantscheff, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruecker, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blagborough, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zakutansky, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeeman, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mannila, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scheurer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angulo-Barturen, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martínez, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ferrer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanz, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamo, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reader, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Botha, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dechering, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vanachayangkul, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witty, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marsh, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bodenreider, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rochford, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Solapure, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiménez-Díaz, M. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittlin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Donini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campo, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Birkholtz, L.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, K. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Drewes, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kocken, C. H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Delves, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leroy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waterson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Street, L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chibale, K.</span></span> <span> </span><span class="NLM_article-title">Antimalarial Efficacy of MMV390048, an Inhibitor of Plasmodium Phosphatidylinositol 4-Kinase</span>. <i>Sci. Transl. Med.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>9</i></span>, <span class="NLM_elocation-id">eaad9735</span> <span class="refDoi"> DOI: 10.1126/scitranslmed.aad9735</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1126%2Fscitranslmed.aad9735" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=28446690" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2017&author=T.+Paquetauthor=C.+Le+Manachauthor=D.+G.+Cabreraauthor=Y.+Younisauthor=P.+P.+Henrichauthor=T.+S.+Abrahamauthor=M.+C.+S.+Leeauthor=R.+Basakauthor=S.+Ghidelli-Disseauthor=M.+J.+Lafuente-Monasterioauthor=M.+Bantscheffauthor=A.+Rueckerauthor=A.+M.+Blagboroughauthor=S.+E.+Zakutanskyauthor=A.-M.+Zeemanauthor=K.+L.+Whiteauthor=D.+M.+Shacklefordauthor=J.+Mannilaauthor=J.+Morizziauthor=C.+Scheurerauthor=I.+Angulo-Barturenauthor=M.+S.+Mart%C3%ADnezauthor=S.+Ferrerauthor=L.+M.+Sanzauthor=F.+J.+Gamoauthor=J.+Readerauthor=M.+Bothaauthor=K.+J.+Decheringauthor=R.+W.+Sauerweinauthor=A.+Tungtaengauthor=P.+Vanachayangkulauthor=C.+S.+Limauthor=J.+Burrowsauthor=M.+J.+Wittyauthor=K.+C.+Marshauthor=C.+Bodenreiderauthor=R.+Rochfordauthor=S.+M.+Solapureauthor=M.+B.+Jim%C3%A9nez-D%C3%ADazauthor=S.+Wittlinauthor=S.+A.+Charmanauthor=C.+Doniniauthor=B.+Campoauthor=L.-M.+Birkholtzauthor=K.+K.+Hansonauthor=G.+Drewesauthor=C.+H.+M.+Kockenauthor=M.+J.+Delvesauthor=D.+Leroyauthor=D.+A.+Fidockauthor=D.+Watersonauthor=L.+J.+Streetauthor=K.+Chibale&title=Antimalarial+Efficacy+of+MMV390048%2C+an+Inhibitor+of+Plasmodium+Phosphatidylinositol+4-Kinase&doi=10.1126%2Fscitranslmed.aad9735"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1126%2Fscitranslmed.aad9735&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscitranslmed.aad9735%26sid%3Dliteratum%253Aachs%26aulast%3DPaquet%26aufirst%3DT.%26aulast%3DLe%2BManach%26aufirst%3DC.%26aulast%3DCabrera%26aufirst%3DD.%2BG.%26aulast%3DYounis%26aufirst%3DY.%26aulast%3DHenrich%26aufirst%3DP.%2BP.%26aulast%3DAbraham%26aufirst%3DT.%2BS.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DBasak%26aufirst%3DR.%26aulast%3DGhidelli-Disse%26aufirst%3DS.%26aulast%3DLafuente-Monasterio%26aufirst%3DM.%2BJ.%26aulast%3DBantscheff%26aufirst%3DM.%26aulast%3DRuecker%26aufirst%3DA.%26aulast%3DBlagborough%26aufirst%3DA.%2BM.%26aulast%3DZakutansky%26aufirst%3DS.%2BE.%26aulast%3DZeeman%26aufirst%3DA.-M.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DMannila%26aufirst%3DJ.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DScheurer%26aufirst%3DC.%26aulast%3DAngulo-Barturen%26aufirst%3DI.%26aulast%3DMart%25C3%25ADnez%26aufirst%3DM.%2BS.%26aulast%3DFerrer%26aufirst%3DS.%26aulast%3DSanz%26aufirst%3DL.%2BM.%26aulast%3DGamo%26aufirst%3DF.%2BJ.%26aulast%3DReader%26aufirst%3DJ.%26aulast%3DBotha%26aufirst%3DM.%26aulast%3DDechering%26aufirst%3DK.%2BJ.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DVanachayangkul%26aufirst%3DP.%26aulast%3DLim%26aufirst%3DC.%2BS.%26aulast%3DBurrows%26aufirst%3DJ.%26aulast%3DWitty%26aufirst%3DM.%2BJ.%26aulast%3DMarsh%26aufirst%3DK.%2BC.%26aulast%3DBodenreider%26aufirst%3DC.%26aulast%3DRochford%26aufirst%3DR.%26aulast%3DSolapure%26aufirst%3DS.%2BM.%26aulast%3DJim%25C3%25A9nez-D%25C3%25ADaz%26aufirst%3DM.%2BB.%26aulast%3DWittlin%26aufirst%3DS.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonini%26aufirst%3DC.%26aulast%3DCampo%26aufirst%3DB.%26aulast%3DBirkholtz%26aufirst%3DL.-M.%26aulast%3DHanson%26aufirst%3DK.%2BK.%26aulast%3DDrewes%26aufirst%3DG.%26aulast%3DKocken%26aufirst%3DC.%2BH.%2BM.%26aulast%3DDelves%26aufirst%3DM.%2BJ.%26aulast%3DLeroy%26aufirst%3DD.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DWaterson%26aufirst%3DD.%26aulast%3DStreet%26aufirst%3DL.%2BJ.%26aulast%3DChibale%26aufirst%3DK.%26atitle%3DAntimalarial%2520Efficacy%2520of%2520MMV390048%252C%2520an%2520Inhibitor%2520of%2520Plasmodium%2520Phosphatidylinositol%25204-Kinase%26jtitle%3DSci.%2520Transl.%2520Med.%26date%3D2017%26volume%3D9%26doi%3D10.1126%2Fscitranslmed.aad9735" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buenviaje, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, M. C. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fidock, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graumans, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van De Vegte-Bolmer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Gemert, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wirjanata, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebayang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marfurt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suwanarusk, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Price, R. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nosten, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tungtaeng, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gettayacamin, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sattabongkot, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taylor, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walker, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, K. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannery, E. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vinetz, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Renia, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sauerwein, R. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span> <span> </span><span class="NLM_article-title">KAF156 Is an Antimalarial Clinical Candidate with Potential for Use in Prophylaxis, Treatment, and Prevention of Disease Transmission</span>. <i>Antimicrob. Agents Chemother.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">5060</span>– <span class="NLM_lpage">5067</span>, <span class="refDoi"> DOI: 10.1128/AAC.02727-13</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1128%2FAAC.02727-13" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=24913172" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2014&pages=5060-5067&author=K.+L.+Kuhenauthor=A.+K.+Chatterjeeauthor=M.+Rottmannauthor=K.+Gagaringauthor=R.+Borboaauthor=J.+Buenviajeauthor=Z.+Chenauthor=C.+Francekauthor=T.+Wuauthor=A.+Nagleauthor=S.+W.+Barnesauthor=D.+Plouffeauthor=M.+C.+S.+Leeauthor=D.+A.+Fidockauthor=W.+Graumansauthor=M.+Van+De+Vegte-Bolmerauthor=G.+J.+Van+Gemertauthor=G.+Wirjanataauthor=B.+Sebayangauthor=J.+Marfurtauthor=B.+Russellauthor=R.+Suwanaruskauthor=R.+N.+Priceauthor=F.+Nostenauthor=A.+Tungtaengauthor=M.+Gettayacaminauthor=J.+Sattabongkotauthor=J.+Taylorauthor=J.+R.+Walkerauthor=D.+Tullyauthor=K.+P.+Patraauthor=E.+L.+Flanneryauthor=J.+M.+Vinetzauthor=L.+Reniaauthor=R.+W.+Sauerweinauthor=E.+A.+Winzelerauthor=R.+J.+Glynneauthor=T.+T.+Diagana&title=KAF156+Is+an+Antimalarial+Clinical+Candidate+with+Potential+for+Use+in+Prophylaxis%2C+Treatment%2C+and+Prevention+of+Disease+Transmission&doi=10.1128%2FAAC.02727-13"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">KAf156 is an antimalarial clinical candidate with potential for use in prophylaxis, treatment, and prevention of disease transmission</span></div><div class="casAuthors">Kuhen, Kelli L.; Chatterjee, Arnab K.; Rottmann, Matthias; Gagaring, Kerstin; Borboa, Rachel; Buenviaje, Jennifer; Chen, Zhong; Francek, Carolyn; Wu, Tao; Nagle, Advait; Barnes, S. Whitney; Plouffe, David; Lee, Marcus C. S.; Fidock, David A.; Graumans, Wouter; van de Vegte-Bolmer, Marga; van Gemert, Geert J.; Wirjanata, Grennady; Sebayang, Boni; Marfurt, Jutta; Russell, Bruce; Suwanarusk, Rossarin; Price, Ric N.; Nosten, Francois; Tungtaeng, Anchalee; Gettayacamin, Montip; Sattabongkot, Jetsumon; Taylor, Jennifer; Walker, John R.; Tully, David; Patra, Kailash P.; Flannery, Erika L.; Vinetz, Joseph M.; Renia, Laurent; Sauerwein, Robert W.; Winzeler, Elizabeth A.; Glynne, Richard J.; Diagana, Thierry T.</div><div class="citationInfo"><span class="NLM_cas:title">Antimicrobial Agents and Chemotherapy</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">58</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">5060-5067, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">AMACCQ</span>;
        ISSN:<span class="NLM_cas:issn">1098-6596</span>.
    
            (<span class="NLM_cas:orgname">American Society for Microbiology</span>)
        </div><div class="casAbstract">Renewed global efforts toward malaria eradication have highlighted the need for novel antimalarial agents with activity against multiple stages of the parasite life cycle.  We have previously reported the discovery of a novel class of antimalarial compds. in the imidazolopiperazine series that have activity in the prevention and treatment of blood stage infection in a mouse model of malaria.  Consistent with the previously reported activity profile of this series, the clin. candidate KAF156 shows blood schizonticidal activity with 50% inhibitory concns. of 6 to 17.4 nM against P. falciparum drug-sensitive and drug-resistant strains, as well as potent therapeutic activity in a mouse models of malaria with 50, 90, and 99 % EDs of 0.6, 0.9, and 1.4 mg/kg, resp.  When administered prophylactically in a sporozoite challenge mouse model, KAF156 is completely protective as a single oral dose of 10 mg/kg.  Finally, KAF156 displays potent Plasmodium transmission blocking activities both in vitro and in vivo.  Collectively, our data suggest that KAF156, currently under evaluation in clin. trials, has the potential to treat, prevent, and block the transmission of malaria.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4QluxrWtdq7Vg90H21EOLACvtfcHk0lj6cQcTdfffVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhs1eqs7fK&md5=c97e07e4832e871885546880084be5ca</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1128%2FAAC.02727-13&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1128%252FAAC.02727-13%26sid%3Dliteratum%253Aachs%26aulast%3DKuhen%26aufirst%3DK.%2BL.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DBuenviaje%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DBarnes%26aufirst%3DS.%2BW.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLee%26aufirst%3DM.%2BC.%2BS.%26aulast%3DFidock%26aufirst%3DD.%2BA.%26aulast%3DGraumans%26aufirst%3DW.%26aulast%3DVan%2BDe%2BVegte-Bolmer%26aufirst%3DM.%26aulast%3DVan%2BGemert%26aufirst%3DG.%2BJ.%26aulast%3DWirjanata%26aufirst%3DG.%26aulast%3DSebayang%26aufirst%3DB.%26aulast%3DMarfurt%26aufirst%3DJ.%26aulast%3DRussell%26aufirst%3DB.%26aulast%3DSuwanarusk%26aufirst%3DR.%26aulast%3DPrice%26aufirst%3DR.%2BN.%26aulast%3DNosten%26aufirst%3DF.%26aulast%3DTungtaeng%26aufirst%3DA.%26aulast%3DGettayacamin%26aufirst%3DM.%26aulast%3DSattabongkot%26aufirst%3DJ.%26aulast%3DTaylor%26aufirst%3DJ.%26aulast%3DWalker%26aufirst%3DJ.%2BR.%26aulast%3DTully%26aufirst%3DD.%26aulast%3DPatra%26aufirst%3DK.%2BP.%26aulast%3DFlannery%26aufirst%3DE.%2BL.%26aulast%3DVinetz%26aufirst%3DJ.%2BM.%26aulast%3DRenia%26aufirst%3DL.%26aulast%3DSauerwein%26aufirst%3DR.%2BW.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%2BJ.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26atitle%3DKAF156%2520Is%2520an%2520Antimalarial%2520Clinical%2520Candidate%2520with%2520Potential%2520for%2520Use%2520in%2520Prophylaxis%252C%2520Treatment%252C%2520and%2520Prevention%2520of%2520Disease%2520Transmission%26jtitle%3DAntimicrob.%2520Agents%2520Chemother.%26date%3D2014%26volume%3D58%26spage%3D5060%26epage%3D5067%26doi%3D10.1128%2FAAC.02727-13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nagle, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kuhen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gagaring, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Borboa, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Plouffe, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Caldwell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ek, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skolnik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chang, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollenbeck, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuntland, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isbell, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chuan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischli, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brun, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakshminarayana, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rottmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diagana, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winzeler, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tully, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chatterjee, A. K.</span></span> <span> </span><span class="NLM_article-title">Imidazolopiperazines: Lead Optimization of the Second-Generation Antimalarial Agents</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">4244</span>– <span class="NLM_lpage">4273</span>, <span class="refDoi"> DOI: 10.1021/jm300041e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm300041e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4244-4273&author=A.+Nagleauthor=T.+Wuauthor=K.+Kuhenauthor=K.+Gagaringauthor=R.+Borboaauthor=C.+Francekauthor=Z.+Chenauthor=D.+Plouffeauthor=X.+Linauthor=C.+Caldwellauthor=J.+Ekauthor=S.+Skolnikauthor=F.+Liuauthor=J.+Wangauthor=J.+Changauthor=C.+Liauthor=B.+Liuauthor=T.+Hollenbeckauthor=T.+Tuntlandauthor=J.+Isbellauthor=T.+Chuanauthor=P.+B.+Alperauthor=C.+Fischliauthor=R.+Brunauthor=S.+B.+Lakshminarayanaauthor=M.+Rottmannauthor=T.+T.+Diaganaauthor=E.+A.+Winzelerauthor=R.+Glynneauthor=D.+C.+Tullyauthor=A.+K.+Chatterjee&title=Imidazolopiperazines%3A+Lead+Optimization+of+the+Second-Generation+Antimalarial+Agents&doi=10.1021%2Fjm300041e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Imidazolopiperazines: Lead optimization of the second-generation antimalarial agents</span></div><div class="casAuthors">Nagle, Advait; Wu, Tao; Kuhen, Kelli; Gagaring, Kerstin; Borboa, Rachel; Francek, Caroline; Chen, Zhong; Plouffe, David; Lin, Xuena; Caldwell, Christopher; Ek, Jared; Skolnik, Suzanne; Liu, Fenghua; Wang, Jianling; Chang, Jonathan; Li, Chun; Liu, Bo; Hollenbeck, Thomas; Tuntland, Tove; Isbell, John; Chuan, Tiffany; Alper, Philip B.; Fischli, Christoph; Brun, Reto; Lakshminarayana, Suresh B.; Rottmann, Matthias; Diagana, Thierry T.; Winzeler, Elizabeth A.; Glynne, Richard; Tully, David C.; Chatterjee, Arnab K.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4244-4273</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">On the basis of the initial success of optimization of a novel series of imidazolopiperazines, a second generation of compds. involving changes in the core piperazine ring was synthesized to improve antimalarial properties.  These changes were carried out to further improve the potency and metabolic stability of the compds. by leveraging the outcome of a set of in vitro metabolic identification studies.  The optimized 8,8-di-Me imidazolopiperazine analogs I(R = 4-F, 4-Me, 3,4-F2) and II(R = 4-Me, 3-Cl-4-F) III(R = Me, F) exhibited improved potency, in vitro metabolic stability profile and, as a result, enhanced oral exposure in vivo in mice.  The optimized compds. were found to be more efficacious than the current antimalarials in a malaria mouse model.  They exhibit moderate oral exposure in rat pharmacokinetic studies to achieve sufficient multiples of the oral exposure at the efficacious dose in toxicol. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonl3aXJKMqObVg90H21EOLACvtfcHk0lj6cQcTdfffVg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvV2kt7k%253D&md5=6c46f2f5ca76ae5a5089b542ec15e2ac</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1021%2Fjm300041e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300041e%26sid%3Dliteratum%253Aachs%26aulast%3DNagle%26aufirst%3DA.%26aulast%3DWu%26aufirst%3DT.%26aulast%3DKuhen%26aufirst%3DK.%26aulast%3DGagaring%26aufirst%3DK.%26aulast%3DBorboa%26aufirst%3DR.%26aulast%3DFrancek%26aufirst%3DC.%26aulast%3DChen%26aufirst%3DZ.%26aulast%3DPlouffe%26aufirst%3DD.%26aulast%3DLin%26aufirst%3DX.%26aulast%3DCaldwell%26aufirst%3DC.%26aulast%3DEk%26aufirst%3DJ.%26aulast%3DSkolnik%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DWang%26aufirst%3DJ.%26aulast%3DChang%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DB.%26aulast%3DHollenbeck%26aufirst%3DT.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DIsbell%26aufirst%3DJ.%26aulast%3DChuan%26aufirst%3DT.%26aulast%3DAlper%26aufirst%3DP.%2BB.%26aulast%3DFischli%26aufirst%3DC.%26aulast%3DBrun%26aufirst%3DR.%26aulast%3DLakshminarayana%26aufirst%3DS.%2BB.%26aulast%3DRottmann%26aufirst%3DM.%26aulast%3DDiagana%26aufirst%3DT.%2BT.%26aulast%3DWinzeler%26aufirst%3DE.%2BA.%26aulast%3DGlynne%26aufirst%3DR.%26aulast%3DTully%26aufirst%3DD.%2BC.%26aulast%3DChatterjee%26aufirst%3DA.%2BK.%26atitle%3DImidazolopiperazines%253A%2520Lead%2520Optimization%2520of%2520the%2520Second-Generation%2520Antimalarial%2520Agents%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4244%26epage%3D4273%26doi%3D10.1021%2Fjm300041e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Charman, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Andreu, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barker, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blundell, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiu, F. C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crighton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Katneni, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morizzi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pham, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shackleford, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">White, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Almond, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickins, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moehrle, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burrows, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abla, N.</span></span> <span> </span><span class="NLM_article-title">An i<i>n vitro</i> Toolbox to Accelerate Anti - Malarial Drug Discovery and Development</span>. <i>Malar. J.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>19</i></span>, <span class="NLM_elocation-id">1</span> <span class="refDoi"> DOI: 10.1186/s12936-019-3075-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1186%2Fs12936-019-3075-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=31898492" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2020&author=S.+A.+Charmanauthor=A.+Andreuauthor=H.+Barkerauthor=S.+Blundellauthor=A.+Campbellauthor=M.+Campbellauthor=G.+Chenauthor=F.+C.+K.+Chiuauthor=E.+Crightonauthor=K.+Katneniauthor=J.+Morizziauthor=R.+Patilauthor=T.+Phamauthor=E.+Ryanauthor=J.+Saundersauthor=D.+M.+Shacklefordauthor=K.+L.+Whiteauthor=L.+Almondauthor=M.+Dickinsauthor=D.+A.+Smithauthor=J.+J.+Moehrleauthor=J.+N.+Burrowsauthor=N.+Abla&title=An+in+vitro+Toolbox+to+Accelerate+Anti+-+Malarial+Drug+Discovery+and+Development&doi=10.1186%2Fs12936-019-3075-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">An in vitro toolbox to accelerate anti-malarial drug discovery and development</span></div><div class="casAuthors">Charman, Susan A.; Andreu, Alice; Barker, Helena; Blundell, Scott; Campbell, Anna; Campbell, Michael; Chen, Gong; Chiu, Francis C. K.; Crighton, Elly; Katneni, Kasiram; Morizzi, Julia; Patil, Rahul; Pham, Thao; Ryan, Eileen; Saunders, Jessica; Shackleford, David M.; White, Karen L.; Almond, Lisa; Dickins, Maurice; Smith, Dennis A.; Moehrle, Joerg J.; Burrows, Jeremy N.; Abla, Nada</div><div class="citationInfo"><span class="NLM_cas:title">Malaria Journal</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">1</span>CODEN:
                <span class="NLM_cas:coden">MJAOAZ</span>;
        ISSN:<span class="NLM_cas:issn">1475-2875</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Modeling and simulation are being increasingly utilized to support the discovery and development of new anti-malarial drugs.  These approaches require reliable in vitro data for physicochem. properties, permeability, binding, intrinsic clearance and cytochrome P 450 inhibition.  This work was conducted to generate an in vitro data toolbox using standardized methods for a set of 45 anti-malarial drugs and to assess changes in physicochem. properties in relation to changing target product and candidate profiles.  Methods: Ionization consts. were detd. by potentiometric titrn. and partition coeffs. were measured using a shake-flask method.  Soly. was assessed in biorelevant media and permeability coeffs. and efflux ratios were detd. using Caco-2 cell monolayers.  Binding to plasma and media proteins was measured using either ultracentrifugation or rapid equil. dialysis.  Metabolic stability and cytochrome P 450 inhibition were assessed using human liver microsomes.  Sample anal. was conducted by LC-MS/MS.  Results: Both soly. and fraction unbound decreased, and permeability and unbound intrinsic clearance increased, with increasing Log D7.4.  In general, development compds. were somewhat more lipophilic than legacy drugs.  For many compds., permeability and protein binding were challenging to assess and both required the use of exptl. conditions that minimized the impact of non-specific binding.  Intrinsic clearance in human liver microsomes was varied across the data set and several compds. exhibited no measurable substrate loss under the conditions used.  Inhibition of cytochrome P 450 enzymes was minimal for most compds.  Conclusions: This is the first data set to describe in vitro properties for 45 legacy and development anti-malarial drugs.  The studies identified several practical methodol. issues common to many of the more lipophilic compds. and highlighted areas which require more work to customize exptl. conditions for compds. being designed to meet the new target product profiles.  The dataset will be a valuable tool for malaria researchers aiming to develop PBPK models for the prediction of human PK properties and/or drug-drug interactions.  Furthermore, generation of this comprehensive data set within a single lab. allows direct comparison of properties across a large dataset and evaluation of changing property trends that have occurred over time with changing target product and candidate profiles.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrz-G7Yo6U877Vg90H21EOLACvtfcHk0lhgwwRZj-hUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXltlKisQ%253D%253D&md5=a996cd5a032c9042bc957d0bddecbd3b</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1186%2Fs12936-019-3075-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12936-019-3075-5%26sid%3Dliteratum%253Aachs%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DAndreu%26aufirst%3DA.%26aulast%3DBarker%26aufirst%3DH.%26aulast%3DBlundell%26aufirst%3DS.%26aulast%3DCampbell%26aufirst%3DA.%26aulast%3DCampbell%26aufirst%3DM.%26aulast%3DChen%26aufirst%3DG.%26aulast%3DChiu%26aufirst%3DF.%2BC.%2BK.%26aulast%3DCrighton%26aufirst%3DE.%26aulast%3DKatneni%26aufirst%3DK.%26aulast%3DMorizzi%26aufirst%3DJ.%26aulast%3DPatil%26aufirst%3DR.%26aulast%3DPham%26aufirst%3DT.%26aulast%3DRyan%26aufirst%3DE.%26aulast%3DSaunders%26aufirst%3DJ.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DWhite%26aufirst%3DK.%2BL.%26aulast%3DAlmond%26aufirst%3DL.%26aulast%3DDickins%26aufirst%3DM.%26aulast%3DSmith%26aufirst%3DD.%2BA.%26aulast%3DMoehrle%26aufirst%3DJ.%2BJ.%26aulast%3DBurrows%26aufirst%3DJ.%2BN.%26aulast%3DAbla%26aufirst%3DN.%26atitle%3DAn%2520in%2520vitro%2520Toolbox%2520to%2520Accelerate%2520Anti%2520-%2520Malarial%2520Drug%2520Discovery%2520and%2520Development%26jtitle%3DMalar.%2520J.%26date%3D2020%26volume%3D19%26doi%3D10.1186%2Fs12936-019-3075-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khine, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Su, X. Z.</span></span> <span> </span><span class="NLM_article-title">PfCRT and PfMDR1 Modulate Interactions of Artemisinin Derivatives and Ion Channel Blockers</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>6</i></span>, <span class="NLM_elocation-id">25379</span> <span class="refDoi"> DOI: 10.1038/srep25379</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=10.1038%2Fsrep25379" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=27147113" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BC28XnsVeltrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2016&author=R.+T.+Eastmanauthor=P.+Khineauthor=R.+Huangauthor=C.+J.+Thomasauthor=X.+Z.+Su&title=PfCRT+and+PfMDR1+Modulate+Interactions+of+Artemisinin+Derivatives+and+Ion+Channel+Blockers&doi=10.1038%2Fsrep25379"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">PfCRT and PfMDR1 modulate interactions of artemisinin derivatives and ion channel blockers</span></div><div class="casAuthors">Eastman, Richard T.; Khine, Pwint; Huang, Ruili; Thomas, Craig J.; Su, Xin-zhuan</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">25379</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Treatment of the symptomatic asexual stage of Plasmodium falciparum relies almost exclusively on artemisinin (ART) combination therapies (ACTs) in endemic regions.  ACTs combine ART or its deriv. with a long-acting partner drug to maximize efficacy during the typical three-day regimen.  Both lab. and clin. studies have previously demonstrated that the common drug resistance determinants P. falciparum chloroquine resistance transporter (PfCRT) and multidrug resistance transporter (PfMDR1) can modulate the susceptibility to many current antimalarial drugs and chem. compds.  Here we investigated the parasite responses to dihydroartemisinin (DHA) and various Ca2+ and Na+ channel blockers and showed pos. correlated responses between DHA and several channel blockers, suggesting potential shared transport pathways or mode of action.  Addnl., we demonstrated that PfCRT and PfMDR1 could also significantly modulate the pharmacodynamic interactions of the compds. and that the interactions were influenced by the parasite genetic backgrounds.  These results provide important information for better understanding of drug resistance and for assessing the overall impact of drug resistance markers on parasite response to ACTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrWn-9cZTLVRbVg90H21EOLACvtfcHk0lhgwwRZj-hUOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XnsVeltrs%253D&md5=b6cda0676f8281caf56185dc9d3d1fa2</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fsrep25379&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep25379%26sid%3Dliteratum%253Aachs%26aulast%3DEastman%26aufirst%3DR.%2BT.%26aulast%3DKhine%26aufirst%3DP.%26aulast%3DHuang%26aufirst%3DR.%26aulast%3DThomas%26aufirst%3DC.%2BJ.%26aulast%3DSu%26aufirst%3DX.%2BZ.%26atitle%3DPfCRT%2520and%2520PfMDR1%2520Modulate%2520Interactions%2520of%2520Artemisinin%2520Derivatives%2520and%2520Ion%2520Channel%2520Blockers%26jtitle%3DSci.%2520Rep.%26date%3D2016%26volume%3D6%26doi%3D10.1038%2Fsrep25379" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ansbro, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Itkin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zahoranszky-Kohalmi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amaratunga, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miotto, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peryea, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sá, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dondorp, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van der
Pluijm, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wellems, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simeonov, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eastman, R.</span></span> <span> </span><span class="NLM_article-title">Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by <i>Plasmodium falciparum</i> Genotype</span>. <i>ACS Pharmacol. Transl. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1144</span>– <span class="NLM_lpage">1157</span>, <span class="refDoi"> DOI: 10.1021/acsptsci.0c00110</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsptsci.0c00110" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;key=1%3ACAS%3A528%3ADC%252BB3cXit1SgtbjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2020&pages=1144-1157&author=M.+Ansbroauthor=Z.+Itkinauthor=L.+Chenauthor=G.+Zahoranszky-Kohalmiauthor=C.+Amaratungaauthor=O.+Miottoauthor=T.+Peryeaauthor=C.+Hobbsauthor=S.+Suonauthor=J.+S%C3%A1author=A.+Dondorpauthor=R.+van+der%0APluijmauthor=T.+Wellemsauthor=A.+Simeonovauthor=R.+Eastman&title=Modulation+of+Triple+Artemisinin-Based+Combination+Therapy+Pharmacodynamics+by+Plasmodium+falciparum+Genotype&doi=10.1021%2Facsptsci.0c00110"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Modulation of Triple Artemisinin-Based Combination Therapy Pharmacodynamics by Plasmodium falciparum Genotype</span></div><div class="casAuthors">Ansbro, Megan R.; Itkin, Zina; Chen, Lu; Zahoranszky-Kohalmi, Gergely; Amaratunga, Chanaki; Miotto, Olivo; Peryea, Tyler; Hobbs, Charlotte V.; Suon, Seila; Sa, Juliana M.; Dondorp, Arjen M.; van der Pluijm, Rob W.; Wellems, Thomas E.; Simeonov, Anton; Eastman, Richard T.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Pharmacology & Translational Science</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1144-1157</span>CODEN:
                <span class="NLM_cas:coden">APTSFN</span>;
        ISSN:<span class="NLM_cas:issn">2575-9108</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The first-line treatments for uncomplicated Plasmodium falciparum malaria are artemisinin-based combination therapies (ACTs), consisting of an artemisinin deriv. combined with a longer acting partner drug.  However, the spread of P. falciparum with decreased susceptibility to artemisinin and partner drugs presents a significant challenge to malaria control efforts.  To stem the spread of drug resistant parasites, novel chemotherapeutic strategies are being evaluated, including the implementation of triple artemisinin-based combination therapies (TACTs).  Currently, there is limited knowledge on the pharmacodynamic and pharmacogenetic interactions of proposed TACT drug combinations.  To evaluate these interactions, we established an in vitro high-throughput process for measuring the drug concn.-response to three distinct antimalarial drugs present in a TACT.  Sixteen different TACT combinations were screened against 15 parasite lines from Cambodia, with a focus on parasites with differential susceptibilities to piperaquine and artemisinins.  Anal. revealed drug-drug interactions unique to specific genetic backgrounds, including antagonism between piperaquine and pyronaridine assocd. with gene amplification of plasmepsin II/III, two aspartic proteases that localize to the parasite digestive vacuole.  From this initial study, we identified parasite genotypes with decreased susceptibility to specific TACTs, as well as potential TACTs that display antagonism in a genotype-dependent manner.  Our assay and anal. platform can be further leveraged to inform drug implementation decisions and evaluate next-generation TACTs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqNxlcR_dyz0LVg90H21EOLACvtfcHk0ljTdjgkMeu8Yw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXit1SgtbjN&md5=32061e3a74e8faed980d5c1afbb0e937</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1021%2Facsptsci.0c00110&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsptsci.0c00110%26sid%3Dliteratum%253Aachs%26aulast%3DAnsbro%26aufirst%3DM.%26aulast%3DItkin%26aufirst%3DZ.%26aulast%3DChen%26aufirst%3DL.%26aulast%3DZahoranszky-Kohalmi%26aufirst%3DG.%26aulast%3DAmaratunga%26aufirst%3DC.%26aulast%3DMiotto%26aufirst%3DO.%26aulast%3DPeryea%26aufirst%3DT.%26aulast%3DHobbs%26aufirst%3DC.%26aulast%3DSuon%26aufirst%3DS.%26aulast%3DS%25C3%25A1%26aufirst%3DJ.%26aulast%3DDondorp%26aufirst%3DA.%26aulast%3Dvan%2Bder%2BPluijm%26aufirst%3DR.%26aulast%3DWellems%26aufirst%3DT.%26aulast%3DSimeonov%26aufirst%3DA.%26aulast%3DEastman%26aufirst%3DR.%26atitle%3DModulation%2520of%2520Triple%2520Artemisinin-Based%2520Combination%2520Therapy%2520Pharmacodynamics%2520by%2520Plasmodium%2520falciparum%2520Genotype%26jtitle%3DACS%2520Pharmacol.%2520Transl.%2520Sci.%26date%3D2020%26volume%3D3%26spage%3D1144%26epage%3D1157%26doi%3D10.1021%2Facsptsci.0c00110" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-2"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i66"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00034">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_25126"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.1c00034?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00034</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Procedures used for the biological as well as in vitro and in vivo DMPK studies (Supporting Information File 1) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Additional details of the synthetic protocols and compound characterization (Supporting Information File 2) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf">PDF</a>)</p></li><li><p class="inline">SMFA data (Supporting Information File 3) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_003.xlsx">XLSX</a>)</p></li><li><p class="inline">Excel file with molecular strings (Supporting Information File 4) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_004.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_001.pdf">jm1c00034_si_001.pdf (11.98 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_002.pdf">jm1c00034_si_002.pdf (1.81 MB)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_003.xlsx">jm1c00034_si_003.xlsx (605.14 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.1c00034/suppl_file/jm1c00034_si_004.csv">jm1c00034_si_004.csv (8.79 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.1c00034&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-4%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.1c00034%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.1c00034" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                3MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"6799b7454d4fd96e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
